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Biological imaging in the near-infrared (NIR) region is advantageous because: (i) there is low 
biological autofluorescence, (ii) less interaction with and perturbation of biological materials, 
and (iii) NIR light scatters less than visible light.  Several lanthanide cations emit in the NIR and 
in complexes they display: (i) narrow emission bands, (ii) constant emission wavelengths not 
affected by the environment, and (iii) enhanced photostability relative to organic fluorophores.  
Initially we studied the generation-3 poly(amido amine) dendrimer as a platform for organizing 
and sensitizing europium cations.  We demonstrated the capability of this functionalized material 
to preferentially accumulate in tumors and be utilized for both in vivo and ex vivo imaging.  In 
order to more rigidly organize the lanthanides cations we transitioned to using them as the metal 
in metal-organic frameworks (MOFs).  We developed a barcoded MOF, ErxYb1-x-PVDC-1, 
exhibiting enhanced erbium emission relative to Er-PVDC-1, making it a promising material for 
telecommunications devices.  A slight modification to the synthesis yielded a MOF with a 
different crystal structure, Yb-PVDC-3.  The analogous nanoscale version of this MOF, nano-
Yb-PVDC-3 was attained through a reverse microemulsion synthesis.  Altering the ratio of the 
lanthanides in the synthesis resulted in nanoscale barcoded MOFs, nano-NdxYb1-x-PVDC-3, with 
tunable photophysical properties.  The nano-Yb-PVDC-3 was extensively studied for use as a 
biological imaging agent.  It was taken up by cells (HeLa and NIH 3T3) and successfully used 
for live imaging in both the visible and NIR regions.  Focusing on biologically-friendly ligands, 
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va series of size-controllable Yb(BTC)(H2O) MOFs were synthesized using sodium acetate as a 
modulator.  The photophysical properties of these MOFs were not size-dependent, allowing for 
the selection of material based solely on size considerations.  In order to shift the excitation 
wavelength to the NIR region a dye which absorbs at lower energy was incorporated with a 
Yb(BTC)(H2O) nanoMOF to produce a dye-incorporated material.  Despite the incorporation of 
only a very small amount of the dye, its excitation generated sensitized Yb3+ emission.  The dye-
incorporated material was coated with a silica shell to enhance the NIR emission intensity in 
water.  This material has great potential to be used as a biological imaging agent. 
vi
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11.0  INTRODUCTION 
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1.1 NEAR-INFRARED PHOTONS 
The near-infrared (NIR) region of the electromagnetic spectrum is on the lower energy side of 
the visible region; that is to say at wavelengths greater than ~700 nm which cannot be detected 
by the human eye.  The lower energy boundary of the region is less well defined.  The 
Commission Internationale de l’Eclairage (CIE)1 defines it as the 700-1400 nm wavelength 
range; the International Organization for Standardization (ISO)1 specifies the range 780-3000 
nm; the Infrared Processing and Analysis Center (IPAC)2 at the California Institute of 
Technology utilizes the larger region of 700-5000 nm.  For the purpose of this document, the 
NIR range will refer to the region 650-1600 nm unless otherwise stated. 
1.1.1 NIR barcodes and encryption 
Barcodes are optical representations of data, generally relating to the material to which they are 
affixed, which can be read rapidly by a machine.  The most well-known style of barcode is a 
series of parallel vertical black lines on a white background in which the width and spacing of 
each line is varied in order create unique patterns.  This is known as a linear or one-dimensional 
(1-D) barcode.  The barcodes that now appear universally on consumer merchandise are termed 
universal product codes (UPC).3  The first instance of such a barcode being used in a grocery 
store checkout was on a pack of Wrigley’s chewing gum in 1974.3,4  Over time barcodes have 
evolved to include shapes other than lines and have expanded to be two-dimensional (2-D). 
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The universality of these types of barcodes in terms of both generating and reading are 
advantageous in that they allow many users to interface using a common system with well-
developed technology.3  That same universality and ubiquity make them undesirable, however, 
for encryption tags.  There are a multitude of materials that benefit from authentication such as 
identification cards, currency, pharmaceuticals, and military shipments.  In these instances it is a 
security risk for the barcode to be easily reproducible or even noticeable.  For this very reason 
NIR barcodes are being explored. 
NIR emission cannot be detected by the naked human eye, making it impossible to know 
the readout of a NIR barcode without specialized equipment.  Handheld spectrometers are 
becoming more common and should not be a roadblock to utilizing such technology.5,6  Being 
unable to know the readout makes it almost impossible to duplicate the barcode and use it on an 
unauthentic material.  This can help in a variety of areas including reducing forged currency 
being placed into circulation as well as ensuring that pharmaceuticals are untainted. 
1.1.2 NIR biological imaging 
Ideally, all biological imaging would take place in the NIR region of the electromagnetic 
spectrum.  There is a “NIR Window” in which biological species have very little native 
fluorescence (autofluorescence) compared to the ultraviolet (UV) and visible (vis) regions.7,8  
This advantage allows for more sensitive detection as well as easier discrimination of the signal 
from the background.  In the NIR region biological materials have a lower molar absorptivity 
(Figure 1.1) which allows for deeper penetration and leads to less invasive imaging and 
diagnostics.7,8  In addition to NIR light allowing for deeper penetration in tissues, it also provides 
improved resolution optical imaging because NIR light scatters less than visible light.9,10 
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Figure 1.1.  Graphical representation of the reduced absorption of biological materials in the 650-900 nm 
region.  Adapted by permission from Macmillan Publishers Ltd: Nature Medicine (Nat. Med. 2003, 9, 
123-128.), copyright 2003. 
 
 
1.2 LANTHANIDES 
The elements with atomic numbers fifty-seven to seventy-one, lanthanum to lutecium are the 
lanthanides (Ln).  These elements comprise a portion of the larger group of elements known as 
the rare-earths.  With the exception of promethium they are all found in nature, most often as 
ores in the form of lanthanide orthophosphates.11,12  Promethium is not found in nature but as a 
result of the spontaneous fission of 238U and is known to have isotopes ranging from 140Pm to 
156Pm.12  The lanthanides are often present as a mixture in nature and are difficult to separate 
given their similar reactivities.12   
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Figure 1.2.  Lanthanide series. 
 
 
Lanthanide cations (Ln3+) can have coordination numbers that range from three to twelve, 
but eight and nine are the most common for complexes in solution.12  Lanthanide complexes can 
be formed with ligands containing nitrogen, sulfur, and phosphorus, but the most stable 
complexes are formed with ligands that possess oxygen donating groups; Ln3+ acts as a hard 
Lewis acid and forms the most stable bonds with hard Lewis bases.12  The lanthanides are the 
most stable in the tripositive oxidation state (Ln3+), but some lanthanides can also be observed in 
the 2+ oxidation state: Sm2+, Eu2+, and Yb2+, as well as the 4+ oxidation state: Ce4+, Pr4+, and 
Tb4+.12  As the atomic number of the lanthanides increases, the cationic radius (Ln3+) decreases 
from 1.17 Å for lanthanum to 1.00 Å for lutecium in what has been dubbed the “Lanthanide 
Contraction”.12 
1.2.1 Lanthanide luminescence 
The lanthanide cations have the electronic configuration [Xe]4f n where n = 0-14 increasing by 
one electron for each element from lanthanum to lutecium.11-13  These 4f electrons are well 
shielded from external fields by the 5s2 and 5p6 shells, resulting in sharp emission bands that are 
largely unaffected by the environment of the lanthanide.11-13  The lanthanides emit in both the 
visible and NIR regions of the electromagnetic spectrum (Figure 1.3).  Eu3+ and Tb3+ emit in the 
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visible; Nd3+, Ho3+, Er3+, Tm3+, and Yb3+ emit in the NIR; Sm3+, Dy3+ have transitions in both 
visible and NIR domains.11,13-15  
 
 
Figure 1.3.  Normalized emission spectra for selected lanthanide cations.14,15 
 
 
The sharp, distinct bands exhibited by Ln3+ allow for spectral discrimination among 
different lanthanides, whereas organic emission is typically broad (often on the order of 100 nm) 
and consequently more difficult to discriminate.11-13   Lanthanides also have large spectral gaps 
between their excitation and emission bands which prevent re-absorption processes for more 
accurate quantitative detection.11  Lanthanide complexes are not as prone to photobleaching as 
organic fluorophores which allows lanthanide complexes to endure repeated light exposure with 
a negligible loss of signal making them well suited for imaging applications.16  In addition, 
lanthanide complexes have longer lifetimes (micro- to milliseconds) than organic fluorophores 
(nanoseconds) which facilitates temporal discrimination from shorter lived autofluorescence 
(Figure 1.4) and makes them especially advantageous for biological imaging.17 
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Figure 1.4.  Graphical representation of the time delay that can be fixed after the excitation flash during 
spectroscopic measurements to discriminate Ln3+ signal from background autofluorescence as a result of 
the longer luminescence lifetimes of Ln3+.18  
 
 
1.2.2 Antennae effect 
The f → f transitions which occur in Ln3+ are formally LaPorte forbidden.  This first selection 
rule states that transitions are only allowed if there is a change of parity.11,13,19 Therefore, f → f 
transitions are statistically unlikely because of the difficulty of populating their excited states due 
to their small molar absorptivity; however, they are still possible as some parameters will 
decrease the level of forbiddenness.11,13,19  In order to overcome this limitation, energy can be 
transferred to the excited states of lanthanide via the “antenna effect.”20  In this process, a 
chromophore in close proximity to the Ln3+ absorbs as much light as possible and subsequently 
transfers the resulting energy to the accepting excited state of the lanthanides.  The chromophore 
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absorbs a photon of light and promotes an electron to an excited vibrational level of the excited 
electronic state.  There is non-radiative decay to the lowest vibrational level of the excited singlet 
state followed by either emission (fluorescence) or an intersystem crossing to the lower-energy 
triplet state.  Once in the triplet state there is a route for non-radiative decay to the lowest 
vibrational level followed by either emission (phosphorescence) or transfer to the accepting 
excited state of the lanthanide.    The lanthanide excited state can be depopulated through non-
radiative decay or emit via an f → f electronic transition (luminescence).  The most common 
sources of non-radiative decay of the excited state Ln3+ are -OH, -NH, and -CH oscillators.11  
Therefore, an ideal antenna must not only efficiently transfer energy to the Ln3+ but must also 
protect it from solvent molecules. 
 
 
Figure 1.5.  Perrin-Jablonski diagram demonstrating both the mechanism of sensitization of Ln3+ via the 
antenna effect and the potential for relaxation via radiative and non-radiative deactivation. 
 
 
There are three mechanisms of the transfer of energy from the chromophore to the 
lanthanide – Förster, Dexter, and non-concerted electron transfer.  Förster theory21 states that 
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energy transfer takes place through dipole-dipole interactions between a donor and an acceptor, 
and the probability of energy transfer is inversely proportional to R6, where R is the distance 
between the two species.  This mechanism is different from the process of light re-absorption and 
can only take place over limited distances (50-100 Å).  The donor absorbs energy and is excited 
to a vibrational level of the excited electronic state.  Through the process of obtaining thermal 
equilibrium with its surroundings it relaxes to the lowest vibrational level of the excited state 
where it remains for at least 10-8 seconds before relaxing to the ground state.  The acceptor must 
have an absorption transition whose energy matches the emission transition of the donor.  When 
this requirement is met, and there is energetic coupling between the donor and the acceptor, the 
transfer of excitation energy from donor to acceptor takes place.  Dexter theory22 states that 
energy transfer occurs via an exchange interaction through orbital overlap between the donor and 
the acceptor.  This requires the donor and the acceptor to be in much closer proximity than 
necessary for the Förster mechanism.  As most lanthanide cations cannot be reduced due to their 
redox potential, the electron exchange between the donor and the acceptor must be concerted to 
avoid any change in the oxidation state of the Ln3+.  In addition, Dexter’s theory is expanded 
from Förster’s theory to include forbidden transitions. 
For some specific lanthanide cations (Eu, Sm, and Yb) a redox or electron transfer 
mechanism has been used to describe the energy transfer.23,24  In these complexes the excited 
state ligand reduces the Ln3+, so the oxidation potential of the donor and the reduction potential 
of the Ln3+ determine the feasibility of the process.23,24 
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1.2.3 Luminescence quenching 
Not all lanthanides emit with the same intensity.  The strength of emission depends on how 
easily the excited state(s) can be populated and how easily they can be de-populated via non-
radiative decay.11,13  Population of the excited state(s) depends a great deal on the efficiency of 
sensitization by the chromophore.  The ease of non-radiative decay is directly related to the size 
of the energy gap between the accepting level and ground state of the lanthanide.11,13  The 
smaller the gap, the more opportunities for non-radiative decay due to overtones of-CH, -NH, or 
-OH oscillations.  Eu3+ and Tb3+ both have relatively large energy gaps, which is part of the 
reason why extensive work has been done with these lanthanides.11,13,25 
Special attention has been paid to -OH oscillations because of the interaction that occurs 
in aqueous solutions.  It has been shown that the rate of non-radiative deactivation of Ln3+ is 
directly proportional to the number of -OH oscillators in the inner coordination sphere of the 
lanthanide.26-30  Extensive experimental work has been done to develop an empirical relationship 
that helps quantify the number of water molecules interacting in the inner coordination sphere 
(q).31-35 The general equation is11,13: 
CBkkAq ODOH  )( 22  
Equation 1.1. 
where kH2O and kD2O are the deactivation rate constants (which are inversely proportional to the 
observed lifetimes) in H2O and D2O, respectively; and A, B, and C are lanthanide-specific values 
determined experimentally.  A represents the sensitivity to inner sphere quenching, and 
experimentally determined values have been greatly debated in the literature.  C is a constant 
which represents the quenching of outer sphere water molecules.36  The value of B is equal to the 
value of kXH in the equation: 
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CNHnOnNHnOHXHk    
Equation 1.2. 
where α, β, γ, and δ are the respective contributions of the oscillators to deactivation of the 
excited state of a particular Ln3+, and nOH, nNH, and nO=CNH are the number of -OH, -NH, and 
carboxylic oxygens of the amide -NH oscillators that are in the inner coordination sphere of 
Ln3+, respectively.32,34 
1.3 DENDRIMERS 
One way to increase the emitted signals of lanthanide complexes and the corresponding detection 
sensitivity is to create polymetallic complexes which possess a large number of sensitizers per 
unit volume.  This strategy can be achieved by coordinating a large number of emitting 
lanthanide cations within the interior of a dendrimer where their need for a high coordination 
number can be satisfied while placing them in proximity to several chromophores attached to the 
ends of the branches of the dendrimer. 
1.3.1 Dendrimer structure and synthesis 
Dendrimers are a class of highly branched star-like molecules.37-39  There are three main regions 
of a dendrimer: the core, the interior branches (sometimes called the dendritic structure), and the 
terminal functional groups.37,38  At the heart of the dendrimer is the core, from which branches 
extend.  The core plus one series of branches extending from the termini is referred to as 
generation zero (G0) dendrimer.  Adding another series of branches to each of the termini results 
 12 
in a generation-1 (G1) dendrimer.  As the number of generations increase, so too do the number 
of terminal groups. 
Taking the poly(amido amine) (PAMAM) dendrimer39 as an example: the core, 
ethylenediamine, can be seen in Figure 1.6.  
 
 
Figure 1.6.  Ethylenediamine core of the PAMAM dendrimer. 
 
 
Adding branches to the two nitrogen atoms results in a G0 PAMAM dendrimer, which 
can be seen in Figure 1.7.  There are now four terminal amine groups. 
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Figure 1.7.  Structure of G0 PAMAM dendrimer. 
 
 
Adding branches to the terminal amines results in a G1 PAMAM dendrimer, which can 
be seen in Figure 1.8.  There are now eight terminal amine groups. 
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Figure 1.8.  Structure of G1 PAMAM dendrimer. 
 
 
Adding branches to the terminal amines results in a generation-2 (G2) PAMAM 
dendrimer, which can be seen in Figure 1.9.  There are now 16 terminal amine groups. 
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Figure 1.9.  Structure of G2 PAMAM dendrimer. 
 
 
Adding branches to the terminal amines results in a generation-3 (G3) PAMAM 
dendrimer, which can be seen in Figure 1.10.  There are now 32 terminal amine groups. 
 
 15 
H2N
NH2
N
NH HN
H2N
H2N
N
N
NH
HN
O
O
O
O
HN
NH
O
O
H2N
H2N
N
HN
HN
H2N
H2N
N
N N
HN
HN
O
O
O
O
HN
HN
O
O
HN
HN
O
O
H2N
H2N
N
HN
NH
H2N
H2N
N
N
HN
NH
O
O
O
O
NH
HN O
O
H2N
H2N
N
HN
NH
NH2
H2N
N
N
N
HNNH
O
O
O
O
NH
HN
O
O
HN
NH
O
O
N
HN
HN
O
O
NH2H2N
N
HNNH
NH2
NH2
N
N
HN
NH
O
O
O
O
NH
HN
O
O
NH2
NH2
N NH
NH
NH2
NH2
N
NN
NH
NH
O
O
O
O
NH
NH
O
O
NH
NH
O
O
NH2
NH2
N
NH
HN
NH2
NH2
N
N
NH
HN
O
O
O
O
HN
NHO
O
NH2
NH2
N
NH
HN
NH2 NH2
N
N
N
NH HNO
O
O
O
HN
NH
O
O
NH
HN
O
O
N
NH
NH
O
O
 
Figure 1.10.  Structure of G3 PAMAM dendrimer. 
 
 
This process of increasing the number of branches for this particular dendrimer can be 
continued through generation-11 (G11).40 
While perhaps most well-known because of their commercial availability41, PAMAM 
dendrimers are only one of many reported dendrimers.  Based on different chemical 
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functionalities, some examples include: poly(propylene imine) (PPI), poly(propylene amine) 
(POPAM), and poly(ethylene imine) (PEI).37,42 
There are two basic, but fundamentally different, ways of synthesizing dendrimers.  The 
divergent method is similar to the example above in which the dendrimer branches are extended 
outward from the core.38,39,42  This method was initially used to synthesize a series of PAMAM 
dendrimers.39  Conversely, the convergent method starts at the termini and builds toward the core 
of the dendrimer.38,42,43  In this case, several dendritic wedges are synthesized and then 
coordinated to a multi-functional core to deliver a complete dendrimer structure.43  Both methods 
are represented in Figure 1.11. 
 
 
Figure 1.11.  Schematic representation of the divergent (left) and convergent (right) methods for 
synthesizing a dendrimer where the black dots represent the reaction sites.42 
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1.3.2 Dendrimer applications 
Due to the relative ease with which the dendrimer scaffold can be modified to suit a variety of 
purposes and functions, dendrimers have been synthesized and modified for an assortment of 
applications.  They have been used as sensors for metal cations44, inorganic anions45, and small 
organic molecules46.  Amphiphillic dendrimers have been compared to micelles38,47 in that they 
have distinct interior and exterior regions and as such have been used to solubilize both 
hydrophobic48-51 and hydrophilic52-54 molecules and have been explored as vehicles for drug 
delivery49,55-66 and photodynamic therapy65,67-69.  Dendrimers are also being probed for potential 
use in health care applications such a gene therapy65,66,70-72 and as magnetic resonance imaging 
(MRI) contrast agents65,73-76. 
1.3.3 Lanthanide-containing dendrimers 
When used as MRI contrast agents, dendrimers often contain gadolinium ions (Gd3+) which are 
coordinated within the branches.  This strategy has been used with other lanthanides77-82, often 
with a goal of enhanced lanthanide luminescence.  This placement is advantageous in that it has 
the potential for the coordination of multiple lanthanides within a single dendritic architecture 
and helps to protect the lanthanide ions from unfavorable interactions with quenching molecules 
such as water.  In a few cases a single lanthanide cation has been utilized as the core of a 
dendrimer.83-86  In these structures it is possible to determine the exact location of the lanthanide 
cation. 
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1.4 METAL-ORGANIC FRAMEWORKS 
Another way in which the advantageous NIR emission of the lanthanides may be utilized while 
simultaneously fulfilling the requirements of sensitization via the antennae effect and protection 
from quenching vibrations is to use lanthanides as the metal ions in metal-organic frameworks 
(MOFs).  As previously described for dendrimer complexes, MOFs can possess a high density of 
lanthanide cations and sensitizers per unit volume.  In contrast to dendrimer complexes, 
however, it is possible to unambiguously identify the location of each lanthanide within the rigid 
structure. 
1.4.1 Metal-organic frameworks 
MOFs are a class of crystalline solid-state materials consisting of metal ions or clusters that are 
periodically linked together by polytopic organic linkers.  Changing the metal ion, the organic 
linker, or any of the synthetic conditions such as solvent, concentration, time, temperature, 
pressure, or pH can change the composition, structure, and properties of the final material.  Since 
MOFs are crystalline structures it is possible to unambiguously identify the position of every 
single atom, making it easier to fully characterize the material and elucidate structure-function 
relationships.  Due to their modular construction, chemical tailorability, and their intrinsic 
porosity, MOFs have been targeted for applications in gas storage87,88, separations87,88, 
catalysis87-89, sensors90,91, drug delivery88,90,92-94, and biological imaging88,90,92,94,95. 
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1.4.2 Secondary building units 
The rigid metal-carboxylate units that are formed may be referred to as secondary building units 
(SBUs).  SBUs have a definite geometry which can be used to predict possible MOF structures.  
SBUs can be discrete clusters96,97 with distinct geometries including triangles, tetrahedrons, 
octahedrons, and cubes.  As an example, the octahedral Zn4O(CO2)6 unit in MOF-5 (Figure 1.12) 
can be viewed as a “joint.”98,99  These joints are connected together by the benzene ring of 
terephthalate, which can be viewed as a “strut.”99  
 
      
 
Figure 1.12.  The Zn4O(CO2)6 (Zn tetrahedra, blue; O, red sphere; C, gray sphere) SBU and an equivalent 
representation of the SBU as a red octahedron (top).  MOF-5 with the same SBUs linked together by 
benzenes in the terephthalate ligand to form a cubic network (bottom).  Reprinted with permission from J. 
Am. Chem. Soc. 2005, 127, 1504-1518.  Copyright 2005 American Chemical Society. 
 
 
SBUs can also take the form of infinite rods or chains as in MOF-75 (Figure l.13) in 
which eight-coordinate Tb3+ ions are coordinated by four carboxyl groups, one bidentate nitrate 
ligand, and two terminal solvent molecules.99 
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Figure 1.13.  Ball and stick representation of MOF-75 SBU (Tb, blue; O, red; C, black) (left).  SBU with 
Tb shown as blue polyhedra (right).  Reprinted with permission from J. Am. Chem. Soc. 2005, 127, 1504-
1518.  Copyright 2005 American Chemical Society. 
 
 
1.4.3 Organic ligands 
Organic ligands are often chosen based on the structure and function they are anticipated to 
impart to a MOF.  By maintaining the same SBU and altering the linker the pore size can be 
systematically increased as was demonstrated with MOF-5 (IRMOF-1).100  The organic ligand in 
MOF-5 is 1,4-benzenedicarboxylic acid (BDC).98  In a series of syntheses progressively longer 
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ligands were used to generate a collection of MOFs having the same topology, but increasing 
pore dimensions (Figure 1.14).100 
 
 Figure 1.14.  IRMOF-n (n = 1, 8, 10, 12, 14, 16; top to bottom) demonstrating the increase in pore size 
(represented by the yellow sphere) as the organic linker increases in length (Zn, blue polyhedra; O, red 
spheres; C, black spheres).  From Science 2002, 295, 469-472.  Reprinted with permission from AAAS. 
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The same system was used to demonstrate that it is also possible to change the 
functionality of the organic ligand while maintaining the same topology.100  The BDC was 
modified with bromo, amino, n-propoxy, n-pentoxy, cyclobutyl, and fused benzene functional 
groups before being used to synthesize IRMOF-2 through IRMOF-7, respectively, which can be 
seen in Figure 1.15.100 
 
 
Figure 1.15.  IRMOF-1 through IRMOF-7 demonstrating different ligand functionality while maintaining 
the same topology (Zn, blue polyhedra; O, red spheres; C, black spheres; Br, green spheres; amino-
groups, blue spheres in IRMOF-3).  From Science 2002, 295, 469-472.  Reprinted with permission from 
AAAS. 
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1.4.4 Lanthanide metal-organic frameworks 
While MOFs are most commonly constructed using transition metal ions, lanthanide ions have 
also been widely used.90,91,95  The ligands are able to fulfill the high coordination number 
necessary for lanthanide cations (Ln3+) as well as protecting them from quenchers.  Additionally 
the ligands function as antennae and can sensitize multiple lanthanides.  As an example, Serre et 
al.101 synthesized a yttrium MOF, MIL-78, and separately doped in europium (Eu3+), terbium 
(Tb3+), or dysprosium (Dy3+).  Excitation at 252 nm resulted in emission of each of those 
lanthanides (Figure 1.16).   
 
 
Figure 1.16.  Optical emission upon excitation at 252 nm of MIL-78 doped with Eu3+ (left), Tb3+ (center), 
and Dy3+ (right).  Reproduced from J. Mater. Chem. 2004, 14, 1540-1543 with permission of The Royal 
Society of Chemistry. 
 
 
Since all Ln3+ possess similar reactivities it is not uncommon to have a series of 
isostructural MOFs in which the ligand stays constant but a variety of lanthanides are 
independently incorporated.90,95  One such example is a series of 1,3,5-benzenetricarboxylic acid 
(BTC) MOFs with the formula Ln(BTC)(DMF)2·H2O (Ln = Tb, Dy, Ho, Er, Tm, Yb; DMF = 
dimethylformamide).102  The only thing that was altered in each synthesis was the 
Ln(NO3)3·xH2O (Ln = Tb, Dy, Ho, Er, Tm, Yb) salt.  Using the ligand 1,4-benzenedicarboxylic 
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acid (BDC) another series of isostructural MOFs, [Ln2(bdc)(H2O)4]n (Ln = Y, La, Ce, Pr, Nd, 
Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm), were synthesized.103   
MOFs are polymetallic with many Ln3+ per unit volume which enables the system to 
overcome the notoriously small quantum yields of NIR-emitting luminescent lanthanide 
materials.  Often only the luminescence properties of the Eu3+ and Tb3+ MOFs are explored due 
to their prominent visible signals (Figure 1.17).90,95  Gadolinium MOFs, while not luminescent, 
have been explored for their potential as a magnetic resonance imaging (MRI) contrast agents 
(Figure 1.17).104-106 
 
  
Figure 1.17.  Magnetic resonance images of the Gd(BDC)1.5(H2O)2 nanoscale MOF (left).  Luminescence 
images (right) of Gd(BDC)1.5(H2O)2 nanoscale MOF (center, no emission) and the same nanoMOF doped 
with 5 mol % Eu (left, red emission) and 5 mol % Tb (right, green emission).  Reprinted from J. Am. 
Chem. Soc. 2006, 128, 9024-9025.  Copyright 2006 American Chemical Society. 
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1.4.5 Nanoscale metal-organic frameworks 
In order to be most effective for biological applications, such as imaging, MOFs need to be 
nanoscale in size.  Lin’s group achieved the creation of nanoscale MOFs (nanoMOFs) through a 
reverse microemulsion synthesis whereby varying the molar ratio of water to surfactant (W) 
altered the size of the resulting particle (Figure 1.18).104,105,107,108  Other methods that have been 
developed include the use of modulators109-111, microwaves112-114, and sonicators114,115, as well as 
a technique called nanoprecipitation in which a poor solvent is added to the reaction mixture, 
causing the nanomaterials to precipitate.116,117 
 
 
Figure 1.18.  Scanning electron microscopy images of the Gd(BDC)1.5(H2O)2 nanoMOF synthesized with 
different W ratios: W = 5 (left) and W = 10 (right).  Reprinted from J. Am. Chem. Soc. 2006, 128, 9024-
9025.  Copyright 2006 American Chemical Society. 
 
 
In order to increase applicability and water stability, nanoMOFs have been coated in 
silica.107,113,116  This extra layer serves multiple purposes in that it keeps potentially toxic metal 
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ions such as Gd3+ from leaching out of the system as free metal ions as well as making the 
material biocompatible.107  Altering the concentration of the silica reagent and the reaction time 
alters the thickness of the shell.107,113,116 
1.5 THIS DISSERTATION 
In this dissertation we present a series of lanthanide-containing polymetallic species which emit 
in the far red portion of the visible spectrum through the NIR.   
Initially we utilized a dendrimer structure to organize and sensitize Eu3+ ions.  In Chapter 
2 we demonstrate that this material can preferentially accumulate within tumors and is easily 
visualized both ex vivo and in vivo using a variety of methods and techniques.  Unfortunately, 
this structure lacks rigidity making it difficult to determine the exact placement of the 
lanthanides.  
In order to more rigorously organize the lanthanides within an architecture, we 
transitioned to using lanthanides as the metal in MOFs.  In our previous work, a barcoded MOF 
(ErxYb1-x-PVDC-1) in which the molar ratio of lanthanides in the synthesis correlated with both 
the composition and emission intensity of the lanthanide in the MOF was created.  In Chapter 3 
we study the Yb-Er energy transfer in this material that makes it suited for use in 
telecommunication devices. 
In Chapter 4 the same ligand is utilized, but through a slightly different synthesis, a new 
MOF resulted, Yb-PVDC-3.  We then sought to miniaturize the MOFs in order to more 
effectively utilize the NIR emission for biological imaging in living cells.  A reverse 
microemulsion synthesis was employed to generate nano-Yb-PVDC-3 and a series of 
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isostructural barcoded nanoMOFs: nano-NdxYb1-x-PVDC-3 which exhibited the expected Yb3+ 
and/or Nd3+ NIR emission.  The nano-Yb-PVDC-3 was not cytotoxic, was stable in water and 
cell lysate, did not photobleach, and was taken up by HeLa and NIH 3T3 cells.  These factors 
allowed for the use of the nanoMOF for what is believed to be the first demonstration of utilizing 
a nanoMOF for lanthanide NIR imaging in living cells using single photon excitation. 
While the previous results were exciting, the limitations of nano-Yb-PVDC-3 were its 
limited monodispersity and the difficulty in reducing its size below 120 nm.  In Chapter 5, an 
alternate approach was to a switch to the biologically friendly 1,3,5-benezentricarboxylic acid 
(BTC) ligand.  Needle-like Yb(BTC)(H2O) crystals were synthesized following literature 
procedures.  Using a modulator approach to demonstrate size-control, various sizes of nano-
Yb(BTC)(H2O) were achieved, ranging from micro-scale rods all the way down to nanoscale 
spheres.  Regardless of their size, these materials all exhibited similar luminescence properties: 
excitation wavelength, Yb3+ NIR emission, quantum yields, and luminescence lifetimes.  This 
material was most efficiently excited using high energy wavelengths, and that could limit their 
use for biological systems.  We therefore chose to use an alternate chromophore for the 
sensitization of the NIR-emitting Yb3+.  The 4-hydroxyl-1-(4-methyl-2-sulfoanilino)-
anthraquinone, was incubated with the nanoMOF in order to shift the excitation wavelength to 
the NIR region, thereby creating the first nanoMOF material which exhibits both excitation and 
emission in the NIR.  A silica shell was added to further enhance the luminescence intensity in 
aqueous environments. 
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2.0  PREFERENTIAL ACCUMULATION WITHIN TUMORS AND IN VIVO 
IMAGING BY FUNCTIONALIZED LUMINESCENT DENDRIMER LANTHANIDE 
COMPLEXES 
The work presented in this chapter has been published as “Preferential accumulation within 
tumors and in vivo imaging by functionalized luminescent dendrimer lanthanide complexes” in 
Biomaterials, 2011, 32, 9343-9352. 
 
This work was done in collaboration with Chad M. Shade, Hyounsoo Uh, Matthias Bischof, 
Zachary P. Thompson (Stéphane Petoud Research Group, University of Pittsburgh), Marco A. 
Alcala, David L. Bartlett, Charles K. Brown (Department of Surgery, University of Pittsburgh 
School of Medicine), Yong J. Lee (Department of Surgery and Department of Pharmacology, 
University of Pittsburgh School of Medicine), Adam R. Meier, Timothy G. Strein (Department 
of Chemistry, Bucknell University), Ruth A. Modzelewski (Department of Medicine, University 
of Pittsburgh School of Medicine), and Shu Ying Kwan (Department of Biological Sciences, 
Carnegie Mellon University). 
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2.1 INTRODUCTION 
Approximately one-third to one-half of the 150,000 Americans diagnosed with colorectal cancer 
(CRC) each year1 will develop hepatic metastasis, and only about 20% of these patients are 
operable.  The five-year survival rate for patients with liver metastasis without treatment is only 
5%.2  Current therapies for treating metastatic lesions include local tumor ablation (i.e., 
radiofrequency ablation, cryotherapy or direct injection of alcohol or acetic acid directly into the 
metastatic lesions)3, transarterial chemoembolization (TACE)4, embolization with radioactive 
microspheres, surgical resection and/or systemic therapy consisting of chemotherapeutic and 
biological agents5.  While all of these strategies can be used to treat hepatic malignancies, some 
are surgically invasive and others are associated with significant systemic toxicity due to lack of 
tumor-specific accumulation.  However, the attainment of a tumor-specific agent that maximizes 
treatment efficacy while minimizing systemic toxicity remains a difficult feat in cancer 
therapeutics.  
One of our aims is to target with high specificity and image liver tumors in colorectal 
liver metastases with in vivo and ex vivo WAG/RijHsd rat models.  A main requirement to 
achieve the goal of targeting and evidencing liver metastasis is the creation of a luminescent 
reporter that will allow for the preferential accumulation in this type of tumor and which will 
emit a stable luminescence signal that can be discriminated from autofluorescence present in 
biological systems.  In this study we have developed a nanoscale dendrimer that preferentially 
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accumulates within tumors in a rat hepatic metastasis model and demonstrated its capacity to 
optically image liver tumors in vivo. 
Dendrimers are discrete, organized polymers whose versatility in the fields of drug-
delivery, site-specific targeting and labeling have been the subject of many articles and reviews.6-
12  Apart from the core of the dendrimer, the interior branches and surface functional groups 
offer two regions which can be manipulated in a versatile way to meet the needs of the designers, 
such as being functionalized to incorporate luminescent molecules.13  As often observed with 
small organic fluorophores, photobleaching can be a strong limitation by leading to fluorescent 
signal decay thereby preventing their use for long term or repetitive measurements in biological 
applications.  Trivalent lanthanide cations such as europium (Eu3+) have been hypothesized to 
provide a unique solution to prevent/limit the effects of photobleaching.14  In this work, we have 
created a dendrimer-lanthanide complex by attaching luminescent moieties to the surface of the 
dendrimer through the end branches and incorporating Eu3+ cations in the internal sites, and 
demonstrated the unique luminescence stability of this complex and its application in our 
WAG/RijHsd rat models. 
2.2 EXPERIMENTAL 
2.2.1 Reagents 
All reagents were used as received, unless otherwise stated.  Generation-3 poly (amido amine) 
dendrimer (G3 PAMAM) was purchased from Dendritech, Inc.  N,N-dimethylformamide (DMF), 
dimethylsulfoxide (DMSO) and N,N-diisopropylethylamine (DIPEA) were purchased from 
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Sigma-Aldrich.  1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid 
hexafluorophosphate (HATU) was purchased from Aldrich.  Regenerated cellulose membrane 
(nominal molecular weight cut-off 12,000-14,000) was purchased from Fisher Scientific. 
Deuterated dimethylsulfoxide (DMSO-d6; 99.9% D) was purchased from Cambridge Isotope 
Laboratories.  Europium (III) nitrate (Eu(NO3)3; 99.99%) was purchased from Alfa Aesar.  
Ketamine and Buprenorphine were purchased from Bedford Labs.  Acepromazine was purchased 
from Boehringer Ingleheim Vetmedica, Inc.  Dulbecco’s Modified Eagle Medium (DMEM) was 
purchased from Gibco.  Trypsin was purchased from Sigma.   
2.2.2 Synthesis of the generation-3 PAMAM 4-amino-1,8-naphthalimide 
dendrimer containing europium ions (Eu-G3P4A18N)  
Glycine-conjugated 4-amino-1,8-naphthalimide was synthesized by a reported method.15  
Glycine-conjugated 4-amino-1,8-naphthalimide was attached on the amine-terminated G3 
PAMAM dendrimer by a standard amide coupling condition: 54.1 mg (2.00×10-4 mol) of 
glycine-naphthalimide conjugate was added to a solution of 29.4 mg (4.26×10-6 mol) of G3 
PAMAM dendrimer in 5 mL of DMF.  92.1 mg (2.42×10-4 mol) of HATU and 70 mL (52 mg; 
4.0×10-4 mol) of DIPEA were added.  The reaction mixture was stirred at room temperature for 2 
days under nitrogen atmosphere while monitoring the disappearance of G3 PAMAM dendrimer 
by thin layer chromatography (TLC).  The compound was purified by dialysis using a 
regenerated cellulose membrane in DMSO for 3 days.  The solution recovered from the dialysis 
membrane was dried in a vacuum oven (40 °C, 50 mbar) to yield G3P4A18N as a brown solid 
(52.5 mg, 82%).  1H NMR (300 MHz, DMSO-d6, δ): 8.54 (br s, 32H), 8.32 (br s, 32H), 8.15 (br 
s, 32H), 8.10 (br s, 32H), 7.90 (br s, 32H), 7.76 (m, 28H), 7.56 (br s, 32H), 7.40 (br s, 64H), 6.78 
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(br s, 32H), 4.56 (br s, 64H), 3.08 (m, 184H), 2.61 (m, 120H), 2.39 (m, 60H), 2.16 (m, 120H) 
(Figure 2.1).  Elemental analysis (EA) calcd for C750H864N186O156·32DMSO·64H2O: C, 52.47; H, 
6.40; N, 13.98.  Found: C, 51.74; H, 6.29; N, 13.76.  The Eu3+ complex of G3P4A18N (Eu-
G3P4A18N) was synthesized with the following method adapted from one of our procedures16: 
22.67 mg (1.513×10-6 mol) of G3P4A18N was dissolved in 10 mL of DMSO.  647.5 mL of 18.7 
mM Eu(NO3)3 solution in DMSO (1.21×10-5 mol) was added to the dendrimer solution.  The 
mixture was diluted to 25.00 mL and incubated at room temperature for 7 days.  The resulting 
solution (60.5 mM) was used as obtained. 
 
 
Figure 2.1.  1H-NMR spectrum and peak assignment for G3P4A18N in DMSO-d6. 
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2.2.3 Mobility determination by capillary zone electrophoresis 
The Eu-G3P4A18N dendrimer samples were characterized with electrophoretic analysis by 
capillary zone electrophoresis (CZE) with diode array ultraviolet (UV) absorbance detection with 
an Agilent CE system (Agilent Technologies).  A 75.0 mm interior diameter unmodified fused 
silica capillary (Polymicro Technologies) 34.0 cm in total length and 8.5 cm to the detector 
(short end) was employed.  The background electrolyte was 40 mM phosphoric acid in 30% 
DMSO and 70% 18 MΩ-cm water at pH of 2.3. Each day prior to use, the capillary was 
preconditioned with 1 M sodium hydroxide (NaOH) for 5 minutes, 18 MΩ-cm water for 15 
minutes, and running buffer for 15 minutes.  The capillary was flushed with running buffer for 2 
minutes in between analysis.  A separation potential of 17.0 kV was employed and a co-flow 
pressure of 10 mbar was also applied during the electrophoresis.  Dendrimer samples were tested 
at a concentration of 3 mg/mL in DMSO.  Hydrodynamic injection (50 mbar, 1.5 s) was 
employed, and the capillary was maintained at 25 °C.  Detection was performed at 450 nm and 
280 nm, and ultraviolet-visible (UV-vis) spectra were collected for each peak.  A small co-flow 
pressure of 10 mbar during electrophoresis was needed to reliably detect the neutral zone 
corresponding to the DMSO from the injection plug, and the migration time for this solvent zone 
was used to calculate the electroosmotic mobility of the system. 
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2.2.4 Spectroscopic characterization of Eu-G3P4A18N 
Absorption spectra were recorded on samples in a PerkinElmer Lambda 9 BX Spectrometer, 
coupled with a personal computer using software supplied by PerkinElmer.   
Steady-state emission and excitation spectra were analyzed using a modified Horiba 
Jobin Yvon Spex Fluorolog-322 Spectrofluorometer coupled to a personal computer with 
software supplied by Horiba Jobin Yvon Inc.  Emission and excitation spectra were corrected for 
the instrumental function.  Samples were placed in 1 mm quartz fluorescence cells purchased 
from NSG Precision Cells, Inc. 
The Eu3+ luminescence lifetime measurements were performed using a neodymium 
yttrium aluminum garnet (Nd:YAG) Continuum Powerlite 8010 laser (354 nm, third harmonic) 
as the excitation source.  Emission was collected at a right angle to the excitation beam, and 
signals arising from the 5D0 → 7F2 Eu3+ transition (615 nm) were selected by a Spectral Products 
CM 110 1/8 m monochromator.  The signal was monitored using a Hamamatsu R928 
photomultiplier coupled to a 500 MHz bandpass digital oscilloscope (Tektronix TDS 754D).  For 
each flash, the experimental decay was recorded with a resolution of 50,000 points.  To minimize 
experimental contribution, signals from >1000 flashes were collected and averaged.  
Luminescence decay curves were analyzed with Origin 7.0 software.  The experimental decay 
curves were fitted to single, double, and triple exponential models using the Chi-squared criteria 
to discriminate the best exponential fit.   Four independent decay curves were collected for the 
sample. 
For the photobleaching experiments, approximately 0.9 mL of each solution (0.2 mM in 
30% DMSO/H2O) was transferred into a 0.9 mL semimicro absorbance cuvette supplied by 
Varian (catalog number 66-100127-00).  The cuvette was stoppered and parafilmed at the 
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beginning of each trial to prevent solvent evaporation.  Photobleaching was quantified with a 
PerkinElmer UV/Vis, collecting at 240 nm/min scan rates.  Samples were exposed to white light 
from the Xenon lamp of the Horiba Jobin Yvon Spex Fluorolog-322 Spectrofluorometer in-
between scans.  A water circulator was used to maintain constant room temperature (23 °C) 
within the fluorimeter during long periods of exposure. 
For the quantum yield experiments, spectra were collected and analyzed using the Horiba 
Jobin Yvon Spex Fluorolog-322 fitted with an integrating sphere17 using quartz tubes as sample 
holders.  A 20 mM solution of Eu-G3P4A18N in 30% DMSO/H2O was used for this analysis, 
and all spectra were corrected for the response of the lamp before integration of the signals.  
Integrated values were used to determine the quantum yield by calculating the ratio of the 
number of photons emitted by the sample divided by the number photons absorbed by the 
sample. 
2.2.5 Animals 
Four- to six-week-old male WAG/RijHsd rats were purchased from Harlan, Netherlands.  Rats 
were fed ad libitum and maintained in environments with controlled temperature of 22-24 °C and 
12 hour light and dark cycles.  All procedures involving the rats were in accordance with the 
Guide for the Care and Use of Laboratory Animals (National Research Council, 1996) and on a 
protocol approved by the Institutional Animal Care and Use Committee of the University of 
Pittsburgh. 
 41 
2.2.6 Generation of colorectal metastasis by single tumor implantation 
While others have initiated colorectal metastasis by injecting cancer cells via the portal vein, 
superior mesenteric vein18 or spleen19, these approaches lead to small diffuse lesions which are 
difficult to study20.  We generated the isolated hepatic colorectal metastasis model by way of 
implanting CC531 tumor pieces into rat livers.  Fourteen twenty-to-thirty-week-old 
WAG/RijHsd rats were anesthetized with a single intraperitoneal injection of 70 mg/kg of 
Ketamine and 2.5 mg/kg of Acepromazine.  An intramuscular injection of 0.1 mg/kg of 
Buprenorphine was also administered for analgesia prior to incision.  Following midline incision, 
CC531 tumor nodules (1 × 2 mm weighing 25 mg) were implanted in the subcapsular area of the 
left lateral lobe (LLL) of the rat.  These implanted tumor nodules were isolated from CC531 
tumors grown hepatic implants in WAG/RijHsd rats.  The tumors were placed about 5 mm deep 
to the subcapsular area of the LLL of the liver where it was easily found 20-30 days later when 
the rat underwent a second laparotomy for gastroduodenal artery (GDA) cannulation and hepatic 
infusion of the Eu-G3P4A18N solution. 
2.2.7 Cell culture and generation of colorectal metastasis by splenic injection 
CC531 cell line is a moderately differentiated colon adenocarcinoma syngeneic to WAG/RijHsd 
rats.21  Tumor cells were tested and found to be virus- and mycoplasma-free.  CC531 cells were 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine 
serum.  Cells were maintained by serial passage.  Tumor cells were then harvested with a 
solution of 0.25% trypsin, washed three times in 0.9% NaCl solution buffered with 1.4 mM 
phosphate (PBS), and adjusted to a suspension containing 2×106 viable (trypan blue exclusion 
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test) tumor cells per 200 mL of PBS, which were then injected into the spleen to generate 
metastatic tumor nodules in the liver.  Metastatic lesions to the liver were observed 20-25 days 
later after a midline incision was performed. 
2.2.8 Luminescence imaging of hepatic tumors 
In vivo administration of the Eu-G3P4A18N (300 mL of a 60 mM solution in 10% DMSO/H2O) 
was captured as it was being infused and selectively associating with the liver tumor.  The 
imaging system used to detect the luminescence of the dendrimer is custom-made, combining 
either a Andor DU 434-BR-DD cooled charge coupled device (CCD) camera (Andor 
Technology; South Windsor, CT, USA) or Rolera XR fast digital CCD camera (QImaging; 
Surrey, Canada) fitted with a 50 mm AF Nikkor lens containing a minimum aperture of F16 and 
maximum aperture of F1.4.  The emission filters used were 610/30 nm and a 740/140 nm cutoff 
in wavelength (Chroma Technologies).  The rat livers on living animals were excited using four 
5 Watt LEDs emitting at 450 nm (Lumileds Lighting).  Qcapture software (QImaging) was used 
for the data acquisition. 
Luminescence imaging of 10 mm tumor sections following hepatic arterial infusion of 
functionalized dendrimers was accomplished with an Olympus FV1000MPE multi-photon laser-
scanning unit fitted to an IX81 microscope (Olympus Corp.).  Illumination for two-photon 
excitation at 820 nm was provided by a mode-locked Chameleon Ultra Ti:Sapphire laser 
(Coherent, Inc.).  An Olympus 25× objective with N.A. of 1.05 was used to acquire images.  
Luminescence emission was collected with an external photomultiplier tube using a 570-625 nm 
bandpass filter.  Scan resolution was set to 1024 × 1024 pixels at 4096 grey scales. 
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2.2.9 Histopathology of liver tumor sections 
Tissue sections (10 microns) from dendrimer-infused livers were also processed for routine 
hematoxylin and eosin (H&E) and immunohistochemistry staining.  Tissues were fixed with 2% 
paraformaldehyde for 2 hours at 4 °C, and then left overnight in 30% sucrose at 4 °C.  The 
samples were frozen in a liquid nitrogen-cooled bath of 2-methyl-butane and cryosectioned.  
Sections were labeled with monoclonal CD31 (ABR MA1-26196) and Alexa Fluor 647 
phalloidin (Invitrogen A22287).  Goat anti mouse Cy3 secondary antibody for CD31 and DAPI 
followed.  Images were then recorded on an Olympus FV1000 confocal microscope. 
2.3 RESULTS AND DISCUSSION 
2.3.1 Functionalized dendrimer with Eu3+ 
We have designed and synthesized a nanoscale dendrimer complex that achieves site-specificity 
requirements and tested its use in live animal imaging.  The dendrimer provides a versatile 
organic framework to which multiple fluorophores have been covalently attached. Connecting 
organic fluorophores to the surface of the dendrimer can drastically improve the stability of the 
association when compared to occupying the interior cavities and being secured through 
secondary interactions.  As a luminescent moiety, we have chosen 4-amino-1,8-naphthalimide 
since this molecule is hypothesized to emit a significant amount of photons in the red/near-
infrared region of the electromagnetic spectrum.  Such emission wavelengths allow for sensitive 
detection due to the absence of native fluorescence of biological systems in this spectral region 
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(improvement of the signal-to-noise ratio).  Higher generation dendrimers have a larger number 
of terminal branches, which correlates to the number of fluorophores which can be substituted on 
the surface of each dendrimer, thereby increasing the overall absorptivity and number of emitted 
photons per unit volume and further improving signal intensity. 
Figure 2.2.  The chemical structure of the Eu-G3P4A18N dendrimer. Substitution of the end branches is 
designated by R, glycine-conjugated 4-amino-1,8-naphthalimide (shown at the bottom right corner).  The 
gray spheres indicate the hypothesized coordination of eight lanthanide cations (Eu3+) within the 
dendrimer nanocomplex (modified dendrimer size approximately 3 nm). 
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By providing alternate routes of energy transfer with respect to photoreaction, 
luminescent lanthanide cations such as Eu3+ are hypothesized to partially depopulate the excited 
state(s) of fluorophores when the donor-acceptor energy levels are sufficiently well matched, 
thereby preventing significant photobleaching from occurring.  Poly(amido amine) dendrimers 
(PAMAM) contain numerous binding sites along the alternating amide bond architecture of their 
arms, a requirement for coordinating metal cations.22  A lanthanide complex was based on a 
generation-3 PAMAM dendrimer (G3 PAMAM or G3P), capable of coordinating multiple Eu3+ 
cations within the interior.  The 32 amino end branches of the generation-3 dendrimer were 
functionalized with 4-amino-1,8-naphthalimide fluorophores (4A18N) using glycine linkers to 
yield the functionalized dendrimer: generation-3-PAMAM-(glycine-4-amino-1,8-
naphthalimide)32 (G3P4A18N).  The complete functionalization of each dendrimer branch was 
confirmed by 1H NMR and elemental analysis (see Section 2.2.2).  Eight Eu3+ cations were 
coordinated within the branches to yield the Eu3+ complex Eu-G3P4A18N by following a 
procedure that we have previously developed for a dendrimer carrying different fluorophores16.  
Capillary zone electrophoresis (CZE) analysis of the Eu-G3P4A18N dendrimer with detection at 
450 nm gave rise to one major peak with a cationic electrophoretic mobility of 1.39×10-4 cm2/Vs 
(Figure 2.3).  A minor component present in some samples represented no more than 7% by peak 
area and had a mobility of about 6.8×10-5 cm2/Vs.  The UV-vis spectrum obtained from the 
major peak is consistent with the expected spectrum for the dendrimer.  These data are consistent 
with a well-defined species not indicating any significant dispersity.  The chemical structure of 
Eu-G3P4A18N is depicted in Figure 2.2.  The substitution of end branches is designated by “R”, 
defined in the lower right corner with glycine-conjugated 4A18N.  The gray spheres indicate the 
hypothesized coordination of the lanthanide, Eu3+, within the dendrimer nanocomplex.  
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Figure 2.3.  Electropherogram of Eu-G3P4A18N obtained at 450 nm upon CZE analysis of 3 mg/mL (in 
DMSO) sample of Eu-G3P4A18N.  Peak 1 corresponds to the dendrimer; Peak 2 reveals the presence of 
an impurity; Peak 3 is DMSO solvent zone (to mark flow).  The insets are UV-vis spectra collected from 
peaks 1 and 3. 
 
 
The absorption spectrum indicates an apparent maximum at approximately 440 nm 
(Figure 2.4, dotted line); however, it is worth noting that the compound does absorb significantly 
at longer wavelengths.  The molar extinction coefficient is 5000 cm-1mol-1L at 630 nm, which is 
almost two times larger than that of Photofrin at the same wavelength23.  Absorption at longer 
wavelengths is attractive for biological imaging since photons at these wavelengths generate very 
little autofluorescence and are not harmful for biological systems, preventing any perturbation of 
the system to be monitored.  The luminescence emission spectrum indicates the presence of a 
prominent broad band with a significant component in the red/NIR part of the electromagnetic 
spectrum (Figure 2.4, solid line). 
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Figure 2.4.  Spectra of the Eu-G3P4A18N dendrimer complex used for luminescence imaging 
experiments. The luminescence emission spectrum (λex = 452 nm, solid line) displays a prominent band 
with an intensity maximum at 550 nm and a tail extending into the red/NIR part of the spectrum.  The 
shaded area of the emission spectrum indicates the luminescence signal detected during the confocal 
microscopy experiments.  A steady-state excitation spectrum (λem = 555 nm, dashed line) collected upon 
monitoring the maximum intensity of the luminescence band, overlaps significantly with the absorption 
spectrum (dotted line). 
 
 
The collection of luminescence lifetime measurements arising from Eu3+-centered 
emission was made possible with the help of the spectroscopic resolution of a laser exciting at 
354 nm.  A monoexponential decay of 1.09(±0.03) ms was fitted best from the experimental 
decay curve.  This value is in good agreement with comparable systems16 and provides good 
evidence that each of the eight Eu3+ cations located within the dendrimer are both well protected 
and are surrounded by a similar coordination environment inside the dendritic architecture.  The 
similar coordination environment around each of the lanthanide cations is a strong indication that 
only one well-defined species is present in solution.  Polydispersity would result in several 
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luminescence lifetimes as these cations are highly sensitive to their environment.  The quantum 
yield of the compound upon excitation at 450 nm is 2.9(±0.1)%.  This value is relatively low, but 
the overall sensitivity provided by the imaging agent will be related to the number of emitted 
photons per unit of volume and, in this case, the small quantum yield will be compensated by the 
high density of luminescent 4-amino-1,8-naphthalimide groups. 
When specific conditions are met, the electronic structures of lanthanide cations are 
hypothesized14 to stabilize the excited states of organic fluorophores against photobleaching.  To 
analyze this hypothesis, the absorbance of the 1,8-naphthalimide derivative was monitored as a 
function of time upon exposure to white excitation light (Figure 2.5).  In the absence of Eu3+, the 
absorbance of G3P4A18N decreased exponentially.  This behavior indicates that the 
fluorophores are vulnerable to photobleaching.  In the presence of Eu3+, the absorbance of Eu-
G3P4A18N experienced a modest decrease within the first hour of exposure to white light; 
however, the absorbance maintained constant values for the remainder of the experiment.  
Indeed, the exciting side-by-side comparison depicted in Figure 2.5 lends evidence to the idea 
that the eight Eu3+ provide increased stabilization to the electronic structure of the thirty-two 4-
amino-1,8-naphthalimide fluorophores (singlet and triplet states).  This feature is advantageous 
for applications, allowing for an extended shelf life, longer exposure time to excitation light, and 
repeatability of experiments.  Such stabilization for a molecular complex in solution has been, to 
the best of our knowledge, only reported in one previously published article.14 
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Figure 2.5.  Photobleaching analysis of the Eu-G3P4A18N dendrimer complex used in luminescence 
imaging experiments.  The absorbance of G3P4A18N was monitored as a function of time upon exposure 
to white light.  In the absence of Eu3+ (open circle), the absorption decreased exponentially for the 
duration of the experiment, leading to an overall decrease approaching 30%.  The trend observed in the 
presence of Eu3+ (filled square) was a modest decrease in absorbance during the first minutes, followed by 
an impressive level of stability for the same duration. 
 
 
We plan to analyze more deeply this exciting phenomenon in order to obtain control of it.  
We will test the different luminescent lanthanide cations to identify the one that is the most 
efficient.  These future experiments will be useful for elucidating the underlying mechanism of 
chromophore stabilization. 
2.3.2 Hepatic arterial infusion of Eu-G3P4A18N 
Regional hepatic delivery of Eu-G3P4A18N was made possible by infusion via the 
gastroduodenal artery (GDA) of 160-330 gm WAG/RijHsd rats.  This technique involves the 
 50 
isolation of the vasculature of the liver by clamping closed the common hepatic artery, portal 
vein and infra-hepatic inferior vena cava (Figure 2.6).  A polyethylene 10 (PE-10) catheter was 
inserted retrograde into the GDA for a length of approximately 4 mm and secured with two 6-0 
silk sutures (Figure 2.7).  Infusion of 7 mL of 100 units/mL of heparinized normal saline was 
made into the GDA of a live WAG/RijHsd rat to temporarily evacuate the hepatic blood volume 
prior to delivery of the functionalized dendrimer complex.  To demonstrate its preferential 
accumulation in tumors, Eu-G3P4A18N (0.8 mg/g total body weight) was infused through the 
GDA followed by 5 mL of normal saline to ensure full distribution of the dendrimer into the 
liver.  The liver was excised following infusion to evaluate the luminescence signal emitted by 
the Eu-G3P4A18N in the tumor and the background liver parenchyma. 
 
 
Figure 2.6.  Diagram of the GDA cannulation illustrating the isolation of the liver with clamping of the 
major vessels: portal vein, infra-hepatic inferior vena cava, and the common hepatic artery.  The 
cannulation is indicated by a syringe and catheter leading into the site of the GDA. 
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Figure 2.7.  Cannulation of the GDA.  A 1 mm polyethylene catheter was inserted into the GDA (white 
arrow) and then secured with two 6-0 silk ties (yellow arrow).  The hepatic artery was isolated with a silk 
tie (blue arrow). The portal vein was also isolated using a silk tie (green arrow).  The liver is shown above 
with the dome of the left lateral lobe (LLL) reflected at the top of the photo and the right medial lobe 
(RML) immediately to the left of the LLL.  Liver is being shown in the anterior to posterior view. 
 
 
2.3.3 Ex vivo imaging of Eu-G3P4A18N infusion 
Imaging of ex vivo rat livers demonstrated that high-intensity luminescence was observable in 
the tumors only seconds following an ex vivo Eu-G3P4A18N infusion (Figure 2.8) when 
observing emission signals at 610 nm or at 740 nm.  Although some minor uptake by the non-
tumorous portion of the liver was observed, these background signals were negligible in the 
red/NIR range of imaging.  In animals with extra-hepatic intra-abdominal tumor deposits, no 
luminescence was observed in these tissues (data not shown).  To confirm that Eu-G3P4A18N 
enhancement is occurring specifically in the tumor tissues, histological evaluation of the 
luminescent foci demonstrated that they were adenocarcinomas (Figure 2.9). 
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Figure 2.8.  A cannulated ex vivo liver infused with Eu3+, G3P or Eu-G3P4A18N with luminescence 
imaging and analysis.  Left: White light image of an ex vivo liver with an established tumor implant.  The 
white circle indicates the location of the tumor within the liver.  Right: Luminescence image (λex = 450 
nm, λem = 610/30 nm) of liver after Eu-G3P4A18N infusion.  The circle shows the luminescence emitted 
by the tumor area only seconds after infusion of the Eu-G3P4A18N complex. 
 
 
 
 
Figure 2.9.  20× Hematoxylin and eosin (H&E) stained section of the tumor from the same liver showing 
the transition zone between adenocarcinoma on the left and normal liver parenchyma on the right of the 
solid black line. 
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To verify that Eu-G3P4A18N has the exclusive capacity to label tumors in the liver, rat 
livers were infused in vivo with Eu3+ cations only, dendrimers without Eu3+ or naphthalimide 
(G3P), or Eu-G3P4A18N.  Figure 2.10 demonstrates the gross and luminescence images of the 
livers infused with the three different molecules or cations.  The Eu3+-only infusion and the 
dendrimer-only infusion both show minimal or no luminescence arising from the tumor when 
compared to the tissue autofluorescence.  However, intrahepatic Eu-G3P4A18N infusion 
demonstrated specific higher intensity luminescence in the tumor.  These data are represented 
quantitatively in Figure 2.10.  
 
 
Figure 2.10.  Gross photographs (top row) and luminescence images (bottom row) of the livers 
containing tumors (arrows) that were implanted 20–30 days prior to infusion and excised at 0 hour time 
point.  Images are from liver infused with Eu3+ only (first column), G3P (non-functionalized dendrimer 
without Eu3+; second column), or Eu-G3P4A18N (third column).  Average tumor luminescence was 
corrected for background autofluorescence in the resulting graph.  Asterisks represent specular reflection 
of the liver.  Scale bars represent 1 cm. 
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2.3.4 Multiple tumor imaging with Eu-G3P4A18N 
Multiple metastatic tumor nodules were generated in a rat liver via a splenic injection of CC531 
colorectal cancer cells.  After infusion of Eu-G3P4A18N, the rat liver was excised and imaged 
by luminescence.  Figure 2.11 (top row) shows the gross and corresponding luminescence 
photographs of an ex vivo liver.  This liver was used as a control and was not infused with the 
dendrimer complex to demonstrate that the metastatic tumor nodules themselves have minimal 
native fluorescence within the spectral region of detection (595-625 nm).  Figure 2.11 (bottom 
row) presents the gross and corresponding luminescence photographs of another ex vivo rat liver 
with metastatic lesions.  The metastatic nodules display a more intense luminescence signal than 
the background after infusion of Eu-G3P4A18N. 
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Figure 2.11.  Colorectal metastasis to the liver without (top row) and with (bottom row) infusion of Eu-
G3P4A18N.  In the top row arrows show tumor nodules in the liver of a rat generated after a splenic 
injection of CC531 tumor cells.  No dendrimer was infused into this liver.  The second image shows the 
absence of luminescence in the nodules.  In the bottom row arrows show metastatic lesions in another 
liver of a rat from a splenic injection of CC531 tumor cells.  The liver was infused with Eu-G3P4A18N 
(300 µL of a 60 µM solution in 10% DMSO/H2O).  Luminescence images (λex = 450 nm, λem = 610/30 
nm) were taken with a Rolera XR NIR-sensitive CCD camera. 
 
 
2.3.5 Retention time of the Eu-G3P4A18N in tumors 
To determine the retention time of the dendrimer in the tumor post-infusion, rats were injected 
intrahepatically with Eu-G3P4A18N and sacrificed at the following time points: 0 hours, 4 
hours, 24 hours, and 72 hours (Figure 2.12).  Sustained luminescence signals from the tumors 
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were observed at every time point post-infusion.  Background autofluorescence of the liver was 
accounted for and the resulting bar graph (Figure 2.12) demonstrates quantitatively that signals 
from the tumors were present up to 72 hours post injection. 
 
 
Figure 2.12.  Gross and luminescent photographs of tumors located in the livers of rats with analysis of 
the tumor luminescence.  Gross (top row) and luminescent (bottom row) images of the livers containing 
tumors (arrows) that were implanted 20–30 days prior to infusion and excised at 0 hour, 4 hour, 24 hour, 
and 72 hour time points after hepatic infusion with Eu-G3P4A18N.  Average signals obtained from the 
tumors were compared to that of tissue autofluorescence and displayed in the resulting graph.  Asterisks 
represent specular reflection.  Scale bars represent 1 cm. 
 
 
2.3.6 In vivo imaging of the Eu-G3P4A18N infusion 
To evaluate the preferential accumulation in tumors of our functionalized dendrimer in vivo, in 
vivo intrahepatic infusion of Eu-G3P4A18N in anesthetized rats (Figure 2.13) was performed.  
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Localized luminescence was observed in the tumor tissues within seconds following the 
beginning of the infusion. This result is consistent with our previous observations in the ex vivo 
setting. The infused liver was excised and sectioned for red/NIR microscopy. We found that the 
signal-to-noise ratio was improved when luminescence was detected at 740/140 nm (image not 
shown) as compared to 610/30 nm. 
 
 
Figure 2.13.  In vivo colorectal hepatic tumor localization after the infusion of Eu-G3P4A18N and 
histological imaging using confocal and multi-photon scanning microscopy.  Left: White light photograph 
of an in vivo rat liver containing a tumor.  Center and Right: Luminescent images (λex = 450 nm, λem = 
610/30 nm) of the abdominal cavity of the rat before (center) and after (right) Eu-G3P4A18N infusion. 
 
 
The use of a two-photon excitation scanning confocal microscope allowed us to confirm 
that the luminescence signal of the dendrimer was present within the vasculature of the liver 
(Figure 2.14, left).  Higher magnifications of the tissue sections revealed that the luminescence is 
located outside of the vessels in the perivascular space (Figure 2.14, right).  Figure 2.15 also 
show a section of tumor from a rat liver that was infused with Eu-G3P4A18N displaying the 
same association of the dendrimer with the vasculature under confocal microscopy.  Tumor 
vasculature is disorganized and displays widened inter-endothelial junctions and fenestrae that 
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range from 400 to 800 nm in size.24  Thus, tumor vasculature is often described as “leaky”, 
allowing for larger molecules to extravasate the vascular endothelium into the extravascular 
space and in the process bypass normal liver parenchyma.  The relatively small size of our 
dendrimer25 facilitates its exit through the fenestrae and allows it to be trapped in the 
extravascular spaces of the tumor.  The confocal microscopy observations are consistent with the 
hypothesis that the Eu-G3P4A18N complex has increased extravasation from the leaky tumor 
vasculature and, therefore, is more likely to be trapped in the perivascular spaces of the tumor. 
 
 
Figure 2.14.  Left: 20× confocal microscopic image of a section of liver without the tumor after Eu-
G3P4A18N infusion, no luminescence of the dendrimer is observed (λex = 488 nm, λem = 567 nm).  
Vessels are labeled with CD-31 (red), nuclei of hepatocytes with DAPI (blue) and dendrimer (green).  
Right: Eu-G3P4A18N can be seen in green (arrows) with the 40× magnification of a confocal 
microscopic image of tumor in the liver after infusion.  The same colored labels are used. 
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Figure 2.15.  Left: 25× magnification of a tumor section in a rat liver after infusion of Eu-G3P4A18N 
(two-photon λex = 820 nm, λem = 570–625 nm).  The nuclei of cancer cells are seen in blue, the aberrant 
vessels are depicted in red, and the dendrimer is designated in green (arrows) to show the association of 
Eu-G3P4A18N with the tumor vasculature seen in red.  Right: 60× magnification of another section of 
tumor within the same liver also demonstrating the same concept. 
 
 
2.4 CONCLUSION 
We have designed and synthesized a luminescent marker based on a generation-3 dendrimer 
covalently substituted with thirty-two luminescent 4-amino-1,8-naphthalimide groups via glycine 
linkers, and complexed with eight equivalents of trivalent europium cations (Eu-G3P4A18N).  
The large number of luminescent groups results in more sensitive detection due to the large 
number of fluorophores per unit volume.  Lanthanide cations coordinated within the dendrimer 
branches allow for stabilization of the fluorophores against photobleaching and result in a robust 
luminescent marker.  These unique properties make real-time luminescence imaging of hepatic 
tumors in the WAG/RijHsd rat model possible.  We have observed that the luminescence located 
in the tumor was visible within seconds following hepatic arterial infusion of the dendrimer.  
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This rapid visualization compares favorably with other fluorescent agents such as pH sensitive 
fluorescent markers26, the incorporation of which may take hours in order to achieve observable 
fluorescence, or green fluorescent proteins (GFPs) and luciferase-based strategies where there is 
also limited control over the timing of the genetic expression.  In addition, luciferase-based 
strategies require tumor cells to express this gene prior to inducing tumors, a method that is not 
compatible with clinical studies.  Moreover, small molecule fluorophores such as fluorescein and 
cyanine dyes tend to photobleach rapidly, thus limiting their usefulness in the diagnostic setting. 
Our modified dendrimer complex25 is significantly smaller than the 100 nm and 300 nm 
sized nanoparticles used in other tumor detection studies27, minimizing disturbance of the 
biological system to be observed.  Size-specificity is advantageous for improved distribution, 
thereby maximizing potential tumor tissue penetration and preferential accumulation.28  In our 
proposed metastatic tumor model, we have demonstrated our ability to unambiguously detect the 
presence of a tumor within seconds post-infusion and up to 72 hours in vivo within the liver 
tumor tissue.  The enhanced viability of the luminescent dendrimer complex localized within 
tumor tissue avails the strategy to multiple potential clinical applications in both imaging and 
therapeutic settings.  As demonstrated in this study, by utilizing the nanoscale size and 
photophysical stability of the Eu3+ dendrimer complex, we were able to preferentially 
accumulate within and image tumor tissue in our rat hepatic metastasis model with near-infrared 
imaging. 
Peptide molecules, such as the RGD peptide29,30, and tumor-specific antibodies have been 
demonstrated to have tumor targeting specificity31-33.  The attachment of such peptide and 
antibody entities to the dendrimer complex described in this report is anticipated to further 
improve preferential accumulation within tumors.  The synthetic versatility of our functionalized 
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dendrimer platform allows us to adapt this preferentially-accumulating system to address a wide 
array of biological questions.  For example, coordination of a radionuclide such as yttrium-90 by 
our dendrimer should allow for targeted delivery of radiotherapeutic agents to the interior of 
tumors.  The many opportunities which exist for modifying the dendrimer platform will lead to a 
broad field of applications in detecting and monitoring biological events. 
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3.0  YB TO ER ENERGY TRANSFER WITHIN A METAL-ORGANIC 
FRAMEWORK FOR TELECOMMUNICATION DEVICES WITH ENHANCED 
ERBIUM EMISSION 
This work was performed in collaboration with Kiley A. White (Nathaniel L. Rosi Research 
Group, University of Pittsburgh), Demetra A. Czegan (Stéphane Petoud Research Group, 
University of Pittsburgh), and Svetlana V. Eliseeva (Centre de Biophysique Moléculaire, Centre 
National de la Recherche Scientifique, Orléans, France). 
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3.1 INTRODUCTION 
The luminescent lanthanide erbium has been widely studied for practical use in photonic 
materials and optical telecommunication devices.1,2  Due to the shielding of the 4f electrons by 
the 5s and 5p electrons the atom-like, sharp emission bands of the lanthanide cations occur at 
fixed wavelengths which have constant values regardless of environmental conditions such as pH 
and temperature.3  The characteristic emission of erbium (III) cations, Er3+, at 1.5 μm is located 
in the minimum-loss transmission window of silica fibers in optical telecommunication devices, 
making it ideally suited for use in such applications.1,2,4,5  Due to the forbidden nature of the 4f 
→ 4f transition, the direct excitation of erbium ions in an efficient manner is difficult.  It is well-
established that the “antennae effect” can be used to overcome this limitation and increase 
lanthanide luminescence.6  In this approach lanthanide cations are placed in close proximity to 
antennae, chromophoric molecules with high absorptivity that transfer energy to sensitize the 
lanthanide cations.  The coordination environment around lanthanide cations, and thus the 
organization of antennae, significantly impacts the luminescent properties of the complex.  In 
order to obtain a sufficient luminescence intensity, lanthanide cations need to be well protected 
from -OH, -NH, and -CH vibrations, the overtones of which quench luminescence intensity and 
decrease luminescence lifetimes.7  
In order to effectively utilize erbium in telecommunication devices the challenge of low 
molar absorptivity needs to be overcome.  One strategy is based on ytterbium to erbium energy 
transfer since Yb3+ has an absorption cross-section that is ~10x greater than that of Er3+.8  Yb3+ 
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and Er3+ have been co-doped into a variety of materials such as a yttrium aluminum garnet 
(YAG) matrix9, glass10,11, thin films4,5,12,13, and crystals14.  In order to realize Er3+ emission these 
materials were excited at ~940 nm or ~980 nm by pumping the excited state of Yb3+.  The energy 
was transferred to the excited state of Er3+ from Yb3+, and enhanced Er3+ emission was observed.  
Additionally, there have been Yb-Er complexes in which the Yb3+ ions were not directly 
pumped, but instead the ligands were excited and subsequently sensitized the Yb3+, allowing for 
Yb3+ to Er3+ energy transfer.15-17  We have taken a novel approach of using Yb3+ and Er3+ in 
various ratios as the metal in fixed and constant distances in metal-organic frameworks. 
Metal-organic frameworks (MOFs), composed of metal ions or clusters linked together 
by organic ligands, are an attractive class of materials for organizing and protecting lanthanide 
cations.  MOFs have been used for many applications such as gas storage, drug delivery, 
catalysis, sensing, and biomedical imaging.18-23  MOFs have been previously shown to enhance 
the photophysical properties of the lanthanide cations due to some of their advantageous features.  
First, they have rigid structures in which the metal ions and ligands are well-organized and 
spatially constrained. These structures can incorporate a large number of metal cations per unit 
of volume and the metal ion coordination spheres are often completely saturated by the ligands. 
In the context of lanthanide luminescence, these features are important because increasing the 
density of lanthanide cations within a material will result in the increase of emission intensity per 
unit of volume.24  The high number of chromophoric groups will help maximize the absorption 
of excitation light, also leading to more photons emitted by the MOF.  Second, MOFs exhibit a 
variety of topologies and in some cases their structures can be designed.  Therefore, one can 
control the positions of the metal ions and ligands within a MOF, which permits precise tuning 
of MOF properties. For example, Chen et al. demonstrated enhanced Er3+ emission within a 
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MOF by replacing terephthalate with perfluoranated terephthalate.25  Third, one can target 
multiple metal ion MOFs26-28, allowing for the incorporation of multiple luminescent lanthanides 
and multiple signals into a single material.  Using this strategy, we incorporated both Yb3+ and 
Er3+ into a MOF and demonstrated an increase in the quantum yield of Er3+ upon increasing the 
amount of Yb3+.  To the best of our knowledge this is the first report of using a mixed-metal 
MOF to enhance the intensity of Er3+ emission. 
3.2 EXPERIMENTAL 
3.2.1 Reagents 
Reagents were obtained from commercial sources and used as received without further 
purification.  The H2-PVDC was synthesized according to a previously published method.29   
The 1,4-dimethoxybenzene (99%), paraformaldehyde (PFA; 95%), sodium methoxide (0.05 M in 
methanol), anhydrous methanol (99.8%), ytterbium (III) nitrate pentahydrate (Yb(NO3)3·5H2O; 
99.999%), and erbium (III) nitrate pentahydrate (Er(NO3)3·5H2O; 99.9999%) were purchased 
from Sigma–Aldrich.  Hydrobromic acid (HBr; 33 wt% in acetic acid) was purchased from 
Fluka.  Anhydrous chloroform (CHCl3; 99.8%) and anhydrous toluene (99.8%) were purchased 
from Acros.  Triphenylphosphine was purchased from MCB Reagents.  Methanol (Certified 
ACS), tetrahydrofuran (Certified ACS), and potassium hydroxide (KOH; Certified ACS pellets) 
were purchased from Fisher.  Methyl 4-formylbenzoate (>98%) was purchased from TCI.  N,N-
dimethylformamide (DMF; ACS grade) was purchased from Emmanuel Merck Darmstadt.  
Nitric acid (HNO3; ACS Reagent, 36.5–38.0%) and glacial acetic acid (Baker Analyzed 
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Reagent), and hydrochloric acid (HCl, 36.5-38.0%, Baker Analyzed ACS Reagent) were 
purchased from J. T. Baker.  Ethanol (EtOH; 200 proof) was purchased from Decon 
Laboratories, Inc. 
3.2.2 Synthesis of ErxYb1-x-PVDC-1 MOFs 
The procedures for the synthesis of the Yb-PVDC-129 and ErxYb1-x-PVDC-128 have been 
previously reported in the literature.  
3.2.2.1 Synthesis of Yb-PVDC-1 
In a glass vial (4 mL), a solution of 4,4'-(1E,1'E)-2,2'-(2,5-dimethoxy-1,4-phenylene)bis(ethene-
2,1-diyl)dibenzoic acid (H2-PVDC) (8.60 mg, 0.020 mmol) in DMF (0.4 mL) was added to a 
solution of Yb(NO3)3·5H2O (6.75 mg, 0.015 mmol) and 1M HNO3(aq) (20.0 L) in DMF (0.3 
mL) to produce a neon green solution.  The vial was capped and placed in an 85 ºC isotemp oven 
for 48 hours to produce yellow crystalline needles of the product.  The crystals were collected, 
washed with DMF (4 × 3 mL), and air dried.   
3.2.2.2 Synthesis of Er0.32Yb0.68-PVDC-1 
In a glass vial (4 mL), a solution of 4,4'-(1E,1'E)-2,2'-(2,5-dimethoxy-1,4-phenylene)bis(ethene-
2,1-diyl)dibenzoic acid (H2-PVDC) (8.60 mg, 0.020 mmol) in DMF (0.4 mL) was added to a 
solution of Yb(NO3)3·5H2O (1.02 mg, 0.0025 mmol) in DMF (0.050 mL), Er(NO3)3·5H2O  (0.55 
mg, 0.00125 mmol) in DMF (0.025 mL), and 1M HNO3(aq) (10.0 L) to produce a neon green 
solution.  The vial was capped and placed in a 100 ºC isotemp oven for 72 hours to produce 
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yellow crystalline needles.  The crystals were collected, washed with DMF (4 × 3 mL), and air 
dried. 
3.2.2.3 Synthesis of Er0.58Yb0.42-PVDC-1  
In a glass vial (4 mL), a solution of 4,4'-(1E,1'E)-2,2'-(2,5-dimethoxy-1,4-phenylene)bis(ethene-
2,1-diyl)dibenzoic acid (H2-PVDC) (8.60 mg, 0.020 mmol) in DMF (0.4 mL) was added to a 
solution of Yb(NO3)3·5H2O (1.02 mg, 0.0025 mmol) in DMF (0.050 mL), Er(NO3)3·5H2O  (1.66 
mg, 0.00375 mmol) in DMF (0.075 mL), and 1M HNO3(aq) (10.0 L) to produce a neon green 
solution.  The vial was capped and placed in a 100 ºC isotemp oven for 72 hours to produce 
yellow crystalline needles.  The crystals were collected, washed with DMF (4 × 3 mL), and air 
dried.  
3.2.2.4 Synthesis of Er0.70Yb0.30-PVDC-1 
In a glass vial (4 mL), a solution of 4,4'-(1E,1'E)-2,2'-(2,5-dimethoxy-1,4-phenylene)bis(ethene-
2,1-diyl)dibenzoic acid (H2-PVDC) (8.60 mg, 0.020 mmol) in DMF (0.4 mL) was added to a 
solution of Yb(NO3)3·5H2O (1.02 mg, 0.0025 mmol) in DMF (0.050 mL), Er(NO3)3·5H2O (2.77 
mg, 0.00625 mmol) in DMF (0.125 mL), and 1M HNO3(aq) (10.0 L) to produce a neon green 
solution.  The vial was capped and placed in a 100 ºC isotemp oven for 72 hours to produce 
yellow crystalline needles.  The crystals were collected, washed with DMF (4 × 3 mL), and air 
dried. 
3.2.2.5 Synthesis of Er0.81Yb0.19-PVDC-1 
In a glass vial (4 mL), a solution of 4,4'-(1E,1'E)-2,2'-(2,5-dimethoxy-1,4-phenylene)bis(ethene-
2,1-diyl)dibenzoic acid (H2-PVDC) (8.60 mg, 0.020 mmol) in DMF (0.4 mL) was added to a 
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solution of Yb(NO3)3·5H2O (0.56 mg, 0.00125 mmol) in DMF (0.025 mL), Er(NO3)3·5H2O 
(2.77 mg, 0.00625 mmol) in DMF (0.125 mL), and 1M HNO3(aq) (10.0 L) to produce a neon 
green solution.  The vial was capped and placed in a 100 ºC isotemp oven for 72 hours to 
produce yellow crystalline needles.  The crystals were collected, washed with DMF (4 × 3 mL), 
and air dried. 
3.2.2.6 Synthesis of Er-PVDC-1 
In a glass vial (4 mL), a solution of 4,4'-(1E,1'E)-2,2'-(2,5-dimethoxy-1,4-phenylene)bis(ethene-
2,1-diyl)dibenzoic acid (H2-PVDC) (8.60 mg, 0.020 mmol) in DMF (0.4 mL) and a solution of 
Er(NO3)3·5H2O (4.43 mg, 0.01 mmol) in DMF (0.2 mL) were combined with ethanol (95%, 
100.0 μL) to produce a neon green solution.  The vial was capped and placed in a 100 ºC isotemp 
oven for 12 hours to produce yellow crystalline needles of the product.  The crystals were 
collected, washed with DMF (4 × 3 mL), and air dried (2.3 mg, 42.4%).   
Elemental analysis (EA) calcd (%) for Er2(C26H20O6)3(H2O)2·(DMF)6(H2O)8.5: C, 51.04; 
H, 5.49; N, 3.72.  Found: C, 50.97; H, 4.57; N, 3.91.  EA calcd (%) for the chloroform 
exchanged product, Yb2(C26H20O6)3(H2O)2·(CHCl3)2.75(DMF)0.3: C, 48.61; H, 3.44; N, 0.21.  
Found: C, 48.79; H, 3.10; N, 0.21.  FT-IR (KBr 4000-700 cm-1): 3309 (broad, br), 1658 (DMF 
C=O; medium, m), 1601 (m), 1541 (strong, s), 1415 (COO-; very strong, vs), 1209 (s), 1180 
(weak, w), 1107 (w), 1043 (s), 967 (m), 867 (w), 781 (trans C=C-H, s). 
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3.2.3 Instrumentation 
3.2.3.1 Elemental analysis 
The elemental microanalysis (CHN) was performed by the Microanalysis Laboratory at the 
University of Illinois Urbana-Champaign.  Samples were dried under nitrogen flow to remove 
excess solvent prior to submission for analysis.  Energy-dispersive X-ray analysis (EDX) was 
measured on a Philips XL 30 SEM equipped with an EDAX CDU leap detector. 
3.2.3.2 Fourier transform infrared spectroscopy 
Fourier transform infrared (FT-IR) spectra were measured on a Nicolet Avatar 360 FT-IR 
spectrometer using KBr pellet samples.  
3.2.3.3 Powder X-ray diffraction 
Powder X-ray diffraction (PXRD) patterns were collected using a Phillips PW 1830 
diffractometer at 40 kV, 40 mA, for Cu Kα (λ = 1.54056 Å) with a scan speed of 0.20 seconds 
per step and a step size of 0.020°. 
3.2.3.4 Luminescence spectroscopy 
Excitation and emission spectra were measured using a HORIBA Jobin Yvon Fluorolog 3-22 
spectrofluorometer equipped with a R928 Hamamatsu detector for visible detection and with 
either a DSS-IGA020L detector (Electro-Optical Systems, Inc.) for the NIR.  The sample holder 
was an integrating sphere using quartz tubes developed by Frédéric Gumy and Jean-Claude G. 
Bünzli (Laboratory of Lanthanide Supramolecular Chemistry, École Polytechnique Féderale de 
Lausanne, Lausanne, Switzerland) as an accessory to the Fluorolog 3-22 spectrofluorometer 
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(patent pending) and commercialized and manufactured by GMP.30  Spectra were corrected for 
variations in lamp intensity over the spectra range, as well as for excitation monochromator, 
emission monochromator, and detector responses.  The data were analyzed using OriginPro 7.1 
software. 
The spectra were corrected using the following process.  The MOF and background 
(solvent) spectra were each offset to zero at 1600 nm and corrected for variations in the lamp 
intensity.  The background spectrum was subtracted from the MOF spectrum using a scaling 
factor, k.   The value of k was calculated using the equation: 
SBk   
Equation 3.1. 
where B represents the background and S represents the sample, using the intensities of the 
respective spectra at 1300 nm (chosen because there is no Ln3+ signal in that region).  The value 
of k was optimized in order to achieve the flattest baseline.  The resulting spectrum was then 
corrected for the detector. 
3.2.3.5 Quantum yield measurements 
Quantum yield measurements were also collected on the Fluorolog-322 with the integrating 
sphere.  Collecting NIR quantum yields requires the use of both a visible detector and a NIR 
detector; ytterbium tropolonate and erbium tropolonate ([Ln(trop)4]− in DMSO, ΦYb 
=1.9(±0.1)×10−3; ΦEr =1.7(±0.1)×10−4) were used as a references31 for the respective lanthanides.  
The process for collecting a relative quantum yield using the integrating sphere is the following 
step by step process:  
1) Emission spectra of the lamp were collected for the sample (RS+SB), the solvent in which 
the sample is placed (RSB), the reference (see above, RR+RB), and the solvent in which the 
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reference is dissolved (RRB).  Neutral density filters were placed at the excitation port of 
the integrating sphere to control the high intensity of the lamp.  The spectra were 
corrected, as described above, and the bands were integrated.  The resulting integration 
values were used to determine the amount of light that was absorbed by the sample and 
the reference, given by:  
SBSSBS RRR   
Equation 3.2. 
and 
RBRRBR RRR   
Equation 3.3. 
2) Emission spectra of the sample (IS+SB), of the sample solvent (ISB), of the reference 
(IR+RB), and of the reference solvent (IRB) were collected in the NIR range.  A 780 nm 
long-pass filter was placed at the NIR emission port of the integrating sphere to eliminate 
contributions from second order bands.  Emission spectra were corrected for the lamp 
variation, the solvent spectra were subtracted from the appropriate sample and reference 
spectra: 
SBSBSS III    
Equation 3.4. 
and 
RBRBRR III    
Equation 3.5. 
and the resulting spectra were corrected for detector response.  The spectra were not 
corrected for the filters because in the case of a relative quantum yield measurement the 
use of a scalar (see below how such scalar is calculated) corrects for the filters during the 
calculations. 
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3) The known quantum yield of the reference was used to create a scalar (XNIR-VIS) which 
accounts for the use of two different detectors in the visible and in the NIR with a domain 
of overlapping response: 
R
RR
VISNIR I
RX   
Equation 3.6. 
4) The quantum yield of the sample was calculated using the following equation: 
S
SVISNIR
S R
IX   
Equation 3.7. 
 
3.2.3.6 Luminescence lifetimes  
Luminescence lifetimes were measured using a neodymium yttrium aluminum garnet (Nd:YAG) 
Continuum Powerlite 8010 laser (355 nm, third harmonic) as the excitation source.  Emission 
was collected at a right angle to the excitation beam, and wavelengths were selected by a 
Spectral Products CM110 1/8m monochromator.  The signal was monitored by a Hamamatsu 
R316-02 photomultiplier tube and collected on a 500-MHz bandpass digital oscilloscope 
(Tektronix TDS 754D).  Signals from >1,000 flashes were collected and averaged.  Three decay 
curves were collected for each sample, and the data were analyzed using OriginPro 9.1 software 
with exponential fitting modes. 
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3.3 RESULTS AND DISCUSSION 
Yb-PVDC-1 and barcoded ErxYb1-x-PVDC-1 materials have been previously synthesized in our 
lab.28,29  We demonstrated near-infrared (NIR) emission via the antennae effect including 
simultaneous emission of the ytterbium and erbium cations when using the barcoded materials.28  
We showed that by altering the amount of lanthanide cation within the MOF, we could directly 
alter the resulting lanthanide emission intensity.  For the barcoded materials, the resulting ratio of 
Yb3+ to Er3+ emission intensities varied linearly with the lanthanide atomic content.  
Interestingly, the Er3+ emission signal appeared brighter than that of the Yb3+ regardless of the 
lanthanide content.  This result prompted us to probe further as to what was occurring 
spectroscopically. 
3.3.1 Er-PVDC-1 
For a complete study of photophysical properties within the Ln-PVDC-1 system, Er-PVDC-1 
was then synthesized.  Powder X-ray diffraction studies show that Er-PVDC-1 is isostructural 
with Yb-PVDC-1 and ErxYb1-x-PVDC-1. 
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Figure 3.1.  Powder X-ray diffraction (PXRD) patterns showing Er-PVDC-1 is isostructural with Yb-
PVDC-1 and ErxYb1-x-PVDC-1. 
The excitation profile for Er-PVDC-1 shows apparent maxima centered at 280 nm, 370 
nm, and 470 nm, which corresponds to the same maxima observed for Yb-PVDC-1 and ErxYb1-
x-PVDC-1.28,29  Exciting through any of these three wavelengths results in the generation of Er3+ 
emission centered at 1530 nm (Figure 3.2). 
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Figure 3.2.  Normalized excitation and emission spectra of Er-PVDC-1 under DMF. 
 
 
To elucidate how the photophysical properties compare between the doped and the single 
lanthanide MOFs, quantum yields and luminescence lifetimes were systematically collected. 
3.3.2 Quantum yields 
To quantify the overall efficiency of the antenna effect in the MOF material, quantum yields 
were measured (Table 3.1) and plotted as a function of percent of each lanthanide in the MOF 
(Figure 3.3). 
 
 
 
 77 
Table 3.1.  Relative Yb3+ and Er3+ quantum yields (ΦYb, ΦEr) for Yb-PVDC-1, ErxYb1-x-PVDC-1, and Er-
PVDC-1 MOFs*. 
 ΦYb† ΦEr† 
Yb-PVDC-1 3.3(±0.5)×10-3 - 
Er0.32Yb0.68-PVDC-1 6.5(±0.8)×10-4 1.8(±0.4)×10-4 
Er0.58Yb0.42-PVDC-1 1.8(±0.4)×10-4 1.7(±0.4)×10-4 
Er0.70Yb0.30-PVDC-1 8(±2)×10-5 9.98(±0.01)×10-5 
Er0.81Yb0.19-PVDC-1 3.4(±0.4)×10-5 6(±1)×10-5 
Er-PVDC-1 - 8.5(±0.44)×10-5 
*MOFs as crystalline solids under chloroform; †λex = 490 nm 
 
 
10 20 30 40 50 60 70 80 90100
0.0
5.0x10-4
1.0x10-3
1.5x10-3
2.0x10-3
2.5x10-3
3.0x10-3
3.5x10-3
4.0x10-3
Yb
3+
 Q
ua
ntu
m 
Yie
ld
Percent Yb3+ in MOF  
30 40 50 60 70 80 90 1000.0
5.0x10-5
1.0x10-4
1.5x10-4
2.0x10-4
2.5x10-4
Er
3+
 Q
ua
ntu
m 
Yie
ld
Percent Er3+ in MOF  
Figure 3.3.  Left: Plot depicting Yb3+ quantum yields (λex = 490 nm) versus the percent Yb3+ in the MOF 
for Yb-PVDC-1 and ErxYb1-x-PVDC-1.  Right: Plot depicting Er3+ quantum yields (λex = 490 nm) versus 
the percent Er3+ in the MOF for Er-PVDC-1 and ErxYb1-x-PVDC-1. 
 
 
The quantum yield value measured for Yb-PVDC-1 (3.3×10-3) is amongst the highest 
reported for materials under solvent31.  However, the quantum yield for Er-PVDC-1 is much 
lower with a value of 8.5×10-5.  The NIR emission of Er3+ is easily quenched from the second 
vibrational overtones of C-H and O-H bonds (Figure 3.4) resulting in non-radiative deactivation 
due to the small energy difference between the ground and the excited states.   
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Figure 3.4.  Energy levels for Yb, Er, and various vibrational overtones typically responsible for 
quenching. 
 
 
The quantum yields for the mixed lanthanide system suggest the presence of Yb3+ to Er3+ 
energy transfer.  Instead of the quantum yields for each lanthanide increasing/decreasing linearly 
with the corresponding amount of lanthanide content in the crystal, the quantum yield for Yb3+ 
decreases quickly.  As the amount of Er3+ decreases and the Yb3+ increases, the quantum yield 
for Er3+ actually increases.  We rationalize this increase in quantum yield as a result of energy 
transfer from the 2F5/2 level of Yb3+ to the accepting 4I11/2 level of Er3+. 
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Figure 3.5. Jablonski diagram showing the potential energy pathways from the 2F5/2 excited state of Yb3+.  
Solid lines represent luminescence, the dotted line represents energy transfer, and the wavy line represents 
non-radiative decay. 
 
 
It is hypothesized that such energy transfer (Figure 3.5) would take place according to the 
following process based upon existing literature.15-17  Incident light excites the ligand from the 
ground state to the excited singlet state (S0 → S1) followed by intersystem crossing to the triplet 
state (T1).  From the triplet state, energy is transferred to the accepting 2F5/2 level of Yb3+.  This is 
consistent with the Yb3+ being sensitized via the antennae effect which was previously 
demonstrated.29   Some energy is released as NIR emission via 2F5/2 → 2F7/2 transition to Yb3+ 
ground state (~980 nm).  Some energy is transferred from the 2F5/2 level of Yb3+ to 4I11/2 level of 
Er3+ followed by fast non-radiative relaxation to 4I13/2 level of Er3+, ultimately resulting in the 
generation of NIR emission (1550 nm) upon relaxation from the 4I13/2 state to the 4I15/2 ground 
state. 
 80 
3.3.3 Luminescence lifetimes 
In order to confirm our hypothesis we collected luminescence lifetimes and performed an in-
depth analysis.  If indeed there is energy transfer from Yb3+ to Er3+, the lifetime of Yb3+ in the 
mixed metal MOFs should be shorter than the value observed in Yb-PVDC-1.   
When Yb-PVDC-1 was first synthesized its lifetime decay curve (λex = 354 nm) was best 
fit to a four component multi-exponential decay with values of 29(±2), 10(±1), 1.5(±0.5), and 
0.34(±0.06) μs.29  This was rationalized as arising from the four distinct environments of the 
Yb3+ cations present in the MOF, hexa- and octa-coordinated sites on the interior and along the 
external edges of the crystal.   
At the time it was difficult to distinguish the Yb3+ signal from noise in the ErxYb1-x-
PVDC-1 system, and we did not have a detector with the required capabilities to collect Er3+ 
lifetimes and fully analyze the system. 
Once we gained access to a detector with a sufficient detection range to monitor Er3+ 
luminescence lifetimes, additional samples were synthesized in order to complete the full 
characterization of the system and study the energy transfer.  The measured lifetimes are 
summarized in Table 3.2.  The lifetimes of Yb3+ in the mixed-metal system were indeed shorter 
than that of the Yb-PVDC-1.   
In this set of experiments, the Yb-PVDC-1 lifetime was best fit to a mono-exponential 
function and was more than 40 times shorter (0.7 μs versus 29 μs). 
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Table 3.2.  Yb3+ (λem = 980 nm) and Er3+ (λem = 1550 nm) lifetimes (τ) for Yb-PVDC-1, ErxYb1-
x-PVDC-1, and Er-PVDC-1 MOFs*. 
 Yb3+ Er3+ τ1† (μs) τ2† (μs) τ1† (μs) τ2† (μs)
Yb-PVDC-1 0.729(±0.009) - - - 
Er0.32Yb0.68-PVDC-1 0.44(±0.01) 0.13(±0.01) 0.75(±0.01) 0.131(±0.004) 
Er0.58Yb0.42-PVDC-1 0.27(±0.02) 0.081(±0.002) 0.46(±0.01) 0.118(±0.002) 
Er0.70Yb0.30-PVDC-1 0.18(±0.02) 0.054(±0.002) 0.35(±0.04) 0.102(±0.005) 
Er0.81Yb0.19-PVDC-1 0.21(±0.01) 0.063(±0.01) 0.50(±0.02) 0.123(±0.001) 
Er-PVDC-1 - - 0.35(±0.01) 0.110(±0.004) 
*MOFs as a crystalline solid under chloroform; †λex = 354 nm 
 
The luminescence lifetime values reported in the Table 3.2 follow a clear trend.  The Yb3+ 
lifetimes in ErxYb1-x-PVDC-1 are shorter than that of Yb-PVDC-1.  The Er3+ lifetimes in ErxYb1-
x-PVDC-1 are all longer than or equal to those of Er-PVDC-1.  This is more easily visualized 
with plots of lifetime versus percentage of Ln3+ in the MOF (Figure 3.6). 
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Figure 3.6.  Left: Plot of Yb3+ luminescence lifetimes (em = 980 nm) versus the percent Yb3+ in the MOF 
for Yb-PVDC-1 and barcoded ErxYb1-x-PVDC-1.  Right: Plot of Er3+ lifetimes (em = 1550 nm) versus the 
percent Er3+ in the MOF for Er-PVDC-1 and ErxYb1-x-PVDC-1. 
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The trend of the lifetimes depicted in Figure 3.6 is consistent with the trend of the quantum 
yields in Figure 3.3.  This suggests that energy transfer from Yb3+ to Er3+ is taking place, as Er3+ 
emission in indeed enhanced in the presence of Yb3+.  To have a deeper understanding we will 
need to unambiguously determine the lifetimes of these materials, optimally in a variety of 
solvents as well as in the solid state. 
3.4 CONCLUSION 
In a follow-up to previously reported Yb-PVDC-1 and barcoded ErxYb1-x-PVDC-1, we 
synthesized Er-PVDC-1 and studied the luminescence properties of an array of materials.  The 
Er-PVDC-1 MOF, which was isostructural to the other materials, exhibited an excitation 
spectrum that is consistent with the other MOFs as well as characteristic NIR Er3+ emission.  
Interestingly, the quantum yields did not correlate linearly with the percentage of each Ln3+ 
present in the MOF.  Notably, the ErxYb1-x-PVDC-1 MOFs had larger Er3+ quantum yield values 
than Er-PVDC-1.  Luminescence lifetimes were collected in order to confirm that this effect can 
be attributed to Yb3+ to Er3+ energy transfer.  The Yb3+ lifetime for Yb-PVDC-1 was larger than 
the Yb3+ lifetimes for any of the barcoded ErxYb1-x-PVDC-1 MOFs.  The Er3+ lifetimes of 
ErxYb1-x-PVDC-1 were longer than or equal to those of Er-PVDC-1.  This is a strong indication 
that energy transfer from Yb3+ to Er3+ is indeed taking place.  However, the discrepancies in the 
Yb3+ lifetimes collected for Yb-PVDC-1 on different batches using different instrumentation 
must be identified.  Nonetheless, these mixed metal ErxYb1-x-PVDC-1 MOFs demonstrate 
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enhanced erbium emission in comparison to Er-PVDC-1 and hold promise for use in 
telecommunication devices. 
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4.0  LANTHANIDE NEAR-INFRARED IMAGING IN LIVING CELLS WITH YB3+ 
NANO METAL-ORGANIC FRAMEWORKS 
Part of the work presented in this chapter has been published as: “Lanthanide near infrared 
imaging in living cells with Yb3+ nano metal organic frameworks” in the Proceedings of the 
National Academy of Sciences 2013, 110(43), 17199-17204. 
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(Nathaniel L. Rosi Research Group, University of Pittsburgh), and Steven J. Geib 
(Crystallographer, University of Pittsburgh). 
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4.1 INTRODUCTION 
Luminescent reporters emitting in the near-infrared (NIR) region of the electromagnetic 
spectrum are highly advantageous for biological imaging applications for several reasons.  
Biological material has low autofluorescence in the NIR window, which allows facile 
discrimination between the desired signal of the reporter and the background, leading to 
enhanced signal-to-noise ratio and improved detection sensitivity.1  Additionally, NIR light 
scatters less than visible light and therefore results in increased optical imaging resolution.2,3  
Finally, NIR photons interact less with biological material compared to visible photons, thus 
decreasing the risk of disturbing or damaging the biological systems being observed. 
NIR reporters such as cyanine dyes4,5 and quantum dots6 have previously been shown to 
be useful for biological imaging applications.  However, these materials possess broad emission 
bands that limit their ability to be easily discriminated from the background fluorescence due to 
their overlap.  Additionally, cyanine dyes exhibit limited photostability, and quantum dots can 
display blinking emission making it difficult to conduct repeated or long-term experiments for 
such purposes as tracking a moiety or monitoring a rapid occurring process. 
Several lanthanide cations emit in the NIR and have some advantages with respect to 
organic fluorophores and semi-conductor nanocrystals.  Lanthanide cations have narrower 
emission bandwidths than organic fluorophores and semiconductor nanocrystals.  Their emission 
wavelengths are not affected by the environment, allowing them to be used in a broad range of 
conditions, including varied pH and biological environment.  Most luminescent lanthanide 
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reporters are more resistant to photobleaching than organic fluorophores, which enables them to 
be used repeatedly and/or over long periods of time.7-9 
Free lanthanide cations have low extinction coefficients due to the partially forbidden 
nature of the f → f transition. Therefore, lanthanides must be sensitized using a photonic 
converter such as an organic chromophore through the “antennae effect.”10  “Antennae” must be 
placed in sufficiently close proximity to the lanthanide to provide sensitization, resulting in the 
compound emitting a sufficient number of photons for detection. Lanthanides must also be 
protected from -OH, -NH, and -CH vibrational overtones which can quench lanthanide 
luminescence.11 
Despite the fact that several lanthanide complexes emitting in the NIR have been 
described in the literature, as they have exciting properties for biological imaging in vivo11-16, we 
are aware of only one example used for imaging in living cells17.  In that example, two-photon 
excitation was used, requiring specialized laser equipment. 
We have tested a new strategy by designing novel NIR-emitting lanthanide metal-organic 
frameworks (MOFs) that overcome these limitations by incorporating a large number of NIR-
emitting Ln3+ cations and PVDC sensitizers in a small volume.  Using lanthanides as the metal in 
a MOF allows for the creation of well-defined crystalline species that can emit a large number of 
photons per unit volume to promote sensitive detection.  This method provides an avenue for 
both the sensitization and the protection of the lanthanide cations, while simultaneously fulfilling 
their requirement for large coordination numbers. 
We previously reported Yb3+-PVDC NIR-emitting lanthanide MOFs which exhibit 
tunable photophysical properties as bulk materials.18,19  To take advantage of utilizing the PVDC 
ligand/sensitizer, we modified the synthesis and created a new crystalline framework in the bulk 
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phase, Yb-PVDC-3.  Through a reverse microemulsion synthesis20-22, we were able to create a 
nanoscale version of the same MOF (nano-Yb-PVDC-3), an analogous nanoMOF using Nd3+ in 
place of Yb3+ (nano-Nd-PVDC-3), and a series of barcoded nanoMOFs (nano-NdxYb1-x-PVDC-
3).  In first proof-of-principle experiments, we demonstrate the ability of nano-Yb-PVDC-3 to 
operate as a NIR imaging agent in living HeLa and NIH 3T3 cells. 
To date, there have been reports of nanoscale MOFs and coordination polymers for use as 
biosensors21, contrast agents for magnetic resonance imaging (MRI)20,22-25 and computed 
tomography (CT)26, and drug delivery24,25,27; in this chapter, we demonstrate that NIR-emitting 
nanoMOFs can be designed as imaging agents for biological systems. 
4.2 EXPERIMENTAL 
4.2.1 Reagents 
Reagents were obtained from commercial sources and used as received without further 
purification.  The H2-PVDC was synthesized according to a previously published method18.  The 
1,4-dimethoxybenzene (99%), paraformaldehyde (PFA; 95%), sodium methoxide (0.05 M in 
methanol), anhydrous methanol (99.8%), anhydrous benzene (99.8%), methylamine (40 wt% in 
water), hexadecyltrimethylammonium bromide (CTAB; >98% powder), heptane (Reagent Plus, 
99%), ytterbium (III) nitrate pentahydrate (Yb(NO3)3·5H2O; 99.999%), ytterbium (III) chloride 
hexahydrate (YbCl3·6H2O; 99.998%), erbium (III) chloride hexahydrate (ErCl3·6H2O), 
neodymium (III) chloride hexahydrate (NdCl3·6H2O), and dimethylsulfoxide (DMSO; ACS 
Reagent, >99.9%) were purchased from Sigma–Aldrich.  Hydrobromic acid (HBr; 33 wt% in 
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acetic acid) was purchased from Fluka.  Anhydrous chloroform (CHCl3; 99.8%) and anhydrous 
toluene (99.8%) were purchased from Acros.  Triphenylphosphine was purchased from MCB 
Reagents.  Methanol (Certified ACS), tetrahydrofuran (Certified ACS), and potassium hydroxide 
(Certified ACS pellets) were purchased from Fisher.  Methyl 4-formylbenzoate (>98%) was 
purchased from TCI.  N,N-dimethylformamide (DMF; ACS grade) was purchased from 
Emmanuel Merck Darmstadt.  Nitric acid (HNO3; ACS Reagent, 36.5–38.0%) and glacial acetic 
acid (Baker Analyzed Reagent) were purchased from J. T. Baker.  Hexanol (purified) was 
purchased from Spectrum.  Ethanol (200 proof) was purchased from Decon Laboratories, Inc. 
4.2.2 Synthesis of MOFs 
4.2.2.1  Synthesis of Yb-PVDC-3 MOF 
In a 20-mL glass vial, a solution of 4,4′-(1E,1′E)-2,2′-(2,5-dimethoxy-1,4-phenylene)bis(ethene-
2,1-diyl)dibenzoic acid (H2-PVDC; 86.0 mg, 0.20 mmol) in DMF (4.0 mL) was added to a 
solution of Yb(NO3)3·5H2O (22.5 mg, 0.05 mmol) in DMF (1.0 mL) and 1 M HNO3(aq) (1 mL) 
to produce a neon green solution.  The vial was capped and placed in a 105 °C isotemp oven for 
12 hours to produce yellow crystalline needles of the product.  The crystals were collected, 
washed with DMF (4 × 5 mL), and air-dried (29.7 mg, 61.8%).   
Elemental analysis (EA) calcd (%) for Yb1(C26H20O6)1.5(DMF)·0.65DMF·H2O: C, 55.31; 
H, 4.60; N, 2.42.  Found: C, 54.87; H, 4.22; N, 2.51.  EA calcd (%) for the water exchange 
product, Yb1(C26H20O6)1.5(H2O)2·0.25DMF·2.25H2O: C, 52.43; H, 4.46; N, 0.38.  Found: C, 
52.12; H, 3.68; N, 0.30.  FTIR (KBr, 4,000-700 cm−1): 3,424 (broad, br), 3,054 (weak, w), 2,998 
(w), 2,936 (w), 2,830 (w), 1,665 (DMF C=O; medium, m), 1,601 (m), 1,544 (m), 1,413 (COO-; 
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very strong, vs), 1,338 (w), 1,260 (w), 1,211 (strong, s), 1,181 (m), 1,108 (w), 1,044 (s), 965 (m), 
861 (w), 779 (trans C=C−H, s), and 709 (w). 
4.2.3 Synthesis of nano-Ln-PVDC-3 MOFs 
These procedures are based on previously reported reverse microemulsion nanoMOF synthesis20-
22.   
4.2.3.1 Synthesis of nano-Yb-PVDC-3 
The methylammonium salt of the H2-PVDC ligand (PVDC-(NH2CH3)2) was prepared by 
dissolving H2-PVDC in methylamine (40 wt% in water), removing the solvent under reduced 
pressure, and adding a known amount of water to achieve the desired concentration.  A 0.05 M 
solution of CTAB was prepared by dissolving CTAB in a 9:1 (vol/vol) ratio of heptane/hexanol 
and stirring for 30 minutes.  A w = 10 (where w is the H2O/CTAB molar ratio) reaction mixture 
was prepared as follows.  A solution of YbCl3·6H2O (225 μL, 0.05 M in H2O) was added to a 
flask containing the CTAB mixture (25 mL, 0.05 M in heptane/hexanol).  A solution of PVDC-
(NH2CH3)2 (225 μL, 0.05 M in H2O) was added to another flask also containing the CTAB 
mixture (25 mL, 0.05 M).  The flasks were stirred separately for at least 10 minutes until both 
solutions became clear.  The Yb3+ solution was then added to the PVDC solution and stirred for 
24 hours at room temperature.  A yellow solid was isolated via centrifugation at 3,313×g for 30 
minutes, followed by washing with ethanol (3 × 35 mL).  The product was purified by dialysis 
using a regenerated cellulose membrane (nominal molecular weight cut off of 3,500; Fisher 
Scientific) in DMSO for 3 days.  The solid recovered from the dialysis membrane was dried in a 
vacuum oven (40 °C, 40 mbar). 
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4.2.3.2 Synthesis of nano-Er-PVDC-3 
The methylammonium salt of the H2-PVDC ligand (PVDC-(NH2CH3)2) was prepared by 
dissolving H2-PVDC in methylamine (40 wt% in water), removing the solvent under reduced 
pressure, and adding a known amount of water to achieve the desired concentration.  A 0.05 M 
solution of CTAB was prepared by dissolving CTAB in a 9:1 (vol/vol) ratio of heptane/hexanol 
and stirring for 30 minutes.  A w = 10 (where w is the H2O/CTAB molar ratio) reaction mixture 
was prepared as follows.  A solution of ErCl3·6H2O (225 μL, 0.05 M in H2O) was added to a 
flask containing the CTAB mixture (25 mL, 0.05 M in heptane/hexanol).  A solution of PVDC-
(NH2CH3)2 (225 μL, 0.05 M in H2O) was added to another flask also containing the CTAB 
mixture (25 mL, 0.05 M).  The flasks were stirred separately for at least 10 minutes until both 
solutions become clear.  The Er3+ solution was then added to the PVDC solution and stirred for 
24 hours at room temperature.  A yellow solid was isolated via centrifugation at 3,313×g for 30 
minutes, followed by washing with ethanol (3 × 35 mL). 
4.2.3.3 Synthesis of nano-Nd-PVDC-3 
The methylammonium salt of the H2-PVDC ligand (PVDC-(NH2CH3)2) was prepared by 
dissolving H2-PVDC in methylamine (40 wt% in water), removing the solvent under reduced 
pressure, and adding a known amount of water to achieve the desired concentration.  A 0.05 M 
solution of CTAB was prepared by dissolving CTAB in a 9:1 (vol/vol) ratio of heptane/hexanol 
and stirring for 30 minutes.  A w = 10 (where w is the H2O/CTAB molar ratio) reaction mixture 
was prepared as follows.  A solution of NdCl3·6H2O (225 μL, 0.05 M in H2O) was added to a 
flask containing the CTAB mixture (25 mL, 0.05 M in heptane/hexanol).  A solution of PVDC-
(NH2CH3)2 (225 μL, 0.05 M in H2O) was added to another flask also containing the CTAB 
mixture (25 mL, 0.05 M).  The flasks were stirred separately for at least 10 minutes until both 
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solutions became clear.  The Nd3+ solution was then added to the PVDC solution and stirred for 
24 hours at room temperature.  A yellow solid was isolated via centrifugation at 3,313×g for 30 
minutes, followed by washing with ethanol (3 × 35 mL).   
4.2.4 Synthesis of barcoded nano-NdxYb1-x-PVDC-3 MOFs 
4.2.4.1 Synthesis of nano-Nd0.25Yb0.75-PVDC-3 
The methylammonium salt of the H2-PVDC ligand (PVDC-(NH2CH3)2) was prepared by 
dissolving H2-PVDC in methylamine (40 wt% in water), removing the solvent under reduced 
pressure, and adding a known amount of water to achieve the desired concentration.  A 0.05 M 
solution of CTAB was prepared by dissolving CTAB in a 9:1 (vol/vol) ratio of heptane/hexanol 
and stirring for 30 minutes.  A w = 10 (where w is the H2O/CTAB molar ratio) reaction mixture 
was prepared as follows.  A solution of YbCl3·6H2O (168 μL, 0.05 M in H2O) and a solution of 
NdCl3·6H2O (56 μL, 0.05 M in H2O) were added to a flask containing the CTAB mixture (25 
mL, 0.05 M in heptane/hexanol).  A solution of PVDC-(NH2CH3)2 (225 μL, 0.05 M in H2O) was 
added to another flask also containing the CTAB mixture (25 mL, 0.05 M).  The flasks were 
stirred separately for at least 10 minutes until both solutions became clear.  The Nd3+/Yb3+ 
solution was then added to the PVDC solution and stirred for 24 hours at room temperature.  
Yellow solid was isolated via centrifugation at 3,313×g for 30 minutes, followed by washing 
with ethanol (3 × 35 mL). 
4.2.4.2 Synthesis of nano-Nd0.50Yb0.50-PVDC-3 
The methylammonium salt of the H2-PVDC ligand (PVDC-(NH2CH3)2) was prepared by 
dissolving H2-PVDC in methylamine (40 wt% in water), removing the solvent under reduced 
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pressure, and adding a known amount of water to achieve the desired concentration.  A 0.05 M 
solution of CTAB was prepared by dissolving CTAB in a 9:1 (vol/vol) ratio of heptane/hexanol 
and stirring for 30 minutes.  A w = 10 (where w is the H2O/CTAB molar ratio) reaction mixture 
was prepared as follows.  A solution of YbCl3·6H2O (112 μL, 0.05 M in H2O) and a solution of 
NdCl3·6H2O (112 μL, 0.05 M in H2O) were added to a flask containing the CTAB mixture (25 
mL, 0.05 M in heptane/hexanol).  A solution of PVDC-(NH2CH3)2 (225 μL, 0.05 M in H2O) was 
added to another flask also containing the CTAB mixture (25 mL, 0.05 M).  The flasks were 
stirred separately for at least 10 minutes until both solutions became clear.  The Nd3+/Yb3+ 
solution was then added to the PVDC solution and stirred for 24 hours at room temperature.  A 
yellow solid was isolated via centrifugation at 3,313×g for 30 minutes, followed by washing with 
ethanol (3 × 35 mL). 
4.2.4.3 Synthesis of nano-Nd0.75Yb0.25-PVDC-3 
The methylammonium salt of the H2-PVDC ligand (PVDC-(NH2CH3)2) was prepared by 
dissolving H2-PVDC in methylamine (40 wt% in water), removing the solvent under reduced 
pressure, and adding a known amount of water to achieve the desired concentration.  A 0.05 M 
solution of CTAB was prepared by dissolving CTAB in a 9:1 (vol/vol) ratio of heptane/hexanol 
and stirring for 30 minutes.  A w = 10 (where w is the H2O/CTAB molar ratio) reaction mixture 
was prepared as follows.  A solution of YbCl3·6H2O (56 μL, 0.05 M in H2O) and a solution of 
NdCl3·6H2O (168 μL, 0.05 M in H2O) were added to a flask containing the CTAB mixture (25 
mL, 0.05 M in heptane/hexanol).  A solution of PVDC-(NH2CH3)2 (225 μL, 0.05 M in H2O) was 
added to another flask also containing the CTAB mixture (25 mL, 0.05 M).  The flasks were 
stirred separately for at least 10 minutes until both solutions became clear.  The Nd3+/Yb3+ 
solution was then added to the PVDC solution and stirred for 24 hours at room temperature.  A 
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yellow solid was isolated via centrifugation at 3,313×g for 30 minutes, followed by washing with 
ethanol (3 × 35 mL). 
4.2.5 Instrumentation 
4.2.5.1  Fourier transform infrared spectroscopy 
Fourier transform infrared (FTIR) spectra were measured on a Nicolet Avatar 360 FTIR 
spectrometer using KBr pellet samples.  Data were analyzed using the Omnic Software Package 
(Thermo Scientific). 
4.2.5.2  Powder X-ray diffraction 
Powder X-ray diffraction (PXRD) patterns were collected using a Bruker AXS D8 Discover 
powder diffractometer at 40 kV, 40 mA, for Cu Kα (λ = 1.5406 Å) with a scan speed of either 
0.20 s per step or 0.50 s per step and a step size of 0.02018°.  PXRD patterns for the nano-Yb-
PVDC-3 were collected using a Philips PW1830 diffractometer at 40 kV, 40 mA, for Cu Kα (λ = 
1.54056 Å) with a scan speed of 0.50 s per step and a step size of 0.020°. 
4.2.5.3  Scanning electron microscopy 
Samples were coated with palladium for 60 seconds before analysis with a Philips XL 30 
scanning electron microscope (SEM) equipped with an EDAX CDU leap detector for energy 
dispersive X-ray (EDX) analysis.  ImageJ 1.47f software (National Institutes of Health) was used 
to measure the particle dimensions, and OriginPro 8.6 software (OriginLab Corporation) was 
used to process the data.   
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4.2.5.4  Absorption spectroscopy 
Absorption spectra were recorded on a Perkin-Elmer Lambda 9 Spectrometer coupled with a 
personal computer using software supplied by Perkin-Elmer. 
4.2.5.5  Luminescence spectroscopy 
Excitation and emission spectra were measured using a HORIBA Jobin Yvon Fluorolog 3-22 
spectrofluorometer equipped with a R928 Hamamatsu detector for visible detection and a DSS-
IGA020L detector (Electro-Optical Systems, Inc.) for the NIR domain.  All materials were 
measured as crystalline solids in water.  Nano-Yb-PVDC-3 samples were measured as colloidal 
suspensions at 30 μg/mL in 0.1 M HEPES (pH 7.3).  An integrating sphere utilizing quartz tube 
sample holders developed by Frédéric Gumy and Jean-Claude G. Bünzli (Laboratory of 
Lanthanide Supramolecular Chemistry, École Polytechnique Féderale de Lausanne, Lausanne, 
Switzerland) as an accessory to the Fluorolog 3-22 spectrofluorometer (patent pending) and 
commercialized and manufactured by GMP28 was used. 
The spectra were corrected using the following process.  The MOF and background 
(solvent) spectra were each offset to zero at 1600 nm and corrected for variations in the lamp 
intensity.  The background spectrum was subtracted from the MOF spectrum using a scaling 
factor, k.   The value of k was calculated using the equation: 
SBk   
Equation 4.1. 
where B represents the background and S represents the sample, using the intensities of the 
respective spectra at 1550 nm (chosen because there is no Ln3+ signal in that region).  The value 
of k was optimized in order to achieve the flattest baseline.  The resulting spectrum was then 
corrected for the detector. 
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4.2.5.6  Quantum yield measurements 
Quantum yield measurements were also collected on the Fluorolog-322 with the integrating 
sphere.  Collecting NIR quantum yields requires the use of both a visible detector and a NIR 
detector; ytterbium tropolonate and neodymium tropolonate were used as references13 
([Ln(trop)4]- in DMSO, ΦYb = 1.9×10-2; ΦNd = 2.1×10-3) for the respective lanthanides.  The 
process for collecting a relative quantum yield using the integrating sphere is the following step 
by step process:  
1) Emission spectra of the lamp were collected for the sample (RS+SB), the solvent in which
the sample is placed (RSB), the reference (see above, RR+RB), and the solvent in which the
reference is dissolved (RRB).  Neutral density filters were placed at the excitation port of
the integrating sphere to control the high intensity of the lamp.  The spectra were
corrected, as described above, and the bands were integrated.  The resulting integration
values were used to determine the amount of light that was absorbed by the sample and
the reference, given by:
SBSSBS RRR 
Equation 4.2. 
and 
RBRRBR RRR 
Equation 4.3. 
2) Emission spectra of the sample (IS+SB), of the sample solvent (ISB), of the reference
(IR+RB), and of the reference solvent (IRB) were collected in the NIR range.  A 780 nm
long-pass filter was placed at the NIR emission port of the integrating sphere to eliminate
contributions from second order bands.  Emission spectra were corrected for the lamp
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variation, the solvent spectra were subtracted from the appropriate sample and reference 
spectra: 
SBSBSS III    
Equation 4.4. 
and 
RBRBRR III    
Equation 4.5. 
and the resulting spectra were corrected for detector response.  The spectra were not 
corrected for the filters because in the case of a relative quantum yield measurement the 
use of a scalar (see below how such scalar is calculated) corrects for the filters during the 
calculations. 
All three Nd3+ bands were integrated; the band centered at 880 nm was integrated 
over the range 820-910 nm, and the band centered at 1330 nm was integrated over the 
range 1265-1385 nm.  The Yb3+ band centered at 980 nm overlapped with the Nd3+ band 
centered at 1060 nm, so the spectrum was deconvoluted using the DataMax software 
supplied by Jobin Yvon-Horiba.  The deconvolution analysis was applied in the region 
1018-1100 nm for Nd3+ and 910-1018 nm for Yb3+.  The resulting deconvoluted spectra 
were integrated over their entire range of wavelengths. 
3) The known quantum yield of the reference was used to create a scalar (XNIR-VIS) which 
accounts for the use of two different detectors in the visible and in the NIR with a domain 
of overlapping response: 
R
RR
VISNIR I
RX   
Equation 4.6. 
4) The quantum yield of the sample was calculated using the following equation: 
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S
SVISNIR
S R
IX   
Equation 4.7. 
4.2.5.7  Photobleaching studies 
Using the Fluorolog 3-22 setup described above, emission spectra (λex = 355 nm) were collected 
every 30 minutes for a photobleaching study.  The samples were exposed to white light from the 
450W Xenon lamp of the Fluorolog 3-22 between collection of emission spectra. 
4.2.5.8  Luminescence lifetimes 
Luminescence lifetimes were measured using a neodymium yttrium aluminum garnet (Nd:YAG) 
Continuum Powerlite 8010 laser (355 nm, third harmonic) as the excitation source.  Emission 
was collected at a right angle to the excitation beam, and wavelengths were selected by a 
Spectral Products CM110 1/8m monochromator.  The signal was monitored by a Hamamatsu 
R316-02 photomultiplier tube and collected on a 500-MHz bandpass digital oscilloscope 
(Tektronix TDS 754D).  Signals from >1,000 flashes were collected and averaged.  Three decay 
curves were collected for each sample, and the data were analyzed using OriginPro 8.6 software 
with exponential fitting modes. 
4.2.5.9  Alamar Blue assay 
For the cytotoxicity test, 1×104 cells per well were seeded in a 96-well microplate.  After 24 
hours of cell attachment, the cells were treated with increasing concentrations of nano-Yb-
PVDC-3 diluted for 24 hours at 37 °C.  The cytotoxicity was evaluated with the Alamar Blue 
assay (Invitrogen).  Alamar Blue was added to the medium (10% vol/vol), and its fluorescence 
(λex = 530 nm, λem = 590 nm) was measured after 4 hours at 37 °C with a microplate reader 
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(Victor 3V; PerkinElmer).  This assay compared the fluorescence of untreated cells with the 
fluorescence of cells after incubation with nano-Yb-PVDC-3. 
4.2.5.10 Stability in biological media 
The emission of nano-Yb-PVDC-3 was followed during 6 hours in cell lysate. For this, 1×106 
cells (HeLa and NIH 3T3) were collected.  After centrifugation, the pellets were re-suspended in 
water and cell membranes were lysed using a 25-gauge syringe for a mechanical lyse.  The 
lysates were centrifuged again to exclude cell membrane fragments.  Nano-Yb-PVDC-3 was 
diluted in the supernatant, and the emission spectra were measured using the Fluorolog 3-22. 
4.2.5.11 Inductively coupled plasma 
To quantify the concentration of Yb3+ in cells, 1×106 cells were seeded in a six-well microplate.  
After 24 hours of attachment, the cells were incubated with 20, 30, or 40 mg/L of nano-Yb-
PVDC-3 for 24 hours at 37 °C.  Cells were treated with trypsin and centrifuged for 5 minutes at 
423×g.  The pellets were re-suspended in nitric acid overnight before adding PBS buffer to 
achieve a final concentration of 5% nitric acid.  The measurements were taken on an inductively 
coupled plasma (ICP; Ultimate; Jobin Yvon) coupled with a photomultiplier tube and a high 
dynamic detection system. 
4.2.5.12 Confocal microscopy 
Confocal fluorescence imaging was realized with an Axio Observer Z1 fluorescence inverted 
microscope (Zeiss) equipped with an ORCA-R2 high-resolution CCD camera linked to a 
computer driving the Axiovision (Zeiss) acquisition software.  Confocality was obtained by 
means of a Zeiss-ApoTome module of optical sectioning using structured illumination by grids 
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oscillations.  The Zeiss HXP-120 light source (metal halide) was used as an excitation system 
and was combined with an ultraviolet (UV) cube filter unit (λex = 365/12 nm, λem = 445/50 nm) 
to observe phenylene emission.  Optical sections were recorded at magnifications of 20× and 40× 
with Zeiss Plan- APOCHROMAT 20×/0.8 and 40×/1.4 objectives, respectively. 
4.2.5.13 Near-infrared microscopy 
Near-infrared (NIR) epifluorescence microscopy was realized on the same microscope as for 
confocal images, except that the microscope was equipped with an EMCCD Evolve 512 
Photometrics camera.  The Zeiss HXP 120 was combined with a cube filter to observe phenylene 
emission (λex = 365/12 nm, λem = 445/50 nm) with 280 ms of exposure and to observe Yb3+ 
emission (λex = 377/50 nm, λem = long pass 770 nm) with 1 second of exposure. 
4.2.5.14 Spectral fluorescence microscopy 
Cells were plated onto 25-mm round quartz coverslips and incubated for 24 hours with 30 μg/mL 
nano-Yb-PVDC-3 before fixation with 4% PFA.  Fluorescence spectra were recorded on the 
POLYPHEME, the deep ultraviolet inverted microspectrofluorometer installed at the DISCO 
(Dichroïsme, Imagerie, Spectrométrie de masse pour la Chimie et la biOlogie) beamline at 
Synchrotron SOLEIL29.  Excitation at 280 or 340 nm was provided by the continuous emittance 
from the DISCO synchrotron beamline bending magnet and focused on the sample using a 100× 
microscope objective (Zeiss).  One full fluorescence emission spectrum was recorded on each 
point of the image (6 × 10 pixels) with an acquisition time of 10 seconds each.  A fluorescence 
intensity map was reconstructed in the spectral region of interest. 
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4.2.6 Cellular studies 
4.2.6.1  Cell culture 
HeLa (human epithelial ovarian carcinoma) and NIH 3T3 (mouse embryonic fibroblast) cell 
lines obtained from the American Type Culture Collection were grown at 37 °C in a 5% CO2-
humidified atmosphere.  Every 3–4 days, 5×105 cells were seeded into a 25-cm2 plastic flask.  
Cells were cultivated in Minimal Essential Medium (MEM) and in Dulbecco's Modified Eagle's 
Medium (DMEM), respectively, supplemented with 10% FBS and, for HeLa cells, 1% L-
glutamine, 1% penicillin/streptomycin, and 1% of a 100-fold nonessential amino acid solution. 
4.3 RESULTS AND DISCUSSION 
4.3.1 Bulk and nanoscale Ln-PVDC-3 MOFs 
Yb-PVDC-3 crystallizes in the low-symmetry space group P-1 and exhibits infinite Yb-
carboxylate secondary building units (SBUs) along the a-crystallographic direction.  All 
crystallographic data can be found in Appendix A.  The SBU consists of octa-coordinated Yb3+ 
with six carboxylates from three ligands and two oxygen atoms from two DMF molecules.  The 
SBU and crystal structure can be seen in Figure 4.1.  Analogous nanoMOFs: nano-Yb-PVDC-3, 
nano-Er-PVDC-3, and nano-Nd-PVDC-3, were determined to be isostructural to the bulk Yb-
PVDC-3, as evidenced by comparison of their respective powder X-ray diffraction (PXRD) 
patterns (Figure 4.2).  Compared with the previously reported Yb-PVDC-1 and Yb-PVDC-218, 
Yb-PVDC-3 has lower symmetry and its structure is significantly more condensed, with 1-D 
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channels along the a-crystallographic direction measuring ∼43 × 9 Å (Yb3+-Yb3+ center-to-
center distances).  The 1-D channels are very narrow: close contacts (e.g., 0.281, 0.637, and 
0.706 Å) exist between the PVDC linkers lining opposite channel walls.   
 
        
Figure 4.1.  Infinite secondary building unit (SBU) of Yb-PVDC-3 (left) (C, dark gray; O, red; Yb3+, 
green) and crystal structure of Yb-PVDC-3 viewed along the a-crystallographic axis (right). 
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Figure 4.2.  Powder X-ray diffraction (PXRD) patterns for simulated and bulk Yb-PVDC-3, nano-Yb-
PVDC-3, nano-Er-PVDC-3, nano-Nd-PVDC-3, and simulated Nd-PVDC-3. 
 
 
Scanning electron microscopy (SEM) was used to study the size of nano-Yb-PVDC-3.  
The nano-Yb-PVDC-3 MOFs exhibit a block-like morphology (Figure 4.3), having average 
dimensions of 0.5(±0.3) μm (length) by 316(±156) nm (width) by 176(±52) nm (thickness) 
(Figures 4.4-4.6). 
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Figure 4.3.  Representative scanning electron microscopy (SEM) image of nano-Yb-PVDC-3. 
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Figure 4.4.  Histogram for the measured length of nano-Yb-PVDC-3. 
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Figure 4.5.  Histogram for the measured width of nano-Yb-PVDC-3. 
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Figure 4.6.  Histogram for the measured thickness of nano-Yb-PVDC-3. 
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4.3.2 Spectroscopic characterization of nano-Ln-PVDC-3 in water 
The luminescence properties of nano-Yb-PVDC-3, nano-Er-PVDC-3, and nano-Nd-PVDC-3 
were studied in water.  The nano-Er-PVDC-3 exhibited no emission signal.  In the case of both 
nano-Yb-PVDC-3 and nano-Nd-PVDC-3, their excitation spectra (monitoring their Ln3+ 
centered emission at 980 nm and 1060 nm, respectively) were broad with three apparent maxima 
at 280 nm, 365 nm, and 450 nm.  Excitation through any of those bands resulted in Yb3+ 
emission centered at 980 nm for the nano-Yb-PVDC-3 (Figure 4.7) and Nd3+ emission with 
bands centered at 875 nm, 1060 nm, and 1330 nm for the nano-Nd-PVDC-3 (Figure 4.8). 
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Figure 4.7.  Excitation (λem = 980 nm) and emission (λex = 280 nm, 365 nm, and 450 nm) spectra for the 
nano-Yb-PVDC-3 in water. 
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Figure 4.8.  Excitation (λem = 1060 nm) and emission (λex = 280 nm, 365 nm, and 450 nm) spectra for 
nano-Nd-PVDC-3 in water. 
 
 
4.3.3 Barcoded nano-NdxYb1-x-PVDC-3 MOFs 
Since both nano-Yb-PVDC-3 and nano-Nd-PVDC-3 generated NIR emission when excited in 
the visible region, a series of barcoded nanoMOFs with various amounts of Yb3+ and Nd3+ were 
synthesized and studied: nano-Nd0.75Yb0.25-PVDC-3, nano-Nd0.50Yb0.50-PVDC-3, and nano-
Nd0.25Yb0.75-PVDC-3.  Comparison of the PXRD patterns to that of simulated Nd-PVDC-3 
(Figure 4.9) demonstrated that they were isostructural to each other and Nd-PVDC-3, and 
therefore to nano-Yb-PVDC-3 and nano-Nd-PVDC-3 as well.  This experiment allows for the 
assessment of the structure of the nano-Ln-PVDC-3 MOFs as their crystals are too small to 
determine their structures by single crystal X-ray diffraction. 
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Figure 4.9.  Powder X-ray diffraction (PXRD) patterns for simulated Nd-PVDC-3 and the barcoded 
series of nano-NdxYb1-x-PVDC-3 MOFs. 
 
 
The theoretical amounts of Nd3+ and Yb3+ incorporated into the nanoMOFs 
(stoichiometric amounts) were used for naming the materials, but energy dispersive X-ray (EDX) 
analysis was used to determine the actual amount incorporated during synthesis and to verify that 
both lanthanide ions were present within the materials (Table 4.1).  A good correlation between 
the theoretical and experimental values was observed, suggesting that neither of the two Ln3+ is 
preferentially incorporated into the nanoMOF. 
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Table 4.1.  Theoretical and experimental values of Yb3+ and Nd3+ present within the series of nano-
NdxYb1-x-PVDC-3 MOFs. 
Percent Yb3+ Percent Nd3+ 
 Theoretical EDX Theoretical EDX 
nano-Nd0.25Yb0.75-PVDC-3 75 70 25 30 
nano-Nd0.50Yb0.50-PVDC-3 50 50 50 50 
nano-Nd0.75Yb0.25-PVDC-3 25 26 75 74 
 
4.3.4 Spectroscopic characterization of nano-NdxYb1-x-PVDC-3 
The luminescence properties of the entire series of barcoded nanoMOFs were explored in water.  
The nano-Nd0.25Yb0.75-PVDC-3, nano-Nd0.50Yb0.50-PVDC-3, and nano-Nd0.75Yb0.25-PVDC-3 all 
had excitation spectra with apparent maxima of their bands located at 280 nm, 365 nm, and 450 
nm upon monitoring emission at 980 nm (Yb3+) or 1060 nm (Nd3+).  Excitation through any of 
those bands resulted in the simultaneous Yb3+ (980 nm) and Nd3+ emission (875 nm, 1060 nm, 
and 1330 nm).  The intensities of the emission bands are proportional to the amount of each 
lanthanide present.  In Figure 4.10, the spectra are normalized to the Yb3+ emission signal at 980 
nm.  As the relative amount of Nd3+ present increased, so did the emission intensity.  A similar 
situation was observed for the Yb3+ emission in the spectra normalized to Nd3+ emission at 1060 
nm (Figure 4.11).   
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Figure 4.10.  Emission (λex = 450 nm) spectra for nano-NdxYb1-x-PVDC-3 in water normalized to the 
maximum of the Yb3+ emission signal at 980 nm. 
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Figure 4.11.  Emission (λex = 450 nm) spectra for nano-NdxYb1-x-PVDC-3 in water normalized to the 
maximum of the Nd3+ emission at 1060 nm. 
 
 
The Yb3+ and Nd3+ bands were integrated and the fraction of each Ln3+ signal was plotted 
against the fraction of Ln3+ present in the MOF for both Yb3+ and Nd3+ (Figure 4.12).  In both 
cases the observed relationship appeared to be linear.   
 
 112 
20 30 40 50 60 70 800.00
0.05
0.10
0.15
0.20
0.25
0.30
Yb3+ in MOF
as Fraction of Total Ln3+ Content
Yb
3+
 Em
iss
ion
as
 Fr
ac
tio
n o
f T
ota
l E
mi
ss
ion
 
 
20 30 40 50 60 70 80
0.75
0.80
0.85
0.90
0.95
1.00
Nd
3+
 Em
iss
ion
as
 Fr
ac
tio
n o
f T
ota
l E
mi
ss
ion
Nd3+ in MOF
as Fraction of Total Ln3+ Content  
Figure 4.12.  Plots of the fraction of integrated emission for each Ln3+ versus fraction of Ln3+ present for 
Yb3+ (left) and Nd3+ (right). 
 
 
Relative quantum yields were collected for both Yb3+ and Nd3+ in each barcoded 
nanoMOF in order to quantify luminescence efficiencies.  A slight overlap is observed between 
the Yb3+ band at 980 nm and the Nd3+ band at 1060 nm (Figures 4.10 and 4.11).  In order to 
separate these bands for integration they were first deconvoluted, which is a contributing factor 
to the large errors observed in the quantum yield values (Table 4.2).  Despite these errors, we can 
observe an overall trend of the increasing of the quantum yield value with the increasing amount 
of corresponding lanthanide while the quantum yield value of the other lanthanide decreases as 
the amount of that lanthanide decreases.   
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Table 4.2.  Relative quantum yields (Φ) for Yb (ΦYb) and Nd (ΦNd) emission for nano-Yb-PVDC-3, 
nano-NdxYb1-x-PVDC-3, and nano-Nd-PVDC-3 MOFs*. 
ΦYb† ΦNd† 
nano-Yb-PVDC-3 1.0(±0.3)×10-4 - 
nano-Nd0.25Yb0.75-PVDC-3 1.0(±0.4)×10-4 7(±3)×10-4 
nano-Nd0.50Yb0.50-PVDC-3 6(±2)×10-5 8(±1)×10-4 
nano-Nd0.75Yb0.25-PVDC-3 4(±1)×10-5 1.0(±0.1)×10-3 
nano-Nd-PVDC-3 - 4(±1)×10-3 
*nanoMOFs as a crystalline solid under H2O;  † λex = 450 nm 
 
Nano-Yb-PVDC-3 was subsequently studied in greater detail for use in cellular imaging. 
4.3.5 Spectroscopic characterization of nano-Yb-PVDC-3 in HEPES buffer 
Luminescence properties of the nano-Yb-PVDC-3 were studied in 0.1 M HEPES buffer (pH 7.3) 
(Figure 4.13) to be close to physiological conditions.  As observed in water, nano-Yb-PVDC-3 
exhibited Yb3+ luminescence centered at 980 nm upon excitation of the PVDC sensitizer.  The 
overlap of the absorption spectrum of H2-PVDC with the excitation spectrum of the MOF (upon 
monitoring the Ln3+ emission) indicates that the sensitization is occurring via an antenna effect 
through the electronic structure of the PVDC.  Because Yb3+ does not have accepting levels in 
the visible, the observed Yb3+ luminescence must result from the sensitization provided by 
PVDC located in sufficiently close proximity to the lanthanide cations.   
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Figure 4.13.  Overlay of H2-PVDC absorption, nano-Yb-PVDC-3 excitation (λem = 980 nm), visible 
PVDC emission (λex = 355 nm), and NIR Yb3+ emission (λex = 355 nm) spectra recorded in 0.1 M HEPES 
at room temperature. 
 
 
Ideally, reagents for bioanalytical applications and for imaging should emit a constant 
number of photons over time, and their signals should not be affected by species and parameters 
other than the targeted analyte.  A common limitation for organic fluorophores is their tendency 
to photobleach when exposed to light.  Photobleaching test experiments were therefore 
performed by exposing a suspension of nano-Yb-PVDC-3 in 0.1 M HEPES (pH 7.3) to light 
over a period of 13 hours.  Results showed that the Yb3+ signal does not significantly change 
(Figure. 4.14), a strong indication that the material is stable in these conditions and usable over 
this extended period. 
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Figure 4.14.  Photobleaching study by monitoring the Yb3+ emission at 970 nm in 0.1 M HEPES over a 
period of 13 hours.  Error bars represent the standard deviation based on three independent experiments. 
 
 
Quantum yields were recorded to quantify the efficiency of the energy transfer between 
the antenna and Yb3+ and the protection of the lanthanide cations against sources of non-radiative 
deactivation.  Upon excitation at 450 nm, the quantum yield value for the nano-Yb-PVDC-3 is 
5.2(±0.8)×10−5 in 0.1 M HEPES (pH 7.3) (Table 4.3).  Such a value is relatively small in 
comparison to the best luminescent lanthanide compounds11-16, but our approach of using a MOF 
system to maximize the number of chromophores and lanthanide cations per unit volume is 
expected to reduce the negative impact of this limitation (see below).   
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Table 4.3.  Relative quantum yields (Φ) and luminescence lifetimes (τ) of Yb3+-centered emission at 980 
nm. 
Solvent* ΦYb† τ1‡ (μs) τ2‡ (μs) 
nano-Yb-PVDC-3 H2O 1.0(±0.3)×10
-4 7.01(±0.07) 1.51(±0.01) 
0.1 M HEPES 5.2(±0.8)×10-5 4.6(±0.1) 1.04(±0.02) 
*nanoMOFs as a crystalline solid under solvent; † λex = 450 nm; ‡ λex = 354 nm 
 
Luminescence lifetime experimental data (Table 4.3) were best fit with a bi-exponential 
decay curve, indicating that the Yb3+ cations are present within two distinct environments.  All 
the Yb3+ ions have a coordination number of eight (octa-coordinate), and the different 
environments are attributed to the Yb3+ present in the interior of the nanoMOF and the Yb3+ on 
the edges/faces of the crystallites (exterior).  Exterior Yb3+ are more susceptible to non-radiative 
deactivation and are likely responsible for the shorter lifetime values.   
   
4.3.6 Material stability studies  
The stability of Yb-PVDC-3 and nano-Yb-PVDC-3 was rigorously evaluated in various 
conditions, including water, 0.1 M HEPES buffer (pH 7.3), and cellular media.  First, samples of 
Yb-PVDC-3 were soaked in water or 0.1 M HEPES.  At different time points, SEM images were 
collected to visualize bulk structure and PXRD patterns were obtained to confirm retention of 
crystallinity.  In general, SEM images indicate that the crystals remain intact after soaking in 
water (Figure 4.15) or HEPES (Figure 4.16) for up to 4 weeks; however, crystallite 
fragmentation occurs during this time, and the average crystallite size consequently decreases.  
Notably, the faces of the crystallites remain smooth, and no significant pitting was observed on 
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the crystal surfaces.  PXRD patterns of crystallites collected after soaking in either water or 
HEPES buffer for different time intervals indicate retention of crystallinity (Figure 4.17). 
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Figure 4.15.  Scanning electron microscopy images of Yb-PVDC-3 (A) soaked in water for 1 week (B), 2 
weeks (C), 3 weeks (D), and 4 weeks (E). 
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Figure 4.16.  Scanning electron microscopy images of Yb-PVDC-3 (A) soaked in 0.1 M HEPES for 1 
week (B), 2 weeks (C), 3 weeks (D), and 4 weeks (E). 
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Figure 4.17.  Powder X-ray diffraction patterns recorded over a period of seven days for Yb-PVDC-3 
soaked in water (left) or 0.1 M HEPES (right). 
 
 
In order to preserve the luminescence properties of the NIR-emitting reagents and to 
prevent the release of free lanthanide cations in cellular media creating risks of toxicity, the 
nano-Yb-PVDC-3 must remain intact.  Therefore, the crystallite stability was quantitatively 
evaluated in cellular media by monitoring the Yb3+ emission signal upon excitation of the 
antenna.  The signal of the lanthanide cation can only be generated if the antenna effect is present 
and only if the sensitizer is located sufficiently close to the lanthanide.  Therefore, if the MOF 
dissociates via hydrolysis of the Yb-carboxylate bonds, for example, one would expect a 
significant decrease in the luminescence.  The signal arising from Yb3+ was measured at regular 
time intervals after dilution of the nano-Yb-PVDC-3 in cell lysate (HeLa or NIH 3T3 cells) and 
in water as a control.  Intensities of the emission bands compared with initial intensity (recorded 
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upon monitoring the Yb3+ band at 970 nm) are reported in Figure 4.18.  The emission intensity 
remained constant over time, which suggests that the nano-Yb-PVDC-3 structure is not 
significantly modified by cellular components.  Indeed, the constant total intensity of the Yb3+ 
emission signal is a quantitative indication that the measured nanoMOFs retain most of their 
integrity in this environment.  Therefore, we expect that nano-Yb-PVDC-3 will remain intact 
inside of the cell. 
 
 
Figure 4.18.  Spectroscopic evaluation of nano-Yb-PVDC-3 in water and cell lysate.  Emission intensity 
values correspond to the maximum of Yb3+ emission (970 nm). 
 
 
4.3.7 Cytotoxicity of nano-Yb-PVDC-3  
A principal aim of this study was to test nano-Yb-PVDC-3 in cells as NIR imaging agents. 
Human cancer (HeLa) and mouse (NIH 3T3) cells were chosen as representative cell lines.  The 
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nano-Yb-PVDC-3 cytotoxicity was first evaluated for both cell lines using the Alamar Blue 
assay.  The cell proliferation test (Figure 4.19) indicated a similar effect on the two cell lines 
after 24 hours of incubation.  The compound was found to have relatively low toxicity for 
concentrations up to 50 μg/mL.  A working concentration was chosen on the criterion of 90% of 
cellular viability (30 μg/mL).   
 
 
Figure 4.19.  Cellular viability by Alamar Blue assay on HeLa and NIH 3T3 cells after 24 hours of 
incubation with increasing concentrations of nano-Yb-PVDC-3. 
 
 
4.3.8 Cellular uptake 
Internalization of nano-Yb-PVDC-3 by the cells was confirmed with confocal microscopy and 
inductively coupled plasma (ICP) spectrometry experiments.  Microscopy images in Figure 4.20 
show that nano-Yb-PVDC-3 is internalized by cells.  Optical slices of 1 μm (less than cell 
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thickness) were obtained for NIH 3T3 cells after incubation with nano-Yb-PVDC-3 at 30 μg/mL.  
Despite the fact that untreated cells generate autofluorescence at these wavelengths (λex = 365 
nm, λem = 445/50 nm), the chromophore signal could be unambiguously detected inside cells.  
This fluorescence signal is located preferentially in the cytoplasm (and not in the nucleus).   
 
 
Figure 4.20.  Cellular uptake of nano-Yb-PVDC-3 as demonstrated by confocal microscopy of NIH 3T3 
cells after incubation with nano-Yb-PVDC-3 (upper) and of untreated cells (lower).  Brightfield (A), H2-
PVDC emission (λex = 365/12 nm, λem 445/50 nm) (B), and merged (C) images are shown. 
 
 
To confirm results of confocal microscopy, the quantity of nano-Yb-PVDC-3 associated 
with 1×106 cells was measured by ICP (Table 4.4).  More specifically, the amount of Yb3+ in 
cells was measured after 24 hours of incubation of HeLa and NIH 3T3 cells with nano-Yb-
PVDC-3.  ICP results confirm the presence of nano-Yb-PVDC-3 in the cells.  For both cell lines, 
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the Yb3+ amount in cells increases with the amount of nano-Yb-PVDC-3 present in cell 
incubation medium.  No saturation of cellular uptake has been observed at these concentrations.  
The uptake is more pronounced in NIH 3T3 cells than in HeLa cells.  The mechanism of cell 
uptake has not been analyzed at this time and is currently under investigation. 
Table 4.4.  Determination of cellular uptake by ICP. 
Sample 
Concentration of  
nano-Yb-PVDC-3 in 
Cell Media 
(µg/mL) 
Theoretical Concentration 
of Yb3+ in Cell Media 
(µg/mL) 
Concentration of Yb3+ 
in 1×106 cells 
(µg/mL) 
HeLa 
Cells 
0 0 0.000(±0.002) 
20 4.06 0.113(±0.003) 
30 6.09 0.213(±0.003) 
40 8.12 0.270(±0.003) 
NIH 
3T3 
Cells 
0 0 0.000(±0.002) 
20 4.06 0.466(±0.010) 
30 6.09 0.996(±0.020) 
40 8.12 1.130(±0.003) 
4.3.9 Spectral microscopy  
Several cellular compounds are excited by UV light and emit in the visible, such as tryptophan 
(λex = 275 nm, λem = 335 nm), collagen (λex = 335 nm, λem = 405 nm), and NAD(P)H (λex = 340 
nm, λem = 460 nm)30.  To confirm that the detected signal observed with confocal microscopy is 
arising from PVDC emission, spectral fluorescence microscopy analysis was conducted on cells 
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after 24 hours of incubation with nano-Yb-PVDC-3.  At each individual point of the image (step 
size = 3 μm), an emission spectrum was recorded.  The intensity value averaged between 400 
and 600 nm was used to create an intensity map of the cell (Figure 4.21).  This spectral 
fluorescence microscopy experiment permits the discrimination of nano-Yb-PVDC-3 emission 
from cellular autofluorescence.  The signal obtained from untreated cells can be attributed to 
cellular autofluorescence with a maximum of the emission band located at 420 nm (Figure 4.22).  
Spectra obtained from treated cells result from the overlay of autofluorescence emission and 
PVDC emission signals (λem = 455 nm).  This result is a third confirmation that the nanoMOF 
was able to enter incubated cells.   
 
   
Figure 4.21.  Spectral microscopy fluorescence intensity map of untreated NIH 3T3 cells (left) and NIH 
3T3 cells after incubation with nano-Yb-PVDC-3 (right) (λex = 340 nm, λem = 390-650 nm). 
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Figure 4.22.  Spectra corresponding to the mean intensity of each fluorescence intensity map in Figure 
4.21. 
 
 
4.3.10 NIR epifluorescence microscopy 
The ability to use nano-Yb-PVDC-3 as a NIR lanthanide-based imaging agent was tested in a 
NIR microscopy experimental setup.  HeLa and NIH 3T3 cells were incubated with 30 μg/mL 
nano-Yb-PVDC-3 for 24 hours.  Visible chromophore (PVDC) and NIR Yb3+ emission signals 
were both	observed by epifluorescence microscopy in the same field (Figure 4.23).  In the NIR 
microscopy mode, the specific Yb3+ emission signal was collected with good sensitivity (1 
second exposure time can be considered short for NIR signals) as the result of a high signal-to-
noise ratio.  In parallel, switching to visible detection mode, the specific fluorescence arising 
from the PVDC was observed in addition to the cellular autofluorescence, and the resulting 
images were used as a comparison.  The difference observed between the PVDC and Yb3+ 
emission signal results from the discrimination of the NIR signal from the visible 
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autofluorescence arising from the biological material.  Control experiments were also conducted 
in which cells were untreated but underwent the same imaging (Figure 4.24).  Autofluorescence 
was observed in the visible region, but there was virtually no emission in the NIR region.  The 
images presented in Figure 4.23 report NIR microscopy experiments obtained with a lanthanide 
compound in living cells using a conventional excitation source. 
 
 
Figure 4.23.  Visible and NIR microscopy images of nano-Yb-PVDC-3 in HeLa cells (upper) and NIH 
3T3 cells (lower) (λex = 340 nm).  Brightfield (A), H2-PVDC emission (λex = 377/50 nm, λem = 445/50 
nm) (B), and Yb3+ emission (λex = 377/50 nm, λem = long pass 770 nm) (C) images are shown. 
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Figure 4.24.  Visible and NIR microscopy images of untreated HeLa cells (lower) and NIH 3T3 cells 
(upper) (λex = 340 nm).  Brightfield (A), visible emission (λex = 377/50 nm, λem = 445/50 nm) (B), and 
NIR emission (λex = 377/50 nm, λem = long pass 770 nm) (C) images are shown. 
 
 
4.4 CONCLUSION 
We have designed and synthesized a series of barcoded nanoMOFs, nano-NdxYb1-x-PVDC-3, 
which are isostructural and simultaneously emit in the NIR upon excitation.  The amount of each 
Ln3+ utilized in the synthesis correlated well with the amount incorporated into the nanoMOF 
and the resulting emission intensity.  Nano-Yb-PVDC-3 was tested for its ability to operate as a 
NIR imaging agent in cells.  The overlap of the excitation spectra of nano-Yb-PVDC-3 with the 
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absorbance spectra of H2-PVDC demonstrated that the Yb3+ is sensitized through the antenna 
effect, where the sensitizers embedded in the MOF structure are excited and transfer energy to 
the accepting level of the Yb3+ cations.  Nano-Yb-PVDC-3 was shown to be luminescent in 
water and HEPES buffer.  As expected, its quantum yield was low in water, due to the energy 
level of the −OH overtone vibration being so close to that of Yb3+, and it further decreased when 
the nanoMOF was placed in HEPES, likely due to the increase in number of moieties with −OH 
vibrations in solution.  This low quantum yield does not prevent imaging applications because of 
the polysensitizer and polymetallic design.  The energy transfer was conserved after 24 hours of 
incubation in cellular media, indicating that crystalline nano-Yb-PVDC-3 remains in the cells.  
This stability, combined with cytotoxicity results, is promising for using nano-Yb-PVDC-3 as a 
biological probe for in vivo applications.  We have been able to observe NIR microscopy images 
in living cells based on the signal arising from Yb3+, sensitized via the antenna effect.  This 
achievement has been realized by the use of a unique nanoMOF that is able to incorporate a large 
number of lanthanide sensitizers (PVDC) and a large number of NIR-emitting lanthanide cations, 
resulting in an increase in the number of emitted NIR photons per unit volume. 
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5.0  LUMINESCENT SIZE-CONTROLLABLE NANOSCALE METAL-ORGANIC 
FRAMEWORKS WITH BIOLOGICAL NEAR-INFRARED EXCITATION AND 
EMISSION WAVELENGTHS 
This work was performed in collaboration with Sandrine Villette and Sunčica Vujica (Centre de 
Biophysique Moléculaire, Centre National de la Recherche Scientifique, Orléans, France), and 
Alexander B. Spore (Nathaniel L. Rosi Research Group, University of Pittsburgh). 
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5.1 INTRODUCTION 
Imaging biological systems in real time is a powerful diagnostic tool, and a good deal of focus 
has been placed on utilizing the near-infrared (NIR) region of the electromagnetic spectrum to do 
so.  There is a “NIR window” in which biological species absorb significantly less, allowing for 
deeper penetration into tissue and non-invasive investigations.1,2  Lower biological 
autofluorescence signal in the NIR makes it easier to discriminate the desired signal from 
biological background therefore increasing the detection sensitivity and decreasing interpretation 
ambiguity.  NIR light scatters less than visible light leading to enhanced image resolution.3,4  
An ideal luminescent biological imaging reporter would be able to be excited in the NIR, 
emit in the NIR, be non-toxic, and resist biological-, thermal-, and photo-degradations.  There 
are a variety of materials which meet some, but not all, of these requirements.5-7  There are a 
multitude of organic dyes which have both excitation and emission it the biological NIR.6  A 
cyanine dye, indocyanine green (ICG), is approved by the Food and Drug Administration (FDA) 
for direct administration in medical ophthalmologic diagnostics, although it suffers from poor 
photostability.  One way to increase the photostability has been to encapsulate dyes in 
nanoparticles.8,9  While some improvements were achieved over the years, organic fluorophores 
suffer from broad emission spectra which render them unsuitable for multiplexing or barcoding.  
Quantum dots (QDs) are typically brighter and more photostable than organic dyes10, and their 
size-dependent emission allows for the ability to tune the emission wavelength11.  The downfall 
of QDs is the blinking phenomenon they exhibit.12  
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Another complementary approach worth testing is to use lanthanide cations whose unique 
properties explain their emergence for bioanalytical and optical imaging applications.13,14  Their 
emission bands are sharp compared with organic fluorophores and semiconductor nanocrystals, 
and their emission wavelengths are not affected by their chemical and biological environments 
allowing them to be used in a broad range of conditions, including varying pH.14  Lanthanide 
complexes possess long emission lifetimes and a good resistance to photobleaching15-17, which 
enables them to be used repeatedly over long periods of time. 
Lanthanide cations have very low molar extinction coefficients due to the forbidden 
nature of the f → f transition.14  In order to overcome this limitation, an organic chromophore 
needs to be placed in sufficiently close proximity to the lanthanide to act as an “antennae” and 
sensitize the lanthanide cations.18  Additionally, luminescent lanthanide complexes are often 
limited by their low quantum yield.  One way to overcome this is to utilize lanthanides as the 
metal in metal-organic frameworks (MOFs) to create a polymetallic species.  MOFs have well-
defined structures which allow the tridimensional control of the incorporation of a large number of 
chromophoric sensitizers and lanthanide cations in the structure.  Consequently, this results in a large 
number of photons emitted per volume unit, an important advantage that enhances the detection 
sensitivity.17  Another advantage of the MOF structure is that it can be tailored to tune and optimize 
the photoluminescence properties of the luminescent lanthanides.19  Since MOFs are porous it is 
possible to incorporate a variety of molecules and nanomaterials into the pores, including therapeutic 
agents such as anticancer drugs, biogases (nitric oxide), and imaging agents (Gd3+).20-23  
We have recently reported the creation and biological use of nanoscale luminescent 
metal-organic frameworks for in vivo cellular imaging which were internalized by cells, were 
demonstrated to be non-cytotoxic, photostable, and emitted in the NIR with a sufficient intensity 
to allow for sensitive detection.17  This nano-Yb-PVDC-3 MOF used PVDC as the ligand and 
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chromophore with the Yb3+ being both the metal and the NIR emitter.  Here we have transitioned 
to a more biologically-friendly ligand21,24, 1,3,5-benzenetricarboxylic acid (BTC), to synthesize a 
series of Yb3+ MOFs.  Several MOFs have been synthesized with this linker and various 
lanthanides25-29, including the miniaturization29 of Dy(BTC)(H2O), but to the best of our 
knowledge, we describe here the first example of the miniaturization of the Yb(BTC)(H2O) MOF 
and study of its NIR Yb3+ emission.   
In order to shift the excitation wavelength to the NIR we used a totally new approach: the 
incorporation of a NIR absorbing chromophore, 4-hydroxyl-1-(4-methyl-2-sulfoanilino)-
anthraquinone (4hAQ) to act as an antennae within the nanoscale Yb(BTC)(H2O) MOF.  We 
achieved what we believe to be the first example of a nanoscale MOF for biological imaging 
which can both be excited and emit in the NIR.  To further protect the Yb3+ and enhance the 
luminescence signal in water, the dye-incorporated nanoMOFs were coated with a silica shell 
which can be easily functionalized in the future. 
5.2 EXPERIMENTAL 
5.2.1 Reagents 
All reagents were used as received without further purification.  1,3,5-benzentricarboxylic acid 
(BTC; 95%), ammonium hydroxide solution, tetraethyl orthosilicate (TEOS), indocyanine green 
(ICG), and deuterium chloride (DCl; 35 wt% in D2O, 99 atom% D) were purchased from 
Aldrich.  Ytterbium (III) nitrate pentahydrate (Yb(NO3)3∙5H2O; 99.9%) was purchased from 
Strem.  N,N-dimethylformamide (DMF; Certified ACS) and Alexa Fluor 647 (AF647) were 
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purchased from Fisher.  Sodium acetate (NaOAc, anhydrous) was purchased from EM.  Ethanol 
(EtOH; 200 proof) was purchased from Decon Laboratories, Inc.  4-hydroxyl-1-(4-methyl-2-
sulfoanilino)-anthraquinone (4hAQ; >95.0%) was purchased from TCI.  Dimethylsulfoxide 
(DMSO; ACS Reagent, >99.9%) was purchased from Sigma-Aldrich.  Deuterated 
dimethylsulfoxide (DMSO-d6; 99.9%) was purchased from Cambridge Isotope Laboratories.  
Hydrochloric acid (HCl; 36.5-38.0%, Baker Analyzed ACS Reagent) was purchased from J.T. 
Baker. 
5.2.2 Synthetic Procedures 
5.2.2.1 Synthesis of Yb(BTC)(H2O)·DMF MOF 
The following materials were placed in a 20 mL scintillation vial: 0.10 mmol BTC, 0.13 mmol 
Yb(NO3)3∙5H2O, 8 mL DMF, and 2 mL distilled H2O.  The vial was capped, sonicated for ~10 
seconds to completely dissolve the Yb3+ salt, and placed in an isotemp oven at 60 °C for 72 
hours.  The vial was cooled to room temperature, and the white solid was collected via vacuum 
filtration and washed with DMF.  Elemental analysis (EA) calcd (%) for Yb(BTC)(H2O)·DMF: 
C, 30.58; H, 2.57; N, 2.97.  Found: C, 29.86; H, 2.30; N, 3.01. 
5.2.2.2 Synthesis of Yb(BTC)(H2O)·DMF nanoMOF 
The following materials were placed in a 20 mL scintillation vial: 0.10 mmol BTC, 0.13 mmol 
Yb(NO3)3∙5H2O, 8 mL DMF, and 2 mL distilled H2O.  The mixtures were stirred until the 
solutions were clear.  Either 0.1 mmol (1 equivalent wrt BTC), 0.2 mmol (2 equivalents wrt 
BTC), 0.3 mmol (3 equivalents wrt BTC), or 0.35 mmol (3.5 equivalents wrt BTC) NaOAc was 
added, and the mixture was stirred for 10 minutes at room temperature during which time a white 
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precipitate was observed.  The vial was capped and placed in an isotemp oven at 60 °C for 24 
hours.  The vial was cooled to room temperature, and the solid material was collected via 
centrifugation at 10,000 rpm for 5 minutes.  The solid was washed three times with DMF and air 
dried.  Elemental analysis (EA) calcd (%) for Yb(BTC)(H2O)·DMF: C, 30.58; H, 2.57; N, 2.97.  
For 1 equivalent of NaOAc, found: C, 29.60; H, 2.28; N, 2.90.  For 2 equivalents of NaOAc, 
found: C, 29.94; H, 2.33; N, 3.01.  For 3 equivalents of NaOAc, found: C, 30.09; H, 2.39; N, 
3.10.  For 3.5 equivalents of NaOAc, found: C, 30.10; H, 2.34; N, 3.10. 
5.2.2.3 Solvent exchange of Yb(BTC)(H2O)·DMF nanoMOF 
Yb(BTC)(H2O)·DMF synthesized with 3 equivalents of NaOAc was solvent exchanged by 
removing the solvent (initially DMF, subsequently EtOH) and replacing with fresh EtOH after 
10 min (×3), 12 hours, and 24 hours.  Elemental analysis (EA) calcd (%) for 
Yb(BTC)(H2O)·EtOH: C, 29.74; H, 2.50; N, 0.00.  Found: C, 29.12; H, 2.23; N, 0.17. 
5.2.2.4 Anthraquinone incorporation 
A small amount (X mg, where typically X=1) of solid Yb(BTC)(H2O) nanoMOF (3 eq. NaOAc) 
was diluted with EtOH (0.9 × X mL) to achieve a concentration of 1.1 mg/mL.  This solution was 
sonicated for at least 10 hours but up to several days with intermittent periods of mixing in order 
to achieve a homogeneous suspension as determined by visual inspection.  Separately, 4-
hydroxyl-1-(4-methyl-2-sulfoanilino)-anthraquinone (4hAQ) was dissolved in EtOH to create a 
solution with a concentration of 1 mg/mL.  A small volume of 4hAQ solution (X/10 mL) was 
added to the nanoMOF suspension to result in a final concentration of 100 μg/mL 4hAQ and 1 
mg/mL nanoMOF.  This suspension was stirred in the dark for at least 24 hours.  The sample was 
washed twice by centrifugation at 2800×g for 10 minutes, removing the supernatant, and adding 
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EtOH (X mL) to redissolve the pellet.  The final concentration of the suspension was 1 mg/mL 
Yb(BTC)(H2O)+4hAQ.  The sample was either used immediately or it was centrifuged at 
2800×g for 10 minutes, the supernatant was removed, and the Yb(BTC)(H2O)+4hAQ was dried 
under vacuum for a few minutes. 
5.2.2.5 Silica coating 
Yb(BTC)(H2O)+4hAQ was coated with a silica shell using a sol-gel procedure adapted from the 
literature.30  1 mL of Yb(BTC)(H2O)+4hAQ solution at 1 mg/mL in EtOH was further diluted 
with 8.6 mL of EtOH.  Aqueous ammonia (400 μL) was added drop by drop under vigorous 
stirring.  Then 20 μL of tetraethyl orthosilicate (TEOS) was added, and the mixture was left 
stirring for 2 hours in the dark.  An additional aliquot of TEOS (20 μL) was added and the 
suspension was left to stir for an additional 3 hours before purification by two steps of 
centrifugation (2800×g) and re-suspension in EtOH.  After the second step of centrifugation the 
supernatant was removed and either replaced by 1 mL of EtOH for immediate measurement or 
the pellet was dried under vacuum for a few minutes. 
5.2.3 Instrumentation 
5.2.3.1 Elemental analysis 
The elemental microanalysis (CHN) was performed by the Microanalysis Laboratory at the 
University of Illinois Urbana-Champaign.  Samples were dried under nitrogen flow to remove 
excess solvent prior to submission for analysis. 
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5.2.3.2 Fourier transform infrared spectroscopy 
Fourier-transform infrared (FTIR) spectra were collected on a Perkin Elmer Spectrum 100 FTIR 
with a universal attenuated total reflectance (ATR) sampling accessory coupled to a computer 
using Perkin Elmer Spectrum Express software. 
5.2.3.3 Powder X-ray diffraction 
Powder X-ray diffraction (PXRD) patterns were collected using a Phillips PW 1830 
diffractometer at 40 kV, 40 mA, for Cu Kα (λ = 1.54056 Å) with a scan speed of 0.20 seconds 
per step and a step size of 0.020°. 
5.2.3.4 Scanning electron microscopy 
Samples were coated with palladium for 60 seconds before analysis with a Phillips XL 30 
scanning electron microscope (SEM).  ImageJ 1.47v software (National Institutes of Health) was 
used to measure particle dimensions.  OriginPro 9.1 software (OriginLab Corporation) was used 
to process the data. 
5.2.3.5 Transmission electron spectroscopy 
All images were collected with a Philips CM20 transmission electron microscope (TEM) operating at 
200 kV and equipped with a filament Lab6. 
5.2.3.6 Thermogravimetric analysis 
Thermogravimetric analysis (TGA) was conducted on a TGA Q500 thermal analysis system.  
Prior to analysis, samples were dried under nitrogen flow to remove excess solvent.  
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Approximately 5 mg of sample were loaded into a platinum pan and heated under a constant N2 
(UHP) flow from room temperature to 600 °C at a rate of 5 °C/min. 
5.2.3.7 Adsorption 
Gas adsorption isotherms were collected on a Quantachrome Autosorb-1 instrument.  The 
samples were first washed thoroughly with absolute ethanol.  Approximately 100-140 mg of 
each sample was added into a pre-weighed sample analysis tube that had been evacuated and 
backfilled with He before massing.  The samples were degassed at 100 °C under vacuum for ~24 
hours until the pressure change rate was no more than 3 mTorr/min.  A liquid N2 bath was used 
for the N2 adsorption experiments at 77 K.  Ultra high purity (UHP) grade N2 gas adsorbates 
(99.999 %) were used in this study.  
5.2.3.8 Nuclear magnetic resonance spectroscopy 
A solution of 23 μL DCl (35% in D2O) and 1000 μL DMSO-d6 was used to dissolve the solid 
samples for 1H NMR analysis.  A small amount of solid was dissolved in 150 μL of the 
DCl/DMSO solution and diluted with an additional 500 μL DMSO-d6.  Samples were analyzed 
with either a Bruker Avance III 300 MHz or 400 MHz NMR. 
5.2.3.9 Absorption spectroscopy 
Ultraviolet-visible (UV-vis) absorption spectra for the quantification of 4hAQ were collected on 
an Agilent 8453 spectrometer coupled to a personal computer with software supplied by Agilent.  
The solvent for quantification via absorption was analogous to that used for NMR except it was 
not deuterated; 690 μL of concentrated HCl was combined with 130 mL DMSO.  Standard 
solutions of 4hAQ ranged in concentration from 5×10-7 to 1×10-5 M.  4.5 mg of 
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Yb(BTC)(H2O)+4hAQ was dissolved in 2.0 mL of the solvent.  All other absorption 
measurements were recorded on a Jasco V670. 
5.2.3.10 Luminescence spectroscopy 
Excitation and emission spectra were measured using a HORIBA Jobin Yvon Fluorolog 3-22 
spectrofluorometer equipped with a R928 Hamamatsu detector for visible detection and with 
either a DSS-IGA020L detector (Electro-Optical Systems, Inc.) or a H10330-75 detector 
(Hamamatsu) for the NIR.  The sample holder was an integrating sphere using quartz tubes 
developed by Frédéric Gumy and Jean-Claude G. Bünzli (Laboratory of Lanthanide 
Supramolecular Chemistry, École Polytechnique Féderale de Lausanne, Lausanne, Switzerland) 
as an accessory to the Fluorolog 3-22 spectrofluorometer (patent pending) and commercialized 
and manufactured by GMP.31  Spectra were corrected for variations in lamp intensity over the 
spectra range, as well as for excitation monochromator, emission monochromator, and detector 
responses.  The data were analyzed using OriginPro 9.1 software. 
5.2.3.11 Quantum yield measurements 
Quantum yield measurements were also collected on the Fluorolog-322 with the integrating 
sphere.  Collecting NIR quantum yields requires the use of both a visible and a NIR detector; 
ytterbium tropolonate ([Yb(trop)4]− in DMSO, ΦYb =1.9(±0.1)×10−3) was used as a reference32.  
The process for collecting a relative quantum yield using the integrating sphere is the following 
step by step process:  
1) Emission spectra of the lamp were collected for the sample (RS+SB), the solvent in which 
the sample is placed (RSB), the reference (see above, RR+RB), and the solvent in which the 
reference is dissolved (RRB).  Neutral density filters were placed at the excitation port of 
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the integrating sphere to control the high intensity of the lamp.  The spectra were 
corrected, as described above, and the bands were integrated.  The resulting integration 
values were used to determine the amount of light that was absorbed by the sample and 
the reference, given by:  
SBSSBS RRR   
Equation 5.1. 
and 
RBRRBR RRR   
Equation 5.2. 
2) Emission spectra of the sample (IS+SB), of the sample solvent (ISB), of the reference 
(IR+RB), and of the reference solvent (IRB) were collected in the NIR range.  A 780 nm 
long-pass filter was placed at the NIR emission port of the integrating sphere to eliminate 
contributions from second order bands.  Emission spectra were corrected for the lamp 
variation, the solvent spectra were subtracted from the appropriate sample and reference 
spectra: 
SBSBSS III    
Equation 5.3. 
and 
RBRBRR III    
Equation 5.4. 
and the resulting spectra were corrected for detector response.  The spectra were not 
corrected for the filters because in the case of a relative quantum yield measurement the 
use of a scalar (see below how such scalar is calculated) corrects for the filters during the 
calculations. 
 142 
3) The known quantum yield of the reference was used to create a scalar (XNIR-VIS) which 
accounts for the use of two different detectors in the visible and in the NIR with a domain 
of overlapping response: 
R
RR
VISNIR I
RX   
Equation 5.5. 
4) The quantum yield of the sample was calculated using the following equation: 
S
SVISNIR
S R
IX   
Equation 5.6. 
 
5.2.3.12 Photobleaching studies 
Photobleaching experiments were performed using the same instrumental set-up.  A similar 
volume of 60 μL was used for each sample: 4hAQ, (Yb(BTC)(H2O)+4hAQ)@SiO2, Alexa Fluor 
647 (AF647), and indocyanine green (ICG).  All samples were in HEPES buffer (10 mM, pH 
7.4) and were manually mixed using a micropipette prior to each measurement.  A series of 10 
spectra (λex = 580 nm, 14 nm bandpass) were recorded with a 5 minute delay between spectra.  
The samples were maintained under continuous illumination for a total time of one hour.   
Luminescence signal was determined as the integral of the luminescence band of each spectrum 
divided by the integral of the luminescence band of the first recorded spectrum (time = 0 
minutes).  It must be noted that (Yb(BTC)(H2O)+4hAQ)@SiO2 was left in HEPES buffer for 4 
hours prior to the photobleaching experiment in order to reduce the loss of luminescence signal 
due to the penetration of water inside the silica shell.   
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5.2.3.13 Luminescence lifetimes 
Luminescence lifetimes were measured using a neodymium yttrium aluminum garnet (Nd:YAG) 
Continuum Powerlite 8010 laser (355 nm, third harmonic) as the excitation source.  Emission 
was collected at a right angle to the excitation beam, and wavelengths were selected by a 
Spectral Products CM110 1/8m monochromator.  The signal was monitored by a Hamamatsu 
R316-02 photomultiplier tube and collected on a 500-MHz bandpass digital oscilloscope 
(Tektronix TDS 754D).  Signals from >1,000 flashes were collected and averaged.  Three decay 
curves were collected for each sample, and the data were analyzed using OriginPro 9.1 software 
with exponential fitting modes. 
5.3 RESULTS AND DISCUSSION 
5.3.1 Bulk and nanoscale Yb(BTC)(H2O) MOFs 
A previously reported synthesis29 for Dy(BTC)(H2O) was modified to use the NIR-emitting 
Yb3+.  As was reported with the Dy3+ system29, altering the number of equivalents of sodium 
acetate (NaOAc) with respect to the equivalents of 1,3,5-benzenetricarboxylic acid (BTC) ligand 
(Figure 5.1) in the synthesis allowed for excellent size control in the Yb3+ system.  In the absence 
of NaOAc the bulk crystals were long and needle-like (Figure 5.2).  The addition of one, two, 
three, or three and one-half equivalents of NaOAc resulted in increasingly smaller rod-like 
nanoparticles which, upon addition of three and one-half equivalents were spherical (Figure 5.3). 
A size comparison is summarized in Table 5.1, and the corresponding histograms are depicted in 
Figures 5.4-5.8.  
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Figure 5.1.  Structure of 1,3,5-benzenetricarboylic acid (BTC) ligand. 
 
 
 
 
Figure 5.2.  Representative scanning electron microscopy (SEM) image of Yb(BTC)(H2O) MOF 
synthesized in absence of sodium acetate. 
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Figure 5.3.  Representative scanning electron microscopy (SEM) images of Yb(BTC)(H2O) nanoMOF 
synthesized with 1 equivalent (A), 2 equivalents (B), 3 equivalents (C), and 3.5 equivalents (D) of 
NaOAc. 
 
 
 
Table 5.1.  Length and width dimensions of Yb(BTC)(H2O) MOFs synthesized with various amounts of 
sodium acetate.  Errors reported are standard deviations based on at least 50 measurements. 
 0 eq. NaOAc 1 eq. NaOAc 2 eq. NaOAc 3 eq. NaOAc 3.5 eq. NaOAc 
Length (nm) 28(±16)×103 166(±64) 129(±45) 79(±23) - 
Width (nm) 1.9(±0.8)×103 54(±11) 51(±10) 46(±9) 64(±19) 
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Figure 5.4.  Histograms for length (left) and width (right) measurements for Yb(BTC)(H2O) MOF 
synthesized with 0 equivalents of NaOAc. 
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Figure 5.5.  Histograms for length (left) and width (right) measurements for Yb(BTC)(H2O) nanoMOF 
synthesized with 1 equivalent of NaOAc. 
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Figure 5.6.  Histograms for length (left) and width (right) measurements for Yb(BTC)(H2O) nanoMOF 
synthesized with 2 equivalents of NaOAc. 
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Figure 5.7.  Histograms for length (left) and width (right) measurements for Yb(BTC)(H2O) nanoMOF 
synthesized with 3 equivalents of NaOAc. 
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Figure 5.8.  Histogram for width measurements for Yb(BTC)(H2O) nanoMOF synthesized with 3.5 
equivalents of NaOAc. 
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The powder X-ray diffraction (PXRD) patterns (Figure 5.9) collected for these materials 
were identical to each other and an exact match to the previously reported pattern27 for 
Yb(BTC)(H2O)·guest MOF (Figure 5.10).  This chemical formula was corroborated by both 
elemental analysis (see Sections 5.2.2.1 and 5.2.2.2) and thermogravimetric analysis (Figure 
5.11). 
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Figure 5.9.  Powder X-ray diffraction (PXRD) patterns for Yb(BTC)(H2O) MOFs synthesized with 0, 1, 
2, 3, and 3.5 equivalents of NaOAc, and the simulated pattern27 for Yb(BTC)(H2O)·DMF. 
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Figure 5.10.  Infinite secondary building units (SBUs) of Yb(BTC)(H2O) MOF (left) (Yb3+, green; C, 
gray; O, red) and crystal structure of Yb(BTC)(H2O) MOF viewed along the c-crystallographic direction 
(right).  Uncoordinated molecules of H2O and DMF are not shown for clarity; fully evacuated pore 
dimensions are 7×7 Å.   
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Figure 5.11.  Thermogravimetric analysis (TGA) for each of the Yb(BTC)(H2O)·DMF MOFs 
synthesized.  The percent weight loss at 300 °C (represented by the dotted line) is shown in the legend 
and corresponds to the loss of one DMF molecule from the pore and one H2O molecule from the 
framework. 
 
 
5.3.2 Stability of Yb(BTC)(H2O) MOF 
In order to evaluate the water stability of these materials, the bulk MOF was soaked in water for 
28 days.  At various time points the solid was removed from the water and analyzed using PXRD 
(Figure 5.12) and SEM (Figure 5.13) techniques.  These experiments qualitatively demonstrated 
that the material maintains its crystallinity in an aqueous environment. 
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Figure 5.12.  Powder X-ray diffraction (PXRD) patterns for Yb(BTC)(H2O) MOF after soaking in water 
for various amounts of time and the simulated pattern27 for Yb(BTC)(H2O)·DMF. 
 
 
 
          
       
Figure 5.13.  Representative scanning electron microscope (SEM) images of Yb(BTC)(H2O) (A) after 
soaking in water for 1 hour (B), 1 day (C), 4 days (D), 7 days (E), 14 days (F), 21 days (G), and 28 days 
(H). 
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5.3.3 Spectroscopic properties of Yb(BTC)(H2O) MOFs 
The spectrophotometric properties of the MOF and nanoMOFs were initially investigated as 
solid crystalline materials under DMF (Figures 5.14-5.18).  The excitation spectra collected 
while monitoring the Yb3+ emission at 980 nm exhibited one distinct band centered at 285 nm 
which overlays well with the absorption spectrum of BTC (Figure 5.14).  This indicates that the 
BTC ligand is a suitable antenna.  As Yb3+ does not possess accepting electronic levels in the 
ultraviolet-visible range, the only way to obtain the sharp emission band of Yb3+ in this 
experiment is to use the electronic levels present in the BTC.    Excitation at 285 nm resulted in 
the strongest emission intensity, but excitation at 355 nm still produced a measurable signal 
(although ~91% less intense) despite being far on the red shoulder of the excitation band.  
Nevertheless, such excitation wavelength is not optimal for the excitation of imaging agents in 
biological conditions as biological systems absorb an appreciable amount of light in this 285–
355 nm wavelength range.   
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Figure 5.14.  Excitation and emission spectra of Yb(BTC)(H2O) MOF in DMF.  Left: Normalized 
excitation and emission spectra overlaid with the normalized absorption spectrum of BTC.  Right: Non-
normalized emission spectra demonstrating the ~91% decrease in emission intensity when red-shifting the 
excitation wavelength. 
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Figure 5.15.  Excitation and emission spectra of Yb(BTC)(H2O) nanoMOF (synthesized with 1 eq. 
NaOAc) in DMF.  Left: Normalized excitation and emission spectra.  Right: Non-normalized emission 
spectra demonstrating the ~91% decrease in emission intensity when red-shifting the excitation 
wavelength. 
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Figure 5.16.  Excitation and emission spectra of Yb(BTC)(H2O) nanoMOF (synthesized with 2 eq. 
NaOAc) in DMF.  Left: Normalized excitation and emission spectra.  Right: Non-normalized emission 
spectra demonstrating the ~91% decrease in emission intensity when red-shifting the excitation 
wavelength. 
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Figure 5.17.  Excitation and emission spectra of Yb(BTC)(H2O) nanoMOF (synthesized with 3 eq. 
NaOAc) in DMF.  Left: Normalized excitation and emission spectra.  Right: Non-normalized emission 
spectra demonstrating the ~91% decrease in emission intensity when red-shifting the excitation 
wavelength. 
 
 
 
400 600 800 1000 1200 14000.0
0.2
0.4
0.6
0.8
1.0
No
rm
ali
ze
d I
nte
ns
ity
 (a
.u.
)
Wavelength (nm)
 em = 980 nm
 ex = 285 nm
 ex = 355 nm
 
800 1000 1200 1400
0.00
0.05
0.10
0.15
0.20
0.25
Int
en
sit
y (
a.u
.)
Wavelength (nm)
 ex = 285 nm
 ex = 355 nm
 
Figure 5.18.  Excitation and emission spectra of Yb(BTC)(H2O) nanoMOF (synthesized with 3.5 eq. 
NaOAc) in DMF.  Left: Normalized excitation and emission spectra.  Right: Non-normalized emission 
spectra demonstrating the ~91% decrease in emission intensity when red-shifting the excitation 
wavelength. 
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Quantum yields (Table 5.2) were collected upon excitation at wavelengths of 285 nm and 
355 nm.  The different amounts of NaOAc used for these different syntheses did not affect the 
values of quantum yields for each of the two excitation wavelengths, indicating that the size of 
the Yb(BTC)(H2O) MOF does not significantly affect the sensitizer-to-lanthanide energy transfer 
or the protection of the luminescent lanthanide cations against non-radiative deactivations.   
For each of the two wavelengths used for this experiment, a different quantum yield was 
recorded with a significant decrease when the 355 nm excitation wavelength was used.  Such 
observations suggest that two energy paths that do not communicate with each other are present 
in these MOFs.  From these quantitative values it can be concluded that the excitation at 355 nm 
does not generate a large number of photons as both the extinction coefficient and quantum yield 
are lower in comparison to the situation corresponding to an excitation at 285nm. The number of 
photons emitted by the Yb(BTC)(H2O) MOFs are proportional to its brightness which is the 
result of the multiplication of its extinction coefficient by its quantum yield.   
 
 
Table 5.2.  Relative quantum yield values (ΦYb) measured for Yb(BTC)(H2O) MOFs* synthesized with 
various amount of sodium acetate. 
 0 eq. NaOAc 1 eq. NaOAc 2 eq. NaOAc 3 eq. NaOAc 3.5 eq. NaOAc 
λex = 285 nm 2.0(±0.6)x10-2 2.0(±0.6)x10-2 1.8(±0.7)x10-2 1.6(±0.5)x10-2 1.4(±0.6)x10-2 
λex = 355 nm 9(±3)x10-4 1.2(±0.4)x10-3 1.3(±0.4)x10-3 1.0(±0.4)x10-3 1.6(±0.6)x10-3 
*MOFs as a crystalline solid under DMF 
 
Experimental luminescence decay curves were collected for all of the Yb(BTC)(H2O) 
MOFs, and the results are summarized in the Table 5.3.  Each curve was best fit to a mono-
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exponential decay which is indicative of a single environment for the Yb3+ cations in the 
Yb(BTC)(H2O) MOFs.  The calculated Yb3+ lifetime values were similar for the Yb(BTC)(H2O) 
MOFs synthesized with different amounts of NaOAc.  Such results demonstrate that the size of 
these Yb(BTC)(H2O) MOFs does not affect the position or the protection of Yb3+ in the crystal.  
In our group we have previously observed17,19 two luminescence lifetimes for each lanthanide 
coordination site in MOFs where lanthanide cations are the metal connecting the backbone 
ligands.  We rationalized that the longer value was associated with the cations located in the 
interior of the MOF and the shorter value was associated with lanthanide cations located at the 
surface of the MOFs which were more exposed to sources of non-radiative deactivations.  We 
were surprised not to observe a similar situation with this new system.  One hypothesis is that the 
signal that corresponds to the shorter-lived lanthanide cations located on the surface of the MOF 
has a sufficiently low intensity that is below the detection capability of our equipment. 
 
 
Table 5.3.  Luminescence lifetimes (τ) recorded for Yb(BTC)(H2O) MOFs* synthesized with various 
amount of sodium acetate. 
 0 eq. NaOAc 1 eq. NaOAc 2 eq. NaOAc 3 eq. NaOAc 3.5 eq. NaOAc 
τ1† (ns) 9.09(±0.03) 9.15(±0.06) 9.15(±0.04) 9.09(±0.04) 8.9(±0.4) 
*MOFs as a crystalline solid under DMF; †λex = 354 nm 
 
Excitation and emission spectra recorded for the nanoMOFs under water produced 
markedly lower intensities in comparison to the respective measurements performed in DMF.  
Such results can be explained by the exposure of the Yb3+ cations to the presence of an increased 
number of quenching –OH vibrations. As a consequence, while the Yb3+ emission band upon 
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excitation at 285 nm was easily observed, it was very difficult to discriminate the emission band 
from the background when exciting further red at 355 nm (Figures 5.19-5.22). 
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Figure 5.19.  Emission spectra for Yb(BTC)(H2O) nanoMOF (synthesized with 1 eq. NaOAc) in H2O. 
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Figure 5.20.  Emission spectra for Yb(BTC)(H2O) nanoMOF (synthesized with 2 eq. NaOAc) in H2O. 
 
 
 
800 1000 1200 1400
0.00
0.01
0.02
0.03
0.04
0.05
0.06  ex = 285 nm
 ex = 355 nm
Int
en
sit
y (
a.u
.)
Wavelength (nm)  
Figure 5.21.  Emission spectra for Yb(BTC)(H2O) nanoMOF (synthesized with 3 eq. NaOAc) in H2O. 
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Figure 5.22.  Emission spectra for Yb(BTC)(H2O) nanoMOF (synthesized with 3.5 eq. NaOAc) in H2O. 
 
 
5.3.4 4-hydroxyl-1-(4-methyl-2-sulfoanilino)-anthraquinone 
We have been able to synthesize a new family of nanoMOFs, the size of which makes them 
promising imaging agents for biological analysis as they should have minimal interactions in 
biological systems.  Nevertheless, the high energy excitation wavelength of BTC poses a serious 
problem as such photons will strongly interact with and possibly damage biological systems to 
be analyzed.  We therefore decided to evaluate an unpreceded sensitization strategy.  It was 
hypothesized that by sequestering a dye with a more biologically friendly absorption wavelength 
within the pores of the nanoMOF, it would be possible to excite the dye and have it act as the 
antennae to sensitize the Yb3+.  The dye that was selected on the basis of its absorption and 
 161 
relative solubility in water was 4-hydroxyl-1-(4-methyl-2-sulfoanilino)-anthraquinone (4hAQ, 
Figure 5.23). 
 
 
Figure 5.23.  Structure of 4-hydroxyl-1-(4-methyl-2-sulfoanilino)-anthraquinone (4hAQ). 
 
 
An absorption spectrum of 4hAQ was collected in EtOH (50 μg/mL), and a large band 
with an apparent maximum at 600 nm was observed.  Upon the addition of small amounts of 7.5 
mM NaOH the absorption increases and a shoulder of the main band appears around 635 nm 
(Figure 5.24), an indication that the electronic structure of this chromophore is significantly 
affected by the pH of the solution.  
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Figure 5.24.  Absorption spectra of a solution of 4hAQ (50 μg/mL) in EtOH to which was added various 
amounts of a 7.5 mM NaOH solution. 
 
 
Fluorescence spectra of 4hAQ were collected in EtOH (10 μg/mL) with the addition of 
10 μL of 7.5 mM NaOH (Figure 5.25).  The absorption band matches well with the excitation 
spectra collected monitoring the emission at 710 nm.  Excitation in the visible region results in 
the generation of an emission band centered at 675 nm. 
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Figure 5.25.  Excitation and emission spectra of 4hAQ in EtOH, overlaid with the absorption spectrum 
from Figure 5.24 (+30 μL NaOH). 
 
 
5.3.5 Shifting the excitation wavelength 
A 1 mg/mL suspension of Yb(BTC)(H2O) nanoMOF (synthesized with 3 equivalents of NaOAc) 
in EtOH was incubated with a 100 μg/mL solution of 4hAQ in EtOH to create a new material, 
Yb(BTC)(H2O)+4hAQ which is blue in appearance (Figure 5.26).  
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Figure 5.26.  Picture comparing the colors of Yb(BTC)(H2O) nanoMOF (left, white) and 
Yb(BTC)(H2O)+4hAQ (right, blue). 
 
 
EtOH was chosen as solvent due to the solubility of 4hAQ and the ability to maintain a 
suspension of the nanoMOF during the incubation period.  Different concentrations of 4hAQ for 
incubation were tested.  The use of higher concentrations of 4hAQ did not result in increased 
efficiency of sensitization, as determined by comparing the intensity of excitation spectra of the 
resulting Yb(BTC)(H2O)+4hAQ (excitation band at 630 nm) while monitoring the emission 
signal at 980 nm (Figure 5.27) and alternately monitoring the Yb3+ emission at 980 nm upon 
excitation at 278 nm (Figure 5.28).  Since the Yb3+ cation does not have absorbing levels in the 
ultraviolet-visible (UV-vis) region its emission can only be the result of sensitization through the 
antennae effect.  Therefore the persistence of emission signal upon ligand excitation is a good 
indicator that the ligand is in close proximity to the Yb3+ and the nanoMOF remains intact.  
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Figure 5.27.  Excitation spectra recorded upon monitoring the emission signal of Yb3+ (λem = 980 nm) for 
Yb(BTC)(H2O)+4hAQ obtained by incubation with various concentrations of 4hAQ. 
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Figure 5.28.  Emission spectra upon excitation of the BTC (λex = 278 nm) for Yb(BTC)(H2O)+4hAQ 
obtained by incubation with various concentrations of 4hAQ. 
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Figure 5.29.  Plot representing both the integration of the excitation band centered at 600 nm monitoring 
the Yb3+ emission at 980 nm (see Figure 5.27) and the integration of the sharp  Yb3+ emission band at 980 
nm upon excitation at 278 nm (see Figure 5.28) versus different incubation concentrations of 4hAQ. 
 
 
5.3.6 Physical characterization of Yb(BTC)(H2O)+4hAQ 
After dye incorporation, a powder X-ray diffraction (PXRD) pattern of Yb(BTC)(H2O)+4hAQ 
was collected and compared to the as-synthesized material (Figure 5.30).  The PXRD pattern 
indicates that the material has overall maintained its crystallinity and that the 4hAQ has not 
affected its long-range order.  
 
 167 
10 20 30 40 50
 Yb(BTC)(H2O) As synthesized
 Yb(BTC)(H2O)+4hAQ
2-theta  
Figure 5.30.  Powder X-ray diffraction (PXRD) patterns of the as-synthesized Yb(BTC)(H2O) nanoMOF 
and the dye-incorporated Yb(BTC)(H2O)+4hAQ. 
 
 
Prior to the incorporation of the dye, the DMF in the pores of the as-synthesized 
nanoMOF was exchanged with EtOH.  In order to be certain that all of the DMF molecules were 
removed, the nanoMOF was dissolved and analyzed using 1H NMR (Figure 5.31).  Three peaks 
are anticipated for DMF (2.73, 2.89, and 7.96 ppm).33  The peak at 7.96 ppm was not observed, 
and the peak at 2.73 was artificially inflated by the presence of a solvent contaminant (Figure 
5.32).  Comparison of the integration of the peak assigned to the three protons of BTC at 8.63 
ppm to the DMF -CH3 peak at 2.90 ppm revealed that there were less than 0.01 DMF molecules 
per BTC which can be considered a negligible amount.  This fact is important because the 
complete removal of DMF solvent means that no nitrogen is present.  Therefore, after the 
incorporation of the dye, any nitrogen detected via elemental analysis can be attributed to the 
4hAQ.  
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Figure 5.31.  1H NMR spectrum and peak assignments for the ethanol exchanged Yb(BTC)(H2O)·EtOH 
nanoMOF in DCl/DMSO-d6. 
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Figure 5.32.  1H NMR spectrum of the solvent DCl/DMSO-d6 identifying the contaminant which 
overlaps with the anticipated DMF peak at 2.7 ppm. 
 
 
Likewise, 1H NMR spectra were collected for the free 4hAQ and for the 
Yb(BTC)(H2O)+4hAQ.  The position and integration of peaks in the 4hAQ spectrum correspond 
to the structure (Figures 5.33, 5.34).  The 4hAQ is not observable in the spectrum for the 
Yb(BTC)(H2O)+4hAQ (Figure 5.35).  Therefore, this technique cannot be used to quantify the 
amount of 4hAQ present in the Yb(BTC)(H2O)+4hAQ. 
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Figure 5.33.  1H NMR spectrum and peak assignments for 4hAQ in DCl/DMSO-d6. 
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Figure 5.34.  1H NMR spectrum and peak assignments for 4hAQ in DCl/DMSO-d6, zoomed in on the 
7.1-8.4 ppm region. 
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Figure 5.35.  1H NMR spectrum and peak assignments for Yb(BTC)(H2O)+4hAQ in DCl/DMSO-d6 with 
no observable 4hAQ peaks. 
 
 
Aanother approach to quantify the 4hAQ in the nanoMOF is thermogravimetric analysis 
(TGA) coupled with elemental analysis (EA).  A TGA plot for the Yb(BTC)(H2O)+4hAQ was 
compared to that of the ethanol exchanged (Yb(BTC)(H2O)·EtOH) nanoMOF and the as-
synthesized Yb(BTC)(H2O)·DMF nanoMOF (Figure 5.36).  The weight loss percentage of 
Yb(BTC)(H2O)+4hAQ was smaller than that of Yb(BTC)(H2O)·EtOH, which was expected, 
given that the dye-incorporated material should have a larger molar mass.  The percent weight 
loss and elemental analysis of the EtOH exchanged material matched well with the calculated 
 173 
values, with the exception of the nitrogen value (calculated, 0.00; found, 0.17).  The 
experimental elemental analysis for Yb(BTC)(H2O)+4hAQ was 28.26% C, 1.77% H, and 0.13% 
N.  The fact that the experimental percent nitrogen was lower for this material than for the 
ethanol exchanged material (which contained no nitrogen) is a clear indication that elemental 
analysis is not a suitable method for the quantification of the small amount of 4hAQ present. 
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Figure 5.36.  Thermogravimetric analysis (TGA) of the as-synthesized Yb(BTC)(H2O)·DMF nanoMOF 
(green), ethanol exchanged Yb(BTC)(H2O)·EtOH nanoMOF (red), and Yb(BTC)(H2O)+4hAQ (blue). 
 
 
Nitrogen isotherms were collected for Yb(BTC)(H2O)·EtOH nanoMOF and 
Yb(BTC)(H2O)+4hAQ at 77 K (Figure 5.37) to estimate the loading with 4hAQ.  As expected, 
type I isotherms were observed with slightly lower nitrogen uptake for the dye-incorporated 
material at 1 bar.  The calculated BET surface area of the Yb(BTC)(H2O)·EtOH nanoMOF was 
736 m2/g; it was slightly lower, 544 m2/g, for Yb(BTC)(H2O)+4hAQ.  This loss in surface area 
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can be attributed to the dye occupying part of the pore space in the nanoMOFs.  However, 
porosity, albeit lower, is retained through the soaking with the dye, as evidenced by the type I 
isotherm.   
 
 
Figure 5.37.  Nitrogen isotherm recorded at 77 K for Yb(BTC)(H2O)·EtOH nanoMOF (green) and 
Yb(BTC)(H2O)+4hAQ (blue).  Adsorption (filled circles) and desorption (empty circles). 
 
 
Thus far these experiments have all supported the assumption that the 4hAQ is indeed 
present in the Yb(BTC)(H2O)+4hAQ material, but failed to quantify the amount of 4hAQ 
present.   
UV-vis absorption spectroscopy was then used to quantify the amount of 4hAQ in the 
Yb(BTC)(H2O)+4hAQ.  In order to minimize the matrix effect, all of the 4hAQ standards were 
prepared using the same solvent system that would be required to dissolve the 
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Yb(BTC)(H2O)+4hAQ.  For NMR dissolution is accomplished by a mixture of DCl and DMSO-
d6; for UV-vis HCl and DMSO (in the same ratio) were used.  Anthraquinone standards ranging 
in concentration from 5×10-7 to 1×10-5 M were prepared (Figure 5.38).  Additionally, 4.5 mg of 
Yb(BTC)(H2O)+4hAQ were dissolved in 2.0 mL of the HCl/DMSO solvent (Figure 5.38).  
Overlaid absorption spectra with apparent maxima at 590 nm (Figure 5.39) show clearly that as 
the concentration of 4hAQ increases the absorbance signal increases, and that the 
Yb(BTC)(H2O)+4hAQ solution absorption falls within the range of the standard solutions.  The 
absorbance at 590 nm was plotted against the concentration and fit with a linear trendline (Figure 
5.39).  The trendline (y = 88724x – 0.00131) was used to calculate the number of moles of 4hAQ 
present in the Yb(BTC)(H2O)+4hAQ solution and subsequently to determine the molar ratio, 
1:0.078, Yb(BTC)(H2O):4hAQ. 
 
 
Figure 5.38.  Picture of the 4hAQ standard solutions and the 2.25 mg/mL Yb(BTC)(H2O)+4hAQ solution 
that were analyzed via UV-vis absorption spectroscopy. 
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Figure 5.39.  Absorption spectra of the 4hAQ standard solutions and the 2.25 mg/mL 
Yb(BTC)(H2O)+4hAQ solution (left) and the resulting calibration curve based on the absorbance at 590 
nm (right). 
 
 
These experiments collectively reveal that there is very little 4hAQ present in 
Yb(BTC)(H2O)+4hAQ.  Despite this there is still a sufficient amount for the 4hAQ to sensitize 
the Yb3+ and generate NIR emission (see Section 5.3.7).  The exact location of the 4hAQ is also 
unclear.  The dye is a fairly large molecule and it seems physically improbable that it could be 
entirely contained within the pores.  It may, however, be partially inserted at the entrance of a 
pore or it may be “stuck” to the surface of the crystal. 
 
5.3.7 Spectroscopic characterization of Yb(BTC)(H2O)+4hAQ 
The excitation spectrum recorded for Yb(BTC)(H2O)+4hAQ in EtOH (Figure 5.40) shows that 
upon incorporation of the 4hAQ chromophore, a large excitation band with an apparent 
maximum at 600 nm is observed that was not present in the absence of 4hAQ (Figure 5.41) and 
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which matches well with the absorption band of pure 4hAQ (Figure 5.24).  The emission spectra 
(Figure 5.40) indicated that Yb3+ emission signal can obtained by excitation through either the 
BTC ligand (λex = 278 nm) or through the 4hAQ (λex = 600 nm and 650 nm).  
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Figure 5.40.  Excitation spectrum upon monitoring the Yb3+ signal (λem = 980 nm) and emission spectra 
of Yb(BTC)(H2O)+4hAQ in EtOH upon excitation through both the BTC ligand (λex = 278 nm) and the 
4hAQ (λex = 600 nm and 650 nm). 
 
 
Control luminescence spectra were also recorded for the unmodified Yb(BTC)(H2O) 
nanoMOF in EtOH.  As observed in both DMF and H2O, the band with the highest intensity 
present in the excitation spectrum (monitoring the Yb3+ signal, λem = 980) was located at 278 nm.  
In EtOH additional and significantly less intense bands were present at 400 nm and 600 nm 
(Figure 5.41).  Excitation through the ligand (λex = 278 nm) resulted in the expected Yb3+ 
emission centered at 980 nm.  In the absence of 4hAQ, only a very small emission of Yb3+ can 
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be detected when exciting at 600 nm, only 3% of the intensity of the signal recorded in presence 
of 4hAQ (Figure 5.41). 
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Figure 5.41.  Excitation (λem = 980 nm, left) and emission spectra (λex = 600 nm, right) of Yb(BTC)(H2O) 
nanoMOF and Yb(BTC)(H2O)+4hAQ in EtOH. 
 
 
For biological applications, the system must be compatible with aqueous conditions.   
When Yb(BTC)(H2O) was placed in water, its Yb3+ emission signal  decreased by a factor 10 to 
15.  This observation can be explained by the high number of –OH quenchers from the water 
molecules and a good accessibility to the Yb3+ cations due to the limited ability of this MOF to 
protect the lanthanide cations. 
5.3.8 Coating Yb(BTC)(H2O)+4hAQ with silica 
In order to both increase the Yb3+ emission intensity in water and be able to more easily 
functionalize and tune their biological behavior in the future, a silica shell was added.  
Yb(BTC)(H2O)+4hAQ was coated with a silica shell using a sol-gel procedure adapted from the 
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literature30 with tetraethyl orthosilicate (TEOS) in a mixture of EtOH and ammonium hydroxide 
solution (4%).  Immediately after the coating, the luminescence of the resulting coated sample 
was measured in EtOH and compared to that of the uncoated sample (Figure 5.42).  After coating 
with silica, an overall decrease in the intensity of the excitation spectrum was observed. 
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Figure 5.42.  Excitation spectra (monitoring the Yb3+ signal, λem = 980 nm) of Yb(BTC)(H2O) 
nanoMOFs in EtOH, before (Yb(BTC)(H2O)) and after (Yb(BTC)(H2O)+4hAQ) loading with 4hAQ, and 
after silica coating ((Yb(BTC)(H2O)+4hAQ)@SiO2). 
 
 
Then EtOH was removed from the samples and the (Yb(BTC)(H2O)+4hAQ)@SiO2 was 
re-suspended in pure water at a concentration of 1 mg/mL.  The luminescence signal was 
monitored via recording the excitation spectrum (monitoring Yb3+, λem = 980 nm) over a period 
of 5 hours (Figure 5.43).  After a rapid (less than 4 minutes) initial decrease (loss of about 95% 
of luminescence) the signal intensity of Yb(BTC)(H2O)+4hAQ remained stable indicating that 
quenching is indeed originating from water.  A very rapid initial loss of luminescence is also 
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observed for (Yb(BTC)(H2O)+4hAQ)@SiO2, but is limited to a 70% loss of signal (Figure 5.43).  
After this first step, a slow decrease of luminescence occurs.  After 5 hours, the signal is about 
20% of the one in EtOH and remains constant.  The silica coating is proven effective for 
protecting the nanoMOF from quenching due to water.  
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Figure 5.43.  Comparison of the relative intensities of the excitation spectra (monitoring Yb3+; λem = 980) 
of Yb(BTC)(H2O)+4hAQ and (Yb(BTC)(H2O)+4hAQ)@SiO2 in water over a period of 5 hours.  The 
error bars represent the standard deviation. 
 
 
The characterization of the silica shell was done using transmission electron microscopy 
(TEM).  The silica shell can be seen clearly around the Yb(BTC)(H2O)+4hAQ (Figure 5.44).  
Typical thickness of the coating, 13.0(±4.8) nm, was evaluated by measuring more than 40 areas 
from 7 independent coating experiments. 
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Figure 5.44.  Representative transmission electron microscopy (TEM) images of 
(Yb(BTC)(H2O)+4hAQ)@SiO2. 
 
 
5.3.9 Photobleaching studies 
Photobleaching experiments (Figure 5.45) were performed to assess the photostability of 
(Yb(BTC)(H2O)+4hAQ)@SiO2 in 10 mM HEPES buffer (pH 7.4) to estimate its potential as an 
imaging agent and to compare its performance to commercial  organic fluorophores absorbing 
and emitting in a comparable wavelength range, namely Alexa Fluor 647 (AF647) and 
indocyanine green (ICG).  (Yb(BTC)(H2O)+4hAQ)@SiO2 was found to be more resistant to 
photobleaching than the highly photostable AF647, while ICG was poorly resistant.  A similar 
measurement performed on 4hAQ in 10 mM HEPES buffer (pH 7.4) showed that the free 4hAQ 
is not resistant to photobleaching and benefits from the protection achieved by its incorporation 
into the lanthanide nanoMOF.  It must be noted that (Yb(BTC)(H2O)+4hAQ)@SiO2 was left in 
HEPES buffer for 4 hours prior to the photobleaching experiment in order to take into account 
the reduction of luminescence signal due to the penetration of water molecules through the silica 
50 nm 10 nm 
12 nm 
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shell.  The observed decrease of emission signal is the combination of this effect with that of 
photobleaching. 
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Figure 5.45.  Plot comparing the decrease of signal of (Yb(BTC)(H2O)+4hAQ)@SiO2, indocyanine 
Green (ICG), Alexa Fluor 647 (AF647), and 4hAQ (10 mM HEPES buffer).  Luminescence data are 
expressed as percentages derived from the integrated emission signal (λex = 580 nm) divided by the 
integrated signal of the initial spectrum (time = 0 minutes). 
5.4 CONCLUSION 
We have designed, synthesized and characterized a series of size-controllable Yb(BTC)(H2O) 
MOFs which range from long micron-scale needles to nanoscale spheres depending on the 
amount of NaOAc used during the synthesis.  These materials all demonstrate their ability to 
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generate NIR emission arising from Yb3+ when excited at high energy wavelengths (typically 
285 nm).  The emission in water is significantly lower in intensity than in DMF or EtOH.  In 
order to shift the excitation wavelength to a more biologically friendly lower energy wavelength, 
4-hydroxyl-1-(4-methyl-2-sulfoanilino)-anthraquinone (4hAQ) was incorporated into the 
Yb(BTC)(H2O) nanoMOF synthesized with 3 equivalents of NaOAc.  The 4hAQ absorbs around 
600 nm, and exciting the Yb(BTC)(H2O)+4hAQ at this wavelength results in sensitized NIR 
Yb3+ emission.  This material is limited as an imaging agents by its low emission intensity in 
water.  A silica coating was successful in providing efficient protection against quenching.  
Indeed, the (Yb(BTC)(H2O)+4hAQ)@SiO2 exhibits a stronger emission intensity than 
Yb(BTC)(H2O)+4hAQ in water over the course of five hours.  Additionally, it retains its 
emission intensity in HEPES buffer better than commercially available organic fluorophores 
over a time span of one hour as the result of improved protection against photobleaching.  This 
nanoscale material with low energy excitation and emission has great potential to be used as 
imaging agent for biological analysis and medical diagnostics. 
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APPENDIX A 
YB-PVDC-3 CRYSTALLOGRAPHIC DATA 
A.1  SINGLE CRYSTAL X-RAY DIFFRACTION STUDY FOR YB-PVDC-3 
An X-ray crystal structure was determined for C42H41NO12Yb, Yb-PVDC-3, using a single 
crystal on a Bruker Smart Apex CCD diffractometer with graphite-monochromated MoKα (λ= 
0.71073 Å) radiation.  The parameters used during the collection of diffraction data are 
summarized in Table A1.  The crystal was mounted in a glass loop with Paratone® N oil and 
placed in a cold N2 stream (203 K) for data collection. 
Unit-cell parameters and lack of systematic absences indicated Yb-PVDC-3 crystallized 
in triclinic space groups P 1 or P-1; centrosymmetric P-1 was chosen based on E-values and the 
successful solution and refinement of the structure.  Unit-cell dimensions were derived from the 
least-squares fit of the angular settings of 1373 reflections.  Data were corrected for absorption 
using the Bruker program SADABS1.  The structure was solved via direct methods, which 
located Yb and most of the remaining non-hydrogen atoms.  Yb was found to be disordered over 
at least two sites.  The two Yb sites are occupied at 56% and 44%.  Remaining non-hydrogen 
atoms were gradually found from several subsequent different Fourier syntheses.  All non- 
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hydrogen atoms were refined anisotropically excepting O6, O11, C24, C27, O12, N, C40, C41, 
C42, O10, C39A, C39B, and O13.  A total of 47 restraints were applied to optimize the bond 
lengths, bond angles, and atomic displacement parameters.  Idealized atom positions were 
calculated for all hydrogen atoms (d-(Cmethyl-H) = 0.97 Å, d-(Cphenyl-H) = 0.94 Å), U = 1.2 
Uiso of attached carbon).  The coordinated DMF seen in other Ln-PVDC isomorphs could not be 
resolved in this structure, probably because of overlap with the disordered Yb sites. 
All computer programs used in the data collection and refinements are contained in the 
Bruker program packages SMART (vers. 5.625), SAINT (vers. 6.22)1, and SHELXTL (vers. 
6.10)2. 
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Table A.1. Crystal data and structure refinement for Yb-PVDC-3. 
Identification code Yb-PVDC-3 
Empirical formula C42 H41 N O12 Yb 
Formula weight 924.80 
Temperature 203(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.811(2) Å = 77.152(5)° 
b = 10.951(3) Å = 87.703(5)° 
c = 21.944(5) Å = 78.251(6)° 
Volume 2021.1(9) Å3 
Z 2 
Density (calculated) 1.520 Mg/m3
Absorption coefficient 2.377 mm-1
F(000) 932 
Crystal size 0.30 x 0.13 x 0.08 mm3
Theta range for data collection 1.90 to 23.33° 
Index ranges -9<=h<=9, -12<=k<=12, -24<=l<=24
Reflections collected 13440 
Independent reflections 5809 [R(int) = 0.0628] 
Completeness to theta = 23.33° 99.5 % 
Absorption correction Multi-Scan (SADABS) 
Max. and min. transmission 0.8326 and 0.5358 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5809 / 47 / 469 
Goodness-of-fit on F2 1.043 
Final R indices [I>2sigma(I)] R1 = 0.1240, wR2 = 0.2941 
R indices (all data) R1 = 0.1946, wR2 = 0.3318 
Largest diff. peak and hole 2.609 and -1.103 e.Å-3
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Table A.2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for Yb-PVDC- 
3. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
x y z U(eq) 
Yb 2868(2) 4658(4) 4952(1) 85(1) 
Yb' 2770(3) 3647(6) 4893(1) 95(2) 
O(1) 1350(19) 3760(20) 5765(6) 147(7) 
C(1) 80(30) 4220(30) 5975(8) 96(8) 
C(2) -150(30) 3710(20) 6692(8) 79(6) 
O(2) -880(20) 5071(18) 5680(6) 114(6) 
O(3) -5318(12) 2141(10) 9236(4) 61(3) 
C(3) -1370(20) 4356(18) 6963(7) 73(5) 
O(4) -862(12) 1061(10) 11080(4) 61(3) 
C(4) -1650(20) 3916(14) 7592(6) 62(5) 
C(5) -762(18) 2814(13) 7925(6) 48(4) 
O(5) -6970(30) -3110(30) 14275(7) 267(18) 
C(6) 480(20) 2199(17) 7628(7) 73(5) 
O(6) -4643(15) -2821(12) 14550(6) 92(4) 
C(7) 790(20) 2640(20) 7018(8) 82(6) 
O(7) 5710(30) 4594(18) 4345(9) 229(11) 
C(8) -1050(20) 2284(14) 8595(7) 61(4) 
O(8) 3980(20) 3600(20) 4070(8) 199(10) 
C(9) -2431(18) 2474(13) 8855(6) 51(4) 
C(10) -2732(18) 2043(13) 9521(6) 46(4) 
C(11) -4247(18) 1875(13) 9702(6) 50(4) 
O(11) 1960(30) 2110(20) 4938(12) 203(9) 
C(12) -4569(16) 1460(13) 10342(6) 46(3) 
C(13) -3446(18) 1186(12) 10788(6) 47(4) 
C(14) -1932(18) 1357(13) 10603(7) 54(4) 
C(15) -1640(18) 1761(12) 9970(6) 50(4) 
C(16) -3743(18) 692(14) 11455(7) 57(4) 
C(17) -4962(17) 157(13) 11678(7) 58(4) 
C(18) -5236(19) -399(15) 12333(6) 57(4) 
C(19) -6380(20) -1092(16) 12468(7) 74(5) 
C(20) -6590(20) -1747(17) 13074(7) 74(5) 
C(21) -5680(20) -1751(18) 13545(6) 73(5) 
C(22) -4530(20) -1033(18) 13417(7) 77(5) 
C(23) -4350(20) -368(16) 12819(7) 68(5) 
C(24) -5810(20) -2590(20) 14204(9) 120(8) 
C(25) -6867(16) 2003(15) 9390(7) 62(4) 
C(26) 685(18) 1206(16) 10907(7) 64(4) 
C(27) 5030(30) 4160(30) 3970(12) 153(10) 
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C(28) 5770(20) 4130(20) 3316(9) 97(7) 
C(29) 6700(20) 4880(20) 3109(8) 151(12) 
C(30) 7390(20) 5000(20) 2535(9) 116(9) 
C(31) 7062(19) 4330(18) 2145(7) 68(5) 
C(32) 6140(20) 3484(18) 2356(8) 79(5) 
C(33) 5470(20) 3400(20) 2932(9) 86(6) 
C(34) 7770(20) 4369(18) 1507(8) 87(6) 
C(35) 8800(30) 4747(15) 1254(8) 106(9) 
C(36) 9370(20) 4828(14) 592(7) 62(5) 
C(37) 10960(20) 4787(14) 515(7) 61(4) 
C(38) 8419(18) 5052(14) 92(8) 59(4) 
O(12) -830(50) 670(40) 3050(20) 302(17) 
N 870(30) 1960(30) 2892(15) 170(10) 
C(40) 1290(70) 1690(60) 3560(30) 300(30) 
C(41) 1750(40) 2580(30) 2295(16) 172(12) 
C(42) 0(50) 1240(40) 2660(20) 198(15) 
O(10) 1820(50) 6190(30) 5220(20) 410(30) 
C(39A) 13630(40) 4620(30) 884(18) 70(13) 
O(9) 12000(17) 4626(14) 995(6) 48(6) 
C(39B) 13780(70) 4390(50) 740(30) 57(18) 
O(13) 6900(40) 5070(30) -76(15) 81(13) 
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Table A.3.  Bond lengths [Å] and angles [°] for Yb-PVDC-3. 
Yb-Yb' 1.163(3) 
Yb-O(10) 1.95(3) 
Yb-O(2)#1 2.209(16) 
Yb-O(1) 2.345(13) 
Yb-O(6)#2 2.360(13) 
Yb-O(7)#3 2.40(3) 
Yb-O(8) 2.54(2) 
Yb-O(5)#4 2.59(3) 
Yb-O(7) 2.78(2) 
Yb-C(27) 2.89(2) 
Yb-O(11) 3.06(2) 
Yb-Yb#3 4.001(6) 
Yb'-O(11) 1.94(2) 
Yb'-O(6)#2 2.024(14) 
Yb'-O(8) 2.064(16) 
Yb'-O(2)#1 2.181(19) 
Yb'-O(1) 2.257(13) 
Yb'-C(27) 2.83(2) 
Yb'-O(10) 2.98(3) 
Yb'-O(7) 3.08(2) 
O(1)-C(1) 1.24(3) 
C(1)-O(2) 1.21(3) 
C(1)-C(2) 1.57(2) 
C(2)-C(3) 1.35(3) 
C(2)-C(7) 1.36(3) 
O(2)-Yb'#1 2.181(19) 
O(2)-Yb#1 2.209(16) 
O(3)-C(11) 1.361(17) 
O(3)-C(25) 1.423(17) 
C(3)-C(4) 1.389(19) 
C(3)-H(3A) 0.9400 
O(4)-C(14) 1.376(18) 
O(4)-C(26) 1.431(17) 
C(4)-C(5) 1.37(2) 
C(4)-H(4A) 0.9400 
C(5)-C(6) 1.38(2) 
C(5)-C(8) 1.487(19) 
O(5)-C(24) 1.254(16) 
O(5)-Yb#5 2.59(3) 
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C(6)-C(7) 1.36(2) 
C(6)-H(6A) 0.9400 
O(6)-C(24) 1.254(15) 
O(6)-Yb'#2 2.024(13) 
O(6)-Yb#2 2.360(13) 
C(7)-H(7A) 0.9400 
O(7)-C(27) 1.264(18) 
O(7)-Yb#3 2.40(3) 
C(8)-C(9) 1.32(2) 
C(8)-H(8A) 0.9400 
O(8)-C(27) 1.195(18) 
C(9)-C(10) 1.462(17) 
C(9)-H(9A) 0.9400 
C(10)-C(15) 1.346(19) 
C(10)-C(11) 1.41(2) 
C(11)-C(12) 1.413(18) 
C(12)-C(13) 1.361(19) 
C(12)-H(12A) 0.9400 
C(13)-C(14) 1.42(2) 
C(13)-C(16) 1.475(18) 
C(14)-C(15) 1.392(18) 
C(15)-H(15A) 0.9400 
C(16)-C(17) 1.35(2) 
C(16)-H(16A) 0.9400 
C(17)-C(18) 1.462(19) 
C(17)-H(17A) 0.9400 
C(18)-C(23) 1.36(2) 
C(18)-C(19) 1.36(2) 
C(19)-C(20) 1.39(2) 
C(19)-H(19A) 0.9400 
C(20)-C(21) 1.34(2) 
C(20)-H(20A) 0.9400 
C(21)-C(22) 1.39(2) 
C(21)-C(24) 1.544(17) 
C(22)-C(23) 1.37(2) 
C(22)-H(22A) 0.9400 
C(23)-H(23A) 0.9400 
C(25)-H(25A) 0.9700 
C(25)-H(25B) 0.9700 
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C(25)-H(25C) 0.9700 
C(26)-H(26A) 0.9700 
C(26)-H(26B) 0.9700 
C(26)-H(26C) 0.9700 
C(27)-C(28) 1.556(19) 
C(28)-C(29) 1.27(3) 
C(28)-C(33) 1.35(3) 
C(29)-C(30) 1.37(3) 
C(29)-H(29A) 0.9400 
C(30)-C(31) 1.32(2) 
C(30)-H(30A) 0.9400 
C(31)-C(32) 1.35(2) 
C(31)-C(34) 1.50(2) 
C(32)-C(33) 1.37(2) 
C(32)-H(32A) 0.9400 
C(33)-H(33A) 0.9400 
C(34)-C(35) 1.15(3) 
C(34)-H(34A) 0.9400 
C(35)-C(36) 1.51(2) 
C(35)-H(35A) 0.9400 
C(36)-C(38) 1.36(2) 
C(36)-C(37) 1.40(2) 
C(37)-O(9) 1.38(2) 
C(37)-C(38)#6 1.41(2) 
C(38)-O(13) 1.39(4) 
C(38)-C(37)#6 1.41(2) 
O(12)-C(42) 1.25(5) 
N-C(42) 1.39(4) 
N-C(40) 1.48(6) 
N-C(41) 1.58(4) 
C(39A)-O(9) 1.45(4) 
C(39B)-O(13)#6 1.53(6) 
O(13)-C(39B)#6 1.53(6) 
  
Yb'-Yb-O(2)#1 73.3(5) 
O(10)-Yb-O(2)#1 87.8(16) 
Yb'-Yb-O(1) 71.2(5) 
O(10)-Yb-O(1) 79.7(16) 
O(2)#1-Yb-O(1) 87.6(5) 
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Yb'-Yb-O(6)#2 59.0(4) 
O(10)-Yb-O(6)#2 132.7(15) 
O(2)#1-Yb-O(6)#2 132.3(6) 
O(1)-Yb-O(6)#2 78.7(6) 
Yb'-Yb-O(7)#3 133.6(5) 
O(10)-Yb-O(7)#3 63.7(15) 
O(2)#1-Yb-O(7)#3 151.1(8) 
O(1)-Yb-O(7)#3 92.1(6) 
O(6)#2-Yb-O(7)#3 75.6(6) 
Yb'-Yb-O(8) 53.4(6) 
O(10)-Yb-O(8) 148.9(16) 
O(2)#1-Yb-O(8) 75.4(6) 
O(1)-Yb-O(8) 124.5(8) 
O(6)#2-Yb-O(8) 75.6(5) 
O(7)#3-Yb-O(8) 126.6(7) 
Yb'-Yb-O(5)#4 139.8(5) 
O(10)-Yb-O(5)#4 60.2(16) 
O(2)#1-Yb-O(5)#4 80.8(5) 
O(1)-Yb-O(5)#4 138.5(8) 
O(6)#2-Yb-O(5)#4 136.4(6) 
O(7)#3-Yb-O(5)#4 80.4(5) 
O(8)-Yb-O(5)#4 90.9(8) 
Yb'-Yb-O(7) 93.6(5) 
O(10)-Yb-O(7) 120.5(16) 
O(2)#1-Yb-O(7) 113.9(7) 
O(1)-Yb-O(7) 149.5(6) 
O(6)#2-Yb-O(7) 70.8(5) 
O(7)#3-Yb-O(7) 79.2(7) 
O(8)-Yb-O(7) 49.0(6) 
O(5)#4-Yb-O(7) 69.3(7) 
Yb'-Yb-C(27) 75.4(6) 
O(10)-Yb-C(27) 134.7(17) 
O(2)#1-Yb-C(27) 91.1(7) 
O(1)-Yb-C(27) 145.5(8) 
O(6)#2-Yb-C(27) 76.9(7) 
O(7)#3-Yb-C(27) 104.9(7) 
O(8)-Yb-C(27) 24.4(5) 
O(5)#4-Yb-C(27) 74.9(9) 
O(7)-Yb-C(27) 25.7(4) 
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Yb'-Yb-O(11) 12.1(5) 
O(10)-Yb-O(11) 133.6(16) 
O(2)#1-Yb-O(11) 68.6(7) 
O(1)-Yb-O(11) 60.7(7) 
O(6)#2-Yb-O(11) 64.9(6) 
O(7)#3-Yb-O(11) 135.0(6) 
O(8)-Yb-O(11) 63.9(7) 
O(5)#4-Yb-O(11) 144.0(6) 
O(7)-Yb-O(11) 105.7(7) 
C(27)-Yb-O(11) 86.8(7) 
Yb'-Yb-Yb#3 117.3(2) 
O(10)-Yb-Yb#3 95.0(15) 
O(2)#1-Yb-Yb#3 143.8(3) 
O(1)-Yb-Yb#3 128.4(4) 
O(6)#2-Yb-Yb#3 67.8(3) 
O(7)#3-Yb-Yb#3 43.1(5) 
O(8)-Yb-Yb#3 84.3(5) 
O(5)#4-Yb-Yb#3 69.7(5) 
O(7)-Yb-Yb#3 36.1(6) 
C(27)-Yb-Yb#3 61.8(5) 
O(11)-Yb-Yb#3 127.8(5) 
Yb-Yb'-O(11) 160.7(8) 
Yb-Yb'-O(6)#2 91.4(4) 
O(11)-Yb'-O(6)#2 96.9(8) 
Yb-Yb'-O(8) 99.8(8) 
O(11)-Yb'-O(8) 96.8(11) 
O(6)#2-Yb'-O(8) 94.6(6) 
Yb-Yb'-O(2)#1 76.0(5) 
O(11)-Yb'-O(2)#1 95.4(8) 
O(6)#2-Yb'-O(2)#1 167.4(6) 
O(8)-Yb'-O(2)#1 86.6(6) 
Yb-Yb'-O(1) 79.6(6) 
O(11)-Yb'-O(1) 83.4(9) 
O(6)#2-Yb'-O(1) 88.1(6) 
O(8)-Yb'-O(1) 177.2(7) 
O(2)#1-Yb'-O(1) 90.6(6) 
Yb-Yb'-C(27) 81.1(6) 
O(11)-Yb'-C(27) 116.9(10) 
O(6)#2-Yb'-C(27) 83.6(7) 
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O(8)-Yb'-C(27) 21.9(7) 
O(2)#1-Yb'-C(27) 93.3(7) 
O(1)-Yb'-C(27) 158.8(8) 
Yb-Yb'-O(10) 21.6(10) 
O(11)-Yb'-O(10) 139.2(13) 
O(6)#2-Yb'-O(10) 102.5(11) 
O(8)-Yb'-O(10) 116.7(13) 
O(2)#1-Yb'-O(10) 66.0(11) 
O(1)-Yb'-O(10) 62.0(11) 
C(27)-Yb'-O(10) 100.8(12) 
Yb-Yb'-O(7) 64.2(4) 
O(11)-Yb'-O(7) 135.0(9) 
O(6)#2-Yb'-O(7) 68.4(6) 
O(8)-Yb'-O(7) 45.9(7) 
O(2)#1-Yb'-O(7) 104.4(6) 
O(1)-Yb'-O(7) 135.2(7) 
C(27)-Yb'-O(7) 24.2(4) 
O(10)-Yb'-O(7) 85.7(11) 
C(1)-O(1)-Yb' 145.3(15) 
C(1)-O(1)-Yb 131.0(17) 
Yb'-O(1)-Yb 29.20(18) 
O(2)-C(1)-O(1) 124.6(17) 
O(2)-C(1)-C(2) 120(2) 
O(1)-C(1)-C(2) 115(2) 
C(3)-C(2)-C(7) 121.9(16) 
C(3)-C(2)-C(1) 117(2) 
C(7)-C(2)-C(1) 121(2) 
C(1)-O(2)-Yb'#1 170.3(16) 
C(1)-O(2)-Yb#1 139.6(16) 
Yb'#1-O(2)-Yb#1 30.7(2) 
C(11)-O(3)-C(25) 119.2(11) 
C(2)-C(3)-C(4) 118.9(18) 
C(2)-C(3)-H(3A) 120.6 
C(4)-C(3)-H(3A) 120.6 
C(14)-O(4)-C(26) 116.7(11) 
C(5)-C(4)-C(3) 120.4(15) 
C(5)-C(4)-H(4A) 119.8 
C(3)-C(4)-H(4A) 119.8 
C(4)-C(5)-C(6) 118.3(13) 
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C(4)-C(5)-C(8) 122.5(13) 
C(6)-C(5)-C(8) 119.2(14) 
C(24)-O(5)-Yb#5 127.1(19) 
C(7)-C(6)-C(5) 121.5(18) 
C(7)-C(6)-H(6A) 119.2 
C(5)-C(6)-H(6A) 119.2 
C(24)-O(6)-Yb'#2 165.9(15) 
C(24)-O(6)-Yb#2 136.3(14) 
Yb'#2-O(6)-Yb#2 29.5(2) 
C(6)-C(7)-C(2) 118.9(17) 
C(6)-C(7)-H(7A) 120.6 
C(2)-C(7)-H(7A) 120.6 
C(27)-O(7)-Yb#3 177(2) 
C(27)-O(7)-Yb 81.8(17) 
Yb#3-O(7)-Yb 100.8(7) 
C(27)-O(7)-Yb' 66.5(14) 
Yb#3-O(7)-Yb' 115.4(6) 
Yb-O(7)-Yb' 22.11(18) 
C(9)-C(8)-C(5) 123.2(15) 
C(9)-C(8)-H(8A) 118.4 
C(5)-C(8)-H(8A) 118.4 
C(27)-O(8)-Yb' 118(2) 
C(27)-O(8)-Yb 95(2) 
Yb'-O(8)-Yb 26.9(3) 
C(8)-C(9)-C(10) 124.5(14) 
C(8)-C(9)-H(9A) 117.8 
C(10)-C(9)-H(9A) 117.8 
C(15)-C(10)-C(11) 118.0(12) 
C(15)-C(10)-C(9) 123.8(14) 
C(11)-C(10)-C(9) 118.2(13) 
O(3)-C(11)-C(12) 124.1(13) 
O(3)-C(11)-C(10) 116.6(11) 
C(12)-C(11)-C(10) 119.3(14) 
Yb'-O(11)-Yb 7.2(3) 
C(13)-C(12)-C(11) 121.7(13) 
C(13)-C(12)-H(12A) 119.2 
C(11)-C(12)-H(12A) 119.2 
C(12)-C(13)-C(14) 118.7(12) 
C(12)-C(13)-C(16) 122.4(14) 
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C(14)-C(13)-C(16) 118.9(14) 
O(4)-C(14)-C(15) 126.0(14) 
O(4)-C(14)-C(13) 115.3(12) 
C(15)-C(14)-C(13) 118.6(15) 
C(10)-C(15)-C(14) 123.7(14) 
C(10)-C(15)-H(15A) 118.2 
C(14)-C(15)-H(15A) 118.2 
C(17)-C(16)-C(13) 125.2(15) 
C(17)-C(16)-H(16A) 117.4 
C(13)-C(16)-H(16A) 117.4 
C(16)-C(17)-C(18) 126.1(16) 
C(16)-C(17)-H(17A) 117 
C(18)-C(17)-H(17A) 117 
C(23)-C(18)-C(19) 116.8(14) 
C(23)-C(18)-C(17) 124.6(15) 
C(19)-C(18)-C(17) 118.4(14) 
C(18)-C(19)-C(20) 121.1(16) 
C(18)-C(19)-H(19A) 119.5 
C(20)-C(19)-H(19A) 119.5 
C(21)-C(20)-C(19) 121.7(16) 
C(21)-C(20)-H(20A) 119.2 
C(19)-C(20)-H(20A) 119.2 
C(20)-C(21)-C(22) 117.8(13) 
C(20)-C(21)-C(24) 121.6(15) 
C(22)-C(21)-C(24) 120.5(15) 
C(23)-C(22)-C(21) 119.8(16) 
C(23)-C(22)-H(22A) 120.1 
C(21)-C(22)-H(22A) 120.1 
C(18)-C(23)-C(22) 122.8(16) 
C(18)-C(23)-H(23A) 118.6 
C(22)-C(23)-H(23A) 118.6 
O(6)-C(24)-O(5) 128.7(19) 
O(6)-C(24)-C(21) 115.7(16) 
O(5)-C(24)-C(21) 114.4(16) 
O(3)-C(25)-H(25A) 109.5 
O(3)-C(25)-H(25B) 109.5 
H(25A)-C(25)-H(25B) 109.5 
O(3)-C(25)-H(25C) 109.5 
H(25A)-C(25)-H(25C) 109.5 
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H(25B)-C(25)-H(25C) 109.5 
O(4)-C(26)-H(26A) 109.5 
O(4)-C(26)-H(26B) 109.5 
H(26A)-C(26)-H(26B) 109.5 
O(4)-C(26)-H(26C) 109.5 
H(26A)-C(26)-H(26C) 109.5 
H(26B)-C(26)-H(26C) 109.5 
O(8)-C(27)-O(7) 129(3) 
O(8)-C(27)-C(28) 113(2) 
O(7)-C(27)-C(28) 118(2) 
O(8)-C(27)-Yb' 40.2(15) 
O(7)-C(27)-Yb' 89.3(15) 
C(28)-C(27)-Yb' 153.1(18) 
O(8)-C(27)-Yb 61.1(17) 
O(7)-C(27)-Yb 72.5(15) 
C(28)-C(27)-Yb 162.7(18) 
Yb'-C(27)-Yb 23.5(2) 
C(29)-C(28)-C(33) 116.3(17) 
C(29)-C(28)-C(27) 119(2) 
C(33)-C(28)-C(27) 125(2) 
C(28)-C(29)-C(30) 125(2) 
C(28)-C(29)-H(29A) 117.3 
C(30)-C(29)-H(29A) 117.3 
C(31)-C(30)-C(29) 119.2(19) 
C(31)-C(30)-H(30A) 120.4 
C(29)-C(30)-H(30A) 120.4 
C(30)-C(31)-C(32) 117.4(16) 
C(30)-C(31)-C(34)  123.9(18) 
C(32)-C(31)-C(34)  118.6(18) 
C(31)-C(32)-C(33)  121.3(18) 
C(31)-C(32)-H(32A)  119.4 
C(33)-C(32)-H(32A)  119.4 
C(28)-C(33)-C(32)  120.3(18) 
C(28)-C(33)-H(33A)  119.8 
C(32)-C(33)-H(33A)  119.8 
C(35)-C(34)-C(31)  135(2) 
C(35)-C(34)-H(34A)  112.4 
C(31)-C(34)-H(34A)  112.4 
C(34)-C(35)-C(36)  132(3) 
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C(34)-C(35)-H(35A)  114.1 
C(36)-C(35)-H(35A)  114.1 
C(38)-C(36)-C(37)  121.1(14) 
C(38)-C(36)-C(35)  123.4(18) 
C(37)-C(36)-C(35)  115.2(18) 
O(9)-C(37)-C(36)  124.8(15) 
O(9)-C(37)-C(38)#6  116.1(17) 
C(36)-C(37)-C(38)#6  119.1(15) 
C(36)-C(38)-O(13)  143(2) 
C(36)-C(38)-C(37)#6  119.8(15) 
O(13)-C(38)-C(37)#6  97.0(19) 
C(42)-N-C(40)  122(4) 
C(42)-N-C(41)  103(3) 
C(40)-N-C(41)  130(4) 
O(12)-C(42)-N  115(4) 
Yb-O(10)-Yb'  12.7(5) 
C(37)-O(9)-C(39A)  122.2(19) 
C(38)-O(13)-C(39B)#6 125(3) 
Symmetry transformations used to generate equivalent atoms: 
#1 -x,-y+1,-z+1 #2 -x,-y,-z+2 #3 -x+1,-y+1,-z+1 
#4 x+1,y+1,z-1 #5 x-1,y-1,z+1 #6 -x+2,-y+1,-z 
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Table A.4. Anisotropic displacement parameters (Å2x 103) for Yb-PVDC-3. The anisotropic displacement 
factor exponent takes the form: -2π2[ h2 a*2U11 + ... + 2 h k a* b* U12 ]. 
U11 U22 U33 U23 U13 U12 
Yb 88(1) 125(3) 43(1) -15(1) 41(1) -37(1) 
Yb' 107(2) 146(4) 36(1) -6(1) 38(1) -59(2) 
O(1) 110(11) 280(20) 51(8) -15(10) 48(8) -75(13) 
C(1) 105(17) 190(20) 23(9) -10(12) 23(11) -114(18) 
C(2) 93(14) 125(17) 44(10) -30(11) 39(11) -73(14) 
O(2) 125(13) 198(17) 26(6) 13(8) 7(7) -88(12) 
O(3) 63(7) 84(8) 33(5) -9(5) -2(5) -9(6) 
C(3) 106(14) 94(13) 28(8) -8(8) 3(9) -50(12) 
O(4) 61(7) 92(8) 30(5) -8(5) 5(5) -24(6) 
C(4) 101(13) 35(9) 42(8) -4(7) 30(9) -5(9) 
C(5) 74(10) 42(9) 35(7) -18(7) 19(8) -21(8) 
O(5) 220(20) 570(50) 54(9) 47(16) -2(11) -300(30) 
C(6) 82(12) 84(12) 53(10) -12(9) 23(9) -24(10) 
C(7) 67(12) 141(19) 46(10) -31(12) 27(9) -29(13) 
O(7) 370(20) 123(13) 146(15) 31(12) 167(17) -40(16) 
C(8) 80(12) 56(10) 39(8) -6(7) 9(8) -2(9) 
O(8) 107(12) 300(20) 106(12) 59(13) 54(10) 28(14) 
C(9) 64(10) 44(9) 30(7) 10(6) 8(7) -1(8) 
C(10) 65(10) 40(8) 26(7) -1(6) 1(7) 2(8) 
C(11) 75(11) 41(9) 30(8) -8(6) 17(8) -6(8) 
C(12) 45(8) 50(9) 40(8) -8(7) 2(7) -5(7) 
C(13) 68(10) 32(8) 36(8) -5(6) 15(8) -4(7) 
C(14) 72(11) 36(8) 48(9) -6(7) 21(8) -6(8) 
C(15) 61(9) 33(8) 42(8) 7(6) 19(8) 4(7) 
C(16) 62(10) 57(10) 44(8) -4(7) 9(8) -5(8) 
C(17) 53(9) 52(10) 49(9) 13(7) 15(7) 5(8) 
C(18) 67(10) 77(11) 28(8) -13(7) 6(8) -17(9) 
C(19) 90(13) 85(13) 54(10) -5(9) 9(9) -49(11) 
C(20) 96(13) 90(13) 43(9) 0(9) 25(9) -55(11) 
C(21) 93(13) 121(15) 18(7) -18(8) 17(8) -50(12) 
C(22) 90(13) 119(15) 34(8) -13(9) 19(8) -57(12) 
C(23) 73(11) 95(13) 45(9) -18(9) 25(9) -40(10) 
C(25) 43(9) 71(11) 62(10) -13(8) -4(8) 11(8) 
C(26) 63(11) 71(11) 57(10) -16(8) -6(8) -8(9) 
C(28) 112(16) 96(16) 61(12) 14(12) 56(12) -12(13) 
C(29) 270(30) 190(30) 43(11) -49(14) 66(17) -140(30) 
C(30) 170(20) 150(20) 62(13) -26(13) 36(14) -114(19) 
C(31) 63(11) 96(14) 38(9) 0(9) 0(8) -19(10) 
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C(32) 95(14) 81(13) 61(11) -15(10) 10(11) -20(12) 
C(33) 87(14) 99(15) 60(12) 19(11) 19(11) -37(12) 
C(34) 93(14) 89(14) 51(10) 7(9) 44(10) 18(11) 
C(35) 170(20) 42(10) 58(11) 29(8) 58(13) 43(12) 
C(36) 80(12) 49(10) 44(9) -4(7) 24(9) 4(9) 
C(37) 98(14) 41(9) 45(9) -18(7) -6(10) -7(9) 
C(38) 56(10) 35(9) 80(12) -11(8) -4(9) 5(8) 
O(9) 55(10) 65(11) 29(9) -25(7) 8(7) -11(8) 
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Table A.5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for Yb-PVDC-3. 
x y z U(eq)
H(3A) -2005 5092 6729 87 
H(4A) -2463 4379 7791 74 
H(6A) 1124 1459 7855 87 
H(7A) 1636 2213 6822 99 
H(8A) -204 1791 8845 74 
H(9A) -3279 2916 8595 61 
H(12A) -5583 1371 10463 55 
H(15A) -623 1842 9849 60 
H(16A) -3028 754 11747 68 
H(17A) -5704 141 11385 70 
H(19A) -7026 -1128 12145 89 
H(20A) -7406 -2199 13154 89 
H(22A) -3872 -1003 13738 92 
H(23A) -3584 131 12742 82 
H(25A) -7484 2216 9011 93 
H(25B) -7303 2573 9662 93 
H(25C) -6870 1127 9604 93 
H(26A) 1332 975 11279 96 
H(26B) 678 2088 10701 96 
H(26C) 1093 654 10624 96 
H(29A) 6939 5384 3373 181 
H(30A) 8082 5562 2419 140 
H(32A) 5958 2940 2102 95 
H(33A) 4790 2833 3063 103 
H(34A) 7242 3994 1257 105 
H(35A) 9396 5065 1505 127 
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